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ABSTRACT 
 Recent evidence indicates that U.S.-born infants are larger today 
compared to 20 years ago. A strong determinant of neonatal size is maternal 
body mass, where larger mothers deliver larger infants. Consistent evidence 
indicates that higher levels of maternal physical activity (PA) during pregnancy 
reduce the risk of delivering a larger infant. However, this protective effect has 
only been demonstrated in normal weight pregnant women. Little is known about 
the relationship between maternal PA and neonatal size in overweight or obese 
pregnant women. Moreover, no studies have examined the association between 
maternal cardiorespiratory fitness (CRF), an indicator of habitual PA, on infant 
size in this pregnant subpopulation. Thus, the overall purpose of this dissertation 
was to determine if maternal PA moderates the association between maternal 
body mass and infant size and whether maternal PA and/or CRF are associated 
with neonatal size in overweight or obese pregnant women.  
 In study one, logistic regression analyses were performed to evaluate the 
moderating roles of maternal PA in the preconception and prenatal periods on 
the association between maternal body mass index (BMI) and the risk of 
delivering a macrosomic infant. Maternal BMI and physical activity served as the 
main predictor variables. Regression models were adjusted for maternal age and 
race/ethnicity, gestational age and weight gain, smoking and alcohol use, and 
infant sex. Overweight or obese pregnant women had increased odds of
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delivering a macrosomic infant (OR = 1.69, p <0.0001; OR = 1.67, p=0.003). 
Neither maternal PA in the preconception nor prenatal periods modified the 
association between maternal BMI and the risk of delivering a macrosomic 
neonate (OR=0.98, p=0.34; OR=1.00, p=0.13, respectively), after adjusting for 
covariates. The present study does not support the hypothesis that maternal PA 
prior to or during pregnancy alters the relationship between maternal BMI and 
infant size. 
 In study two, multiple linear regression models were constructed to 
determine the independent and joint associations of maternal PA and CRF with 
infant birthweight. Maternal PA and CRF were the main predictors and 
regression models were adjusted for gestational age, maternal age and weight 
gain, and group allocation. After adjusting for covariates, multiple linear 
regression analyses showed that maternal PA (stepsday-1month-1) (β= 0.03 g, 
95% CI: -0.03, 0.08g) and CRF (ml O2·kg-1·min-1) (β= -8.83 g, 95%CI: -42.2, 24.5 g) 
were not independently nor jointly (β= 0.006 g, 95%CI:  -0.005, 0.005 g) 
associated with offspring birthweight. Contrary to hypotheses, maternal PA and 
CRF during pregnancy were not related to infant birthweight in overweight or 
obese pregnant women.  
 In study three, individual trajectories for maternal PA in the prenatal period 
were estimated via repeated measures analyses to represent the change in PA 
from mid (4th month) to late (8th month) pregnancy. Multiple linear regression 
models were then performed to determine the association between change in 
prenatal PA and birthweight. Change in maternal PA was the main predictor and 
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regression models were adjusted for gestational age, weight gain, maternal age 
and group allocation. PA declined from the 4th to the 8th month of pregnancy (-
399.73 ± 371.38 steps∙day-1∙month-1). After adjusting for covariates, multiple 
linear regression analyses showed that the decline in prenatal PA (β= -0.28 g, 
95%CI: -0.70, 0.25 g, p=0.35) was not associated with birthweight. In addition, 
CRF (β= 0.04 g, 95%CI: -0.06 g, 0.14 g, p=0.697) did not exhibit a moderating 
effect. Maternal physical activity declined in mid-to-late pregnancy, and contrary 
to hypotheses, the observed decrement was found to be unrelated to infant 
birthweight. 
 Overall, the findings from these studies demonstrate that higher levels of 
maternal physical activity prior to and during pregnancy do not modify the 
relationship between maternal body mass and neonatal size. In addition, these 
findings indicate that maternal physical activity and cardiorespiratory fitness do 
not independently or jointly associate with neonatal birthweight. These studies 
provide information about these relationships in an understudied subpopulation 
and contribute to this rapidly growing area of research.  Several 
recommendations are suggested to address the limitations of these studies 
including sampling strategies that will increase variability in PA and CRF levels, 
more rigorous and precise measures of PA and infant anthropometry and the 
inclusion of metabolic biomarker assessments.
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INTRODUCTION 
Compelling evidence indicates that higher levels of physical activity (PA) 
and cardiorespiratory fitness (CRF) are associated with numerous health 
benefits(4). These positive health outcomes are documented across various 
subpopulations(8, 21). Specifically, young adult women who participate in 
sufficient amounts of PA and develop healthy levels of CRF exhibit lower levels 
of body fat(19), and improved metabolic(10) and reproductive health(9). 
Moreover, research shows that pregnant women benefit from optimal levels of 
PA and CRF (17), with prenatal PA leading to increased perceptions of energy, 
and reduced feelings of fatigue(11), improved mood(16), and positive effects on 
gestational weight gain(13) and postpartum weight retention(14). Based on 
scientific evidence, women are encouraged to accumulate at least 150 minutes 
of moderate PA per week throughout the duration of their pregnancy(18, 20). 
While there are many well-documented maternal health benefits related to higher 
levels of PA in the prenatal period, much less is known about the effects of PA on 
the neonate. 
Infant birthweight is a strong indicator of fetal development and well-
being(24). Neonates born at either end of the birthweight distribution have 
increased risks of several morbidities and mortality(1, 2). While the birth of small 
and large neonates and their associated health outcomes are of equal public 
health importance, recent evidence indicates that over the past 20 years the
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 average birthweight of U.S.-born infants has increased(12). Consequently, these 
higher birthweights may lead to altered growth trajectories(25), and predispose 
neonates to overweight or obesity and the related adverse cardio-metabolic 
outcomes in childhood and adolescence(7). Importantly, a strong determinant of 
neonatal weight is maternal body mass index. That is, larger mothers tend to 
deliver larger infants(22). This is evidenced by the high rate of larger neonates 
among overweight or obese women(5). Considering the increasing prevalence of 
high body mass index among women of reproductive age(6), evaluating factors 
that may reduce the risk of the development of a larger neonate, especially in the 
overweight or obese population, is important to the long-term health of the infant. 
Consistent evidence demonstrates that higher levels of maternal PA in 
pregnancy protects the fetus from overgrowth, thus promoting the delivery of a 
healthy-sized neonate(23). Unfortunately, the protective effect of maternal PA is 
only demonstrated among normal weight women. As such, little is known about 
the effects of maternal PA during pregnancy in overweight or obese pregnant 
women. Moreover, in normal weight and overweight or obese pregnant women, 
the effects of CRF, an indicator of habitual PA, on neonatal weight is unclear as 
studies assessing this relationship are inconsistent(3, 15) and non-existent in 
these subpopulations, respectively. Thus, the purpose of this dissertation project 
was to evaluate how maternal PA and CRF influence maternal adiposity and 
infant size during the prenatal period. This dissertation included three separate 
studies. The first study analyzed data from the National Maternal Infant Health 
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Survey of 1988 (NMIHS). The second and third study drew data from a previous 
randomized controlled exercise intervention trial(26, 27).  
The aim of the first study was to determine if maternal PA in the 
preconception and prenatal periods modifies the association between maternal 
and infant weight status in a nationally representative sample of mothers 
delivering live-birth infants in 1988. Importantly, only one study to date has 
evaluated this relationship, however this study only considered the impact of 
maternal PA in the preconception period, failing to account for the potential 
influence of PA in the prenatal period. The aim of this study was to independently 
assess the moderating effects of maternal PA in both the preconception and 
prenatal periods on the association between maternal adiposity (i.e. body mass 
index) and infant size (i.e. birthweight, size for gestational age).  
The second study determined the independent and joint associations 
between maternal PA and CRF and infant birthweight in a sample of overweight 
or obese pregnant women. Many studies evaluated the relationship between 
maternal PA in pregnancy and infant size. However, very few studies were 
conducted among overweight or obese women. Currently, no studies examined 
the relationship between maternal CRF and infant birthweight in this group. The 
aim of this study was addressed with three objectives. The first two objectives 
separately assessed the independent associations between maternal PA and 
CRF and infant birthweight. The third objective evaluated the joint association of 
maternal PA and CRF and infant birthweight.  
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The third study determined the influence of the change in maternal PA and 
CRF in the prenatal period and infant birthweight in a sample of overweight or 
obese women. Existing prospective studies evaluating the relationship between 
maternal physical activity and infant size primarily focused on the effects of the 
average level of physical activity across pregnancy or during specific trimesters 
on birthweight. Consequently, these studies failed to account for the naturally 
occurring changes in maternal physical activity. As such, the impacts of the 
changes in maternal physical activity across the prenatal period on infant size are 
largely unknown. The aim of this study was addressed with two objectives. The 
first objective examines the association between the change in maternal PA from 
mid-to-late pregnancy on infant birthweight. The second objective evaluated the 
potential moderating effect of maternal CRF on the association between change 
in maternal PA and infant birthweight.  
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CHAPTER 1 
MODERATING EFFECTS OF MATERNAL PHYSICAL ACTIVITY PRIOR TO 
AND DURING PREGNANCY ON THE RELATIONSHIP BETWEN MATERNAL 
ADIPOSITY AND INFANT MACROSOMIA
10 
 
Abstract 
Purpose: Compelling evidence demonstrates that maternal pre-pregnancy body 
mass index is a significant determinant of infant size. Given the strong metabolic 
effects of physical activity (PA), it is unclear as to whether PA in the prenatal 
period may modify the association between maternal body mass and infant size. 
Therefore, the purpose of this study was to evaluate the modifying effect of 
maternal PA in the preconception and prenatal periods.  
Methods: Data were from National Maternal and Infant Health Survey conducted 
in 1988. Women with singleton pregnancies, delivering term (37 to 44 weeks), 
live-birth infants (n=6,390). Macrosomia was defined as a birthweight greater 
than 4,000g. Maternal PA in the preconception and prenatal periods were self-
reported by the mother. Multiple logistic regression models were performed to 
determine the moderating effects of maternal PA in the preconception and 
prenatal periods. Analyses were adjusted for maternal age, race/ethnicity, 
gestational age and weight gain, smoking and alcohol use, and infant sex. 
Results: Mothers were on average 25 years of age and nearly 25% were 
overweight or obese. In the prenatal period, these women gained approximately 
14 kg (30lbs) and delivered full-term (39.6 ± 1.6 weeks), live-birth infants 
weighing nearly 3300g (3.3kg; 7lbs 4 oz.). Maternal body mass was a significant, 
positive predictor of infant macrosomia (OR = 1.06, p <0.0001).  After adjusting 
for covariates, neither maternal PA in the preconception (OR=0.98, p=0.34) nor 
prenatal (OR=1.00, p=0.13) periods were associated with offspring birthweight. 
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Conclusions: Maternal body mass was a significant, positive predictor of infant 
macrosomia. However, higher levels of maternal PA prior to and/or during 
pregnancy were unrelated to infant macrosomia or birthweight in a nationally 
representative sample of women delivering singleton, term infants. The use of 
more precise measurements of maternal PA and neonatal size are strongly 
recommended.  
Introduction 
 The prevalence of infant macrosomia, defined as a birthweight greater 
than 4,000 g, has increased in US and other developed countries. (4, 14). 
Macrosomic infants are predisposed to altered growth trajectories and increased 
risk of obesity and the associated co-morbidities later in life(8, 24). Maternal body 
mass is a significant predictor of macrosomia (23), where larger mothers tend to 
deliver larger infants. The relationship between maternal body mass and infant 
macrosomia is thought to be a function of the mother’s overall metabolic health, 
which is a strong determinant of the amount of energy reaching the fetus. Thus, 
because mothers with greater body mass often have poorer metabolic 
health(11), their fetuses are often exposed to excess energy resulting in the 
development of a larger infant (9, 16).  
 Considerable scientific evidence demonstrates that participation in 
sufficient levels of physical activity (PA) exerts strong effects on metabolic health. 
Given that maternal metabolic health underlies the relationship between maternal 
body mass and infant birthweight, higher levels of maternal PA prior to and/or 
during pregnancy may be necessary to prevent the development of an overgrown 
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infant, especially in larger mothers. This hypothesis is supported by the rigorous 
evidence demonstrating the effects of PA on several non-communicable 
diseases (NCDs) including non-alcoholic fatty liver and cardiovascular diseases, 
in non-pregnant populations(6, 15). Individuals participating in higher levels of PA 
exhibited reduced risks of several NCDs and specifically, metabolic diseases 
such as type II diabetes mellitus, regardless of weight status(7). As such, it is 
reasonable to suggest that the beneficial effects of PA on metabolic health found 
in non-pregnant populations, may exist in the preconception and/or prenatal 
periods. If so, mothers engaging in higher levels of PA prior to and/or during 
pregnancy may have improved metabolic health, controlling energy supply to 
their fetuses, and subsequently less likely to deliver a macrosomic infant, 
regardless of their body mass.  
 Evidence regarding maternal PA as a potential modifier of the relationship 
between maternal body mass and infant macrosomia is limited (13). To our 
knowledge only one study has evaluated this relationship and found that, for 
overweight or obese pregnant women, physical inactivity before pregnancy 
increased the risk of delivering a macrosomic infant compared to active women. 
A limitation of that study was that the authors did not evaluate PA in the prenatal 
period. It is possible that higher levels of maternal PA in the preconception and-
or prenatal periods may affect infant macrosomia. As such, determining the 
influence of maternal PA prior to and during pregnancy on infant macrosomia is 
important, and these findings may better inform PA guidelines for pregnant and 
future pregnant women. To our knowledge, no studies have evaluated the 
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potential moderating effects of maternal PA in the preconception and prenatal 
periods on infant size. Therefore, the purpose of this study is to determine if 
maternal PA in both the preconception and prenatal periods moderate the 
association between maternal body mass index and the risk of delivering a 
macrosomic infant. 
Methods 
Study Design & Sampling 
Data for the present study were from The National Maternal Infant Health 
Survey (NMIHS). The NMIHS was conducted by the National Center for Health 
Statistics in 1988 in order to identify factors that may be related to poor 
pregnancy outcomes(18). The NMIHS employed a follow-back survey design and 
sampled U.S. women who had a live birth, fetal death or infant death in 1988.  To 
make inferences on a nationally representative sample, the NMIHS used a 
complex survey design that drew stratified samples of live-births, fetal and infant 
deaths identified via registered birth and death certificates. Black, very low 
(<1500g)- and moderately low- birthweight (2500-2499g) infants were 
oversampled. For the purposes of this study, only singleton, live-birth infants and 
their mothers were included in the analyses.  
Study Population & Data Collection 
A total of 13,417 live-birth infants were sampled. To identify factors related 
to poor pregnancy outcomes, mothers of these infants were mailed a 35-page 
questionnaire that inquired about several maternal, paternal and infant 
characteristics during the preconception, prenatal and postnatal periods. The 
14 
 
average recall period, defined as the time between delivery of the infant and the 
receipt of the questionnaire, was 17 months. Of the 13, 417 mothers, 74.2% 
(n=9954) responded to the questionnaire. Some differences in the characteristics 
of mothers whom responded and did not respond to the questionnaire were 
observed. Mothers between the ages of 20 to 39 years, who were White, 
married, had fewer than four children, received early prenatal care, achieved 
more education, and resided in the Midwest region of the U.S. were more likely 
to respond to the questionnaire. Mothers of low-birthweight (<2500g) infants were 
less likely to respond to the questionnaire.  
Outcome Variable: Infant Macrosomia 
Infant macrosomia was the primary outcome variable in this study. 
Macrosomia was defined as a birthweight greater than 4,000g. Birthweight was 
defined as the weight of the infant, in grams, at the time of delivery. Birthweight 
and gestational age data were extracted from birth certificates. Birthweights less 
than 300 grams or greater than 9000 grams were considered implausible(19) and 
excluded from the analyses. 
Exposure Variables 
Maternal Body Mass Index 
 Maternal pre-pregnancy body mass index (BMI) was calculated using the 
standard equation:  = ℎ
  ÷ ℎℎ
 . Maternal pre-pregnancy 
height and weight were self-reported by the mother. In all analyses, maternal BMI 
was treated as a continuous variable. 
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Maternal Physical Activity 
 Maternal PA in the preconception and prenatal periods were examined as 
potential moderating variables in this study. Pre-pregnancy PA was measured 
using the following question: “Did you exercise or play sports at least three times 
a week before you got pregnant...include brisk walking for ½ hour or more, 
jogging, aerobic swimming etc.?” The response was recorded as “yes” or “no.”  
Prenatal PA was assessed using two separate questions. First, mothers were 
asked the following question: “Did you exercise or play sports at least three times 
a week after you got pregnant…include brisk walking for ½ hour or more, 
jogging, aerobic swimming etc.?” the response was recorded as “yes” or “no.” 
Mothers answering ‘yes’ to this question answered the second PA question: 
“How many months of this pregnancy did you engage in exercise or play sports 
at least three times a week?”  In this study, for mothers answering ‘no’ to 
participation in PA in the prenatal period, a value of 0 was entered for the second 
prenatal PA question.  
Covariate Variables: Maternal and Infant 
 Several maternal and infant characteristics were considered as potential 
covariates. Data were extracted from the mothers’ questionnaire and infant birth 
certificate. Maternal demographic characteristics that were considered potential 
covariates were: age (in years), and race/ethnicity (Non-Hispanic White, Non-
Hispanic Black, Hispanic and Other). Maternal pregnancy-related factors 
included as possible covariates were: gestational weight gain (GWG) and parity. 
GWG was calculated as the difference in weight (in pounds) at the time of 
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delivery and prior to pregnancy. Maternal behaviors that were considered 
potential covariates included: smoking status and alcohol use. For these 
behaviors, the mothers self-reported the use of cigarettes or consumption of 
alcohol in the last 12 months prior to delivery. Infant characteristics that acted as 
possible covariates included: sex (male or female) and gestational age (weeks). 
For live-birth infants, gestational ages less than 22 weeks or greater than 44 
weeks were considered implausible(19). 
Analytic Sample 
Of the 9,953 mothers, 9,146 women had singleton pregnancies. Of these 
women, 2,052 women delivered pre-term infants (22 to 36 weeks), and 6,390 
women delivered a live-birth infant between 37 and 44 weeks gestation (i.e. full-
term). In addition, of the women with singleton pregnancies (n=9,146), 264 
women had implausible values for either gestational age (n=248) or infant 
birthweight (n=16), 455 women had missing data for either gestational age 
(n=448) or birthweight (n=7). The final sample size for this study was 6,390 
women. Differences in several maternal and infant demographics and behavioral 
characteristics between the analytic and excluded samples are presented in 
Table 1. 
Statistical Analyses 
To determine if maternal pre-pregnancy and-or prenatal PA moderate the 
association between maternal BMI and infant macrosomia, we performed 
multiple logistic regression analyses. First, we examined the unadjusted main 
effects of maternal BMI on infant macrosomia. Second, we separately assessed 
17 
 
the unadjusted main effects of pre-pregnancy PA and prenatal PA in conjunction 
with maternal BMI on infant macrosomia. Third, to determine the unadjusted 
moderating effects of pre-pregnancy PA and prenatal PA, we entered an 
interaction term between pre-pregnancy PA and maternal BMI and an interaction 
between prenatal PA and maternal BMI, in separate models. Lastly, we entered 
the maternal and infant covariates sequentially.  
Because the NMIHS employed a complex survey design to make 
inferences on a nationally representative sample, weights were generated to 
account for non-response and study design and were included in all statistical 
analyses. All statistical analyses were performed in SAS statistical software 
version 9.4 (Cary, North Carolina). For the multiple logistic regression, with infant 
macrosomia as the outcome variable, odds ratios were estimated. For the 
multiple linear regression analyses, with infant birthweight (in grams) as the 
outcome variable mean regression coefficients were estimated. An alpha level of 
0.05 was used to denote statistical significance for all analyses. 
Results 
The sample characteristics for the women included and excluded in the 
present analyses are documented in Table 1.1. Because the analysis was 
restricted to singleton, full-term pregnancies, differences in gestational age, 
maternal weight gain, maternal body mass index, and infant size were expected. 
No other meaningful significant differences were found.  
For the analytic sample, mothers were, on average, 25 years of age and 
nearly 25% were overweight or obese. In the prenatal period, these women 
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gained approximately 14 kg (30lbs) and delivered full-term (39.6 ± 1.6 weeks), 
live-birth infants weighing nearly 3300g (3.3kg; 7lbs 4 oz.). The prevalence of 
infant macrosomia (9.3%) was slightly above the current U.S. prevalence 
estimate (8%) (14). Roughly 30% and 40% of mothers reported smoking and/or 
alcohol use in the 12 months prior to the birth of their child, respectively. In the 
preconception period, nearly 50% of mothers reported being active at least three 
times per week for at least 30 minutes. Forty-two percent of mothers reported 
being active at least three times per week for at least 30 minutes in the prenatal 
period. These mothers maintained this dose of PA for nearly three months (2.8 ± 
3.8 months) of their pregnancy.  
Preliminary analyses showed that maternal BMI was a significant positive 
predictor of infant size. Specifically, overweight or obese mothers had increased 
odds of delivering a macrosomic infant compared to normal weight mothers (OR 
= 1.69, p <0.0001; OR = 1.67, p=0.0032, respectively). For the unadjusted 
moderating effect of maternal PA in the preconception period, our analyses 
revealed that participation in PA prior to pregnancy did not exhibit a moderating 
effect on the association between maternal BMI and the odds of delivering a 
macrosomic infant (OR = 0.97, p=0.16). Similarly, after adjusting for prenatal PA, 
gestational age and weight gain, maternal age and race/ethnicity, smoking and 
alcohol use, and infant sex, the moderating effect of maternal PA in the 
preconception period remained non-significant (OR=0.98, p=0.34) [see Table 
1.2]. 
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The unadjusted analysis for the moderating effect of maternal PA in the 
prenatal period showed that participation in PA during pregnancy significantly 
modified the association between maternal BMI and the odds of delivering a 
macrosomic infant (OR = 0.995, p=0.04). However, after controlling for 
preconception PA, gestational age and weight gain, maternal age and 
race/ethnicity, smoking and alcohol use, and infant sex, the moderating effect of 
PA in the prenatal period was no longer statistically significant (OR=1.00, p=0.13) 
[see Table 1.3].  
Additional analyses were performed, using multiple linear regression, to 
evaluate the moderating effect of maternal PA prior to and during pregnancy on 
maternal BMI and infant birthweight. Similar to the logistic regression analyses, 
maternal BMI was a significant, positive predictor of infant birthweight (β = 14.55 
± 1.70 g, p<0.0001). Moreover, maternal engagement in PA prior to pregnancy 
did not modify the relationship between maternal BMI and neonatal birthweight in 
the unadjusted or adjusted regression models (β = -2.42 ± 3.38 g, p=0.47; β= - 
1.12 ± 3.26, p=0.73, respectively). Correspondingly, maternal PA during 
pregnancy did not significantly modify the association between maternal BMI and 
infant birthweight in the unadjusted or adjusted regression models (β= -0.82 ± 
0.46 g, p=0.08; β= -0.51 ± 0.45 g, p=0.26, respectively). 
Discussion 
 The purpose of this study was to evaluate the moderating effect of 
maternal physical activity in both the preconception and prenatal periods on the 
relationship between maternal body mass and infant macrosomia. Consistent 
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with previous literature, our study found that maternal body mass was positively 
associated with the delivery of a macrosomic infant. However, there was no 
modifying effect of maternal PA in the preconception period on the association 
between maternal body mass and infant macrosomia. Similarly, in the prenatal 
period, maternal PA was not found to exert a modifying effect on this relationship. 
This present study was unique in that it was the first to evaluate the potential 
modifying effects of maternal PA both prior to and during pregnancy. Only one 
other study, to our knowledge, has evaluated this relationship, however that 
examination was restricted to the preconception period(13). Thus, this present 
study provides important information about the relationships between maternal 
PA and body mass and neonatal size. 
 Our observation that maternal PA in the preconception period does not 
modify the association between maternal body mass and infant macrosomia 
conflicts with the current literature. Only one other study has evaluated this 
relationship and these authors found that in overweight or obese women, low 
levels of maternal PA prior to pregnancy increased the risk of delivering a 
macrosomic neonate(13). The inconsistent findings between these studies may 
be consequent to non-differential misclassification as result of the measurement 
tool used to assess maternal PA. Both studies used a self-reported method to 
evaluate maternal prior to pregnancy, however, questions inquiring used varied 
greatly. In the Krogsgaard et al. (2013) study, women were asked to report the 
frequency, intensity and duration of the physical activities in which they 
participated in the preconception period. In the present study, women were 
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asked about their participation in a specific dose of PA (i.e. three times/week for 
30 minutes). The specificity of the PA dose in this question may have led women 
to be inappropriately categorized as ‘active’ or ‘inactive.’ For example, if a woman 
participated in PA twice per week for 60 minutes, an equivalent dose of PA, she 
would have been classified as ‘inactive’ given she did not meet the three-day per 
week requirement. Consequently, this misclassification may have diluted the 
potential modifying effect of maternal PA, explaining our null observation(22). 
Thus, more open-ended questions or objective measurements of PA may provide 
information that more accurately reflects maternal PA behavior prior to 
pregnancy. 
 In the present study, maternal PA in the prenatal period exhibited no 
moderating effect on the relationship between maternal body mass and neonatal 
size. A possible explanation for this null observation is that the dose of PA these 
women engaged in was insufficient to impact maternal metabolic health and 
subsequently infant birthweight. In this study, women were considered ‘active’ if 
they participated in PA three times per week for at least 30 minutes. This amount 
of PA is less than the dose recommended by the United States Department of 
Health and Human Services and endorsed by the American Congress of 
Obstetricians and Gynecologists(20, 21). These entities encourage pregnant 
women to engage in at least 150 minutes of activity per week. In addition, it is 
likely that these women participated in less PA throughout the prenatal period as 
it is well-documented that maternal PA declines in pregnancy(10, 17). In support 
of this idea, women responding ‘yes’ to being physically active in pregnancy were 
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subsequently asked to report the number of months they maintained this 
behavior. On average, these women participated in this dose of PA for only three 
months of their pregnancy. This suggests that their PA declined, mostly likely in 
the final two trimesters, however we are unable to quantify the extent to which it 
decreased. Consequently, the lower dose and potential decline of maternal PA 
likely resulted in these women participating in levels of PA that were insufficient 
to impact maternal metabolic health, fetal nutrient supply and subsequently fetal 
growth and neonatal size. Currently, in the existing literature a dose of PA that is 
sufficient to regulate fetal nutrient supply and ultimately reduce the risk of infant 
macrosomia, has yet to be identified.  
 Another potential explanation for the null observation of maternal PA in the 
prenatal period as a modifier is non-differential misclassification of maternal PA 
behavior. The question evaluating maternal PA in the prenatal period was similar 
to the question assessing PA in the preconception period, as such, it suffers from 
the same limitations. The specificity of the dose of PA may have resulted in 
women being inappropriately classified as ‘active’ or ‘inactive.’ In addition to this, 
the extensive recall period may have also contributed to the misclassification. 
The average recall period, defined as the amount of time that lapsed between the 
delivery of the neonate and the receipt of the maternal questionnaire, was 17 
months. As such, the ability of the mother to accurately recall her PA behavior 
during her pregnancy (or before pregnancy) may have been significantly 
diminished. Evidence demonstrates that there is an inverse relationship between 
length of the recall period and the ability of an individual to accurately recall their 
23 
 
behavior(2). Due to these considerable limitations of the measurement tool used 
to assess maternal PA, it is possible that our null observation is attributed to non-
differential misclassification. As a result, the potential modifying effect of maternal 
PA in the prenatal period on the relationship between maternal body mass and 
infant size was possibly diluted(22).  
 This study has strengths and limitations. Foremost, this was the first study 
to evaluate maternal PA in the preconception and prenatal periods as a modifier 
of the relationship between maternal body mass and neonatal size. Second, this 
study was conducted using a large, diverse, nationally representative sample of 
women delivering singleton, full-term, live-birth infants in the United States. As 
such, our findings can be generalized to a large sample of women. However, the 
present study also has limitations. First, maternal PA and body mass were 
measured via self-reporting methods. This type of assessment is notorious for 
producing less accurate estimates of behavior compared to more objective 
assessments(1, 5). Consequently, the use of these imprecise and error-prone 
tools may have led to biased, misestimated associations(3). Second, we did not 
consider other potential health behaviors that have been documented to 
influence infant size, including maternal diet (26). Third, although infant 
birthweight is the most widely used metric for infant size, it has limitations. This 
metric is unable to capture vital details about infant size including tissue 
composition (i.e. fat and fat-free mass) that are key to future health risks of these 
neonates(8). Lastly, macrosomia is poorly defined in the current literature. The 
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birthweight thresholds that define macrosomia vary greatly (i.e. > 4000, > 45000, 
> 5000g) (12, 25). As such, it is possible that we misclassified classified infants.  
 In conclusion, the present study observed that maternal PA in the 
preconception and prenatal periods did not exhibit a modifying effect on the 
relationship between maternal body mass and infant size. This was the first study 
to evaluate this relationship and thus, provides important information about these 
relationships and contributes to the rapidly growing field of maternal-child health. 
Future studies should address the limitations of the present study. First, more 
precise assessments of maternal PA behavior and maternal and infant 
anthropometrics are necessary. Second, future researchers should include the 
assessment of metabolic biomarkers, such as serum glucose and lipids. These 
factors are posited to be the mechanisms that underlie these relationships, 
however are often ignored in studies. In conclusion, the findings of this study 
provide no evidence that higher levels of maternal PA in the preconception or 
prenatal periods modify the association between maternal body mass and 
neonatal size. 
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Table 1.1 Maternal and infant sample characteristics 
 Note: *p<0.05; **p<0.01 ***p<0.0001.  The analytic sample was defined as 
women delivering full-term (37 to 44 weeks), live-birth infants in 1988.  The 
excluded sample was defined as women delivering non-full-term infants (<37 
weeks), or those with implausible gestational ages for live-births (<22 or >44 
weeks). †’No’ is the referent group. These values correspond to the raw data 
from the women sampled in the NMIHS survey, sample weights were not applied 
to account for the complex survey design.  
Sample Characteristics Analytic  
Group  
 Excluded  
Group  
 N Mean SD  N Mean SD 
Maternal a         
Age (y)** 6393 25.8 5.7  3388 25.4 6.0 
Race/Ethnicity (%)*** 6393    3388   
NH White  2745 42.9 -----  1151 34.0 ----- 
NH Black 2868 44.9 -----  1842 54.4 ----- 
Hispanic 566 8.9 -----  307 9.1 ----- 
Other. 214 3.4 -----  88 2.6 ----- 
Body Mass Index (kg/m2)*** 6393 23.1 4.6  3388 23.0 4.9 
Underweight (%) 623 9.8 -----  435 12.8  
Normal Weight (%) 4181 65.4 -----  2110 62.3  
Overweight (%) 489 17.2 -----  546 16.1  
Obese (%) 1100 7.7 -----  297 8.8  
Prenatal Behaviors        
Smoking†*** 6393 28.4 -----  3388 33.2 ----- 
Drinking†  6393 38.7 -----  3388 37.8 ----- 
Preconception PA†**  6393 48.5 -----  3388 45.6 ----- 
Prenatal PA†** 6393 42.4 -----  3380 36.9 ----- 
Prenatal PA*** (# of months) 6393 2.8 3.6  3388 2.1 3.0 
Infant***        
Gestational age 6393 39.6 1.6  2877 31.8 5.1 
Gestational weight gain 6393 13.9 8.1  3388 11.1 9.3 
Birthweight (g) 6390 3293.5 595.6  3384 1974.2 999.6 
Macrosomia (%) 6393 9.31 -----  3388 1.6 ----- 
Sex (%)        
Male 6393 51.0 -----  3388 50.2 ----- 
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Table 1.2. Adjusted multiple logistic regression coefficientsa for the moderating 
effect of maternal physical activity in the preconception period on the 
relationship between maternal body mass index and the odds of delivering a 
macrosomic infant (>4,000g). 
a Referent group for the outcome variable = average-for-gestational age (AGA). 
Only regression coefficients for large-for-gestational age are displayed. OR = 
odds ratio. †BMI is calculated from pre-pregnancy weight and height self-
reported by the mother. § ‘No’ is the referent group. * ‘No’ is the referent group. 
** ‘Female’ is the referent group. ***NH = Non-Hispanic, NH White is the referent 
group. Sample weights were applied to account for non-response and study 
design.  
 Parameter Estimates 
Predictors β SE OR p-value 
     
Primary Exposures     
BMI (kg/m2)† 0.09 0.01 1.09 <0.0001 
Preconception PA§ 0.39 0.50 1.48 0.44 
BMI * Preconception PA§ -0.02 0.02 0.980 0.34 
     
Covariates     
Prenatal PA (no. of 
months) 
-0.001 0.02 0.98 0.95 
Gestational Age (weeks) 0.21 0.03 1.24 <0.0001 
Gestational weight gain 0.05 0.01 1.06 <0.0001 
Smoking* -0.76 0.13 0.47 <0.0001 
Drinking* 0.07 0.11 1.08 0.5101 
Infant Sex** 0.58 0.11 1.78 <0.0001 
Maternal Age 0.03 0.01 1.03 0.0013 
Maternal Race/Ethnicity***     
NH Black -0.88 0.11 0.41 <0.0001 
Other -1.30 0.39 0.27 0.0009 
Hispanic -0.27 0.18 0.77 0.13 
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Table 1.3. Adjusted multiple logistic regression coefficientsa for the moderating 
effect of maternal physical activity in the prenatal period (no. of months) on the 
relationship between maternal body mass index and the odds of delivering a 
macrosomic infant (>4,000g). 
a Referent group for the outcome variable = average-for-gestational age (AGA). 
Only regression coefficients for large-for-gestational age are displayed. OR = 
odds ratio.  †BMI is calculated from pre-pregnancy weight and height self-
reported by the mother. § ‘No’ is the referent group. * ‘No’ is the referent group. 
** ‘Female’ is the referent group. ***NH = Non-Hispanic, NH White is the referent 
group. Sample weights were applied to account for non-response and study 
design.
 Parameter Estimates 
Predictors β SE OR p-value 
     
Primary Exposures     
BMI (kg/m2)† 0.09 0.01 1.10 <0.0001 
Prenatal PA 0.10 0.07 1.11 0.13 
BMI * Prenatal PA -0.004 0.003 1.00 0.13 
     
Covariates     
Preconception PA§ -0.08 0.13 0.93 0.55 
Gestational Age 
(weeks) 
0.21 0.03 1.24 <0.0001 
Gestational weight gain 0.05 0.01 1.06 <0.0001 
Smoking* -0.76 0.13 0.47 <0.0001 
Drinking* 0.07 0.11 1.07 0.52 
Infant Sex** 0.58 0.11 1.78 <0.0001 
Maternal Age 0.03 0.01 1.03 0.0010 
Maternal 
Race/Ethnicity*** 
    
NH Black -0.89 0.11 0.41 <0.0001 
Other -1.30 0.39 0.27 0.0010 
Hispanic -0.27 0.18 0.77 0.13 
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CHAPTER 2 
ASSOCIATIONS BETWEEN MATERNAL PHYSICAL ACTIVITY AND 
CARDIORESPIRATORY FITNESS DURING PREGNANCY AND INFANT 
BIRTHWEIGHT
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Abstract 
Purpose: Significant evidence demonstrates that physical activity (PA) during 
pregnancy reduces the risk of delivering heavier infants. However, this 
relationship is restricted to normal-weight pregnant women. In addition, the 
evidence on the impact of maternal cardiorespiratory fitness (CRF), an objective 
indicator of habitual PA, on offspring birthweight is equivocal. Therefore, the 
purpose of this study was to evaluate the relationship between maternal PA and 
CRF during pregnancy and offspring birthweight in a sample of overweight or 
obese pregnant women.  
Methods: This study employed a prospective design using data from a 
randomized controlled exercise intervention trial in sedentary, overweight or 
obese pregnant women with a history of preeclampsia. Women with complete 
data (n=89) on infant birthweight, peak oxygen consumption (at 17 weeks), and 
daily PA measured via a pedometer (17 weeks to delivery) were eligible for 
analyses. Multiple linear regression models were performed to determine the 
independent and joint associations of PA and CRF with offspring birthweight. 
Gestational age, weight gain, and group allocation were considered as 
covariates.  
Results: On average, participants were 32 years old, overweight/obese (BMI 
29.97 ± 7.14 kg/m2), unfit (VO2peak: 19.85 ± 3.35 ml O2·kg-1·min-1), and led low active 
lifestyles (6,579.91 ± 2379.17 steps/day). After adjusting for covariates, multiple 
linear regression analyses showed that maternal PA (stepsday-1month-1) (β= 
0.03 g, 95% CI: -0.03, 0.08g) and CRF (ml O2·kg-1·min-1) (β= -8.8 g, 95%CI: -42.2, 
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24.5 g) were not independently nor jointly (β= 0.006g, 95%CI:  -0.005, 0.02 g) 
associated with offspring birthweight. 
Conclusions: Maternal PA and CRF during pregnancy were not related to infant 
birthweight in overweight or obese pregnant women with a history of 
preeclampsia. Our findings conflict with the inverse relationships found among 
normal weight women. The limited variability in maternal PA and CRF in 
pregnancy, likely consequent to the low active lifestyle led by these women, may 
explain the null findings of this study. Further research is recommended given the 
paucity of studies examining these relationships in overweight or obese pregnant 
women. 
Introduction 
The average birthweight of US-born infants has increased in the U.S, over 
the past 20 years(9). Higher birthweight is associated with altered growth 
trajectories that predispose neonates to obesity and the associated cardio-
metabolic morbidities throughout their lives (3). Intrauterine energy supply is 
considered the strongest predictor of fetal growth, and in excess, leads to higher 
infant birthweights (10). Maternal metabolic health, defined as control of 
circulating levels of blood sugars and lipids, is a major determinant of the energy 
supplied to the fetus. Any loss in metabolic control results in the delivery of 
increased energy supply and fetal overgrowth (5). Importantly, it is also well 
established that maternal body mass is strongly and positively related to offspring 
birth weight and adiposity (15). Specifically, overweight or obese mothers are 
more likely to deliver larger infants. This relationship is posited to be a function of 
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reduced maternal metabolic health leading to augmented fetal energy supply and 
subsequent higher birthweight infants. Nearly 50% of women of reproductive age 
are overweight or obese (4); as such, the exploration of modifiable factors 
enabling these women to control the amount of nutrients supplied to the fetus is 
critical to the health of her offspring. 
Among non-pregnant populations, considerable scientific evidence 
demonstrates that physical activity (PA) and cardiorespiratory fitness (CRF) 
exhibit protective effects on several cardio-metabolic health outcomes (1). This is 
consequent to the improvements in metabolic health (e.g., insulin sensitivity) via 
adaptations to habitual PA (14). Notably, these strong effects persist in the 
presence of excess adiposity. This suggests that the increased prevalence of 
adverse cardio-metabolic health outcomes among overweight or obese persons 
(8) may not be a result of their excess adiposity per se, but rather their lower 
levels of CRF and PA.  It is reasonable to suggest that this same phenomenon 
operates in pregnancy, whereby the lower levels of maternal PA and CRF in 
pregnancy, especially among the overweight or obese women, reduce metabolic 
health, augment energy supply, and result in a larger neonate. Collectively, this 
suggests that adequate levels of maternal PA and CRF may have the potential to 
‘normalize’ the amount nutrients available to the fetus thereby promoting optimal 
fetal growth. 
Many studies have assessed maternal PA and CRF in the prenatal period 
on various maternal-infant health outcomes. Several studies assessed the effects 
of PA on fetal growth, with a recent review of exercise intervention trials 
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concluding a significant protective effect of PA on birthweight (16). Yet, this 
finding was restricted to normal-weight pregnant women, with null effects found 
among their overweight or obese counterparts. The latter finding may be largely 
due to a small number of rigorous intervention studies implemented among this 
subpopulation. Conversely, fewer studies have assessed the effects of maternal 
CRF on offspring growth during infancy. The focus of the existing studies was on 
changes in maternal CRF with advancing gestation (2) and in response to 
exercise training (11). As such, the scientific evidence regarding the impact of 
CRF on birthweight is rather limited and equivocal; previous studies yielded 
reports of positive, negative or null findings (7, 12, 17). Importantly, no studies 
examining this relationship were conducted among obese pregnant women. 
Taken together, the impact of CRF and PA on birthweight in overweight and 
obese pregnant women is extremely limited, warranting further exploration.  
Thus, the overall purpose of this study was to investigate the relationships 
between maternal physical activity and cardiorespiratory fitness in the prenatal 
period and infant birthweight. We addressed the purpose of this study by 
evaluating the independent and joint associations of physical activity and 
cardiorespiratory fitness on birthweight. We conducted a secondary data analysis 
using data from a randomized exercise intervention trial implemented in a sample 
of overweight or obese pregnant women. 
  
37 
 
Methods 
Study Design  
The present study employed a prospective design using data drawn from 
a randomized exercise comparative trial conducted between November 2001 and 
July 2006. Briefly, the primary purpose of the trial was to examine the effects of 
moderate intensity exercise during pregnancy on the incidence of preeclampsia 
and the pathophysiological progress of preeclampsia (e.g. oxidative stress). 
Secondary outcomes included maternal weight gain and birth outcomes(18). 
Participant Eligibility & Recruitment 
Pregnant women were recruited from nine prenatal clinics under two 
medical care systems in Michigan. Women were eligible to participate in the 
exercise trial if they were: 1) less than 14 weeks gestation, 2) diagnosed with 
preeclampsia in a previous pregnancy, 3) had a peak oxygen consumption ≤ 50th 
percentile of women in their respective age-group, and 4) participated in a 
sedentary lifestyle or had a self-reported PA energy expenditure of < 840 kcals 
per day. Exclusion criteria for the exercise trial were: 1) a diagnosis of chronic 
hypertension or pre-gestational diabetes, 2) presence medical or physical 
limitations preventing the participation in exercise, 3) physician instructions 
prohibiting the engagement of prenatal exercise or 4) low mental acuity or 
language barrier preventing effective communication with research staff.  
Randomization and Intervention Groups 
Two hundred and ten women agreed to participate in the study and 41% 
(n=86) of these women did not meet the eligibility criteria. The remaining 124 
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eligible participants were randomly allocated to the intervention group (n= 64) or 
comparative group (n=60). The intervention group consisted of a walking 
exercise program. Participants in this group were instructed to walk for 40 
minutes, five times per week at a moderate intensity (55-69% maximum heart 
rate). In the comparative group, participants engaged in a stretching program of 
equivalent frequency and duration as compared to the exercising group, however 
the women were instructed not to exceed a 10% increase in resting heart rate. 
Women also performed stretching movements via videotape. All participants 
wore Polar S810 heart rate monitors and wristwatch devices to validate their 
adherence to the exercise or stretching programs. Further details on the 
intervention and comparative groups can be found elsewhere (19). For the 
purposes of this study, the data were collapsed across both groups and group 
allocation was controlled for in the analyses. 
Outcome Variable: Infant Birthweight 
Infant weight was the dependent variable in this study and was expressed 
as birthweight in grams. Infant birthweight was defined as the weight of the 
neonate at the time of delivery. Data on birthweight were extracted from the 
mother’s medical records.  
 Exposure Variables: Physical Activity and Cardiorespiratory Fitness  
Daily PA was measured using a pedometer (Digiwalker SW200) attached 
to an elastic belt and worn on the participants’ waist. The participants were 
instructed to wear the pedometer during waking hours and to remove them 
during sleep and any water-based activities (e.g., showering). Additionally, the 
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participants were asked to keep a log of their total daily step counts. The 
pedometers were distributed to the participants at 18 weeks of gestation and 
were retrieved at the end of pregnancy (prior to delivery). For the purposes of this 
study, total daily steps counts were averaged across all the available days for 
each participant to provide an estimate of the average daily PA (steps per day) 
during pregnancy.  
Cardiorespiratory fitness was defined as peak oxygen consumption 
(V̇O2peak) and estimated via a submaximal treadmill test at 17 and 28 weeks of 
gestation. The exercise testing followed the Cornell Exercise Protocol. This 
protocol consisted of walking on a treadmill for eight, two-minute stages with 
progressive increments in speed and grade. Prior to the initiation and throughout 
the exercise test, heart rate, blood pressure, fatigue, oxygen consumption, 
carbon dioxide production and minute ventilation were continuously monitored. 
The metabolic and respiratory markers were assessed using a portable indirect 
calorimeter (VO2000, Medical Graphics Corporation, Minneapolis, MN), that was 
previously validated in a sample of sedentary pregnant women (20) . Heart rate, 
blood pressure and fatigue were assessed throughout the exercise-testing 
period.  V̇O2peak was determined by the highest amount of oxygen consumed 
during the exercise test. V̇O2peak was expressed relative to participants’ body 
weight as milliliters of oxygen per kilogram per minute (mL O2∙kg-1∙min-1).  
Despite the evidence in the literature that CRF remains constant across 
pregnancy when expressed relative to weight gain, in this sample of pregnant 
women there appeared to be considerable variability in the change in CRF from 
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17 to 28 weeks of gestation. As such, for the purposes of this study, CRF at 
weeks 17 gestation were used to provide an estimate of the average level of 
CRF in early pregnancy.  
Covariate Variables: Maternal and Infant Characteristics 
Maternal and infant characteristics considered potential covariates 
included: maternal age, gestational weight gain (GWG), gestational age and 
group allocation. Maternal age and gestational age were extracted from the 
participants’ medical records. Gestational weight gain was calculated using the 
participants’ objectively-measured weight at weeks 17 and 28 weeks of gestation 
(Weight28 weeks – Weight17 weeks). This non-traditional expression of gestational 
weight gain was used as nearly 40% of the data necessary to provide the 
standard expression of gestational weight gain (weight at delivery - pre-
pregnancy weight) was missing. Given the difficulty of women to accurately 
report their pre-pregnancy weight (13) and the assumption that minimal weight is 
gained in the first trimester (6), we created an additional GWG variable using the 
objectively-measured weight at 17 weeks and weight at delivery (Weightdelivery – 
Weight17 weeks). For the significant missing data for ‘weight at delivery’ we 
performed multiple imputation. We then compared the results between both 
expressions of GWG (data not shown), for all analyses performed we found each 
expression exerted a similar impact on the regression coefficients and standard 
errors. As such, we elected to use the objectively-measured weight gained during 
17 and 28 weeks gestation. Group allocation was also considered a potential 
covariate given the exposure of this intervention trial was exercise which may 
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influence some of the independent variables and the outcome variable of 
interest.  
Statistical Analysis 
The demographic, pregnancy-related and behavioral characteristics of this 
sample were determined using Student’s t-tests and Pearson’s Chi-Square test. 
For our analytical approach, we carried out three separate analyses using 
multiple linear regression. In this study, we attempted to determine the following: 
1) the independent association of PA and infant birthweight, 2) the independent 
association of CRF and infant birthweight and 3) the joint associations of PA and 
CRF on infant birthweight.  
For each analysis, the outcome variable was birthweight, expressed in 
grams. The steps to building each of these regression models were identical. We 
first assessed the assumptions of linear regression and all were reasonably 
satisfied. Bivariate associations between all the independent (primary and 
covariates) and dependent variable were performed. To assess the independent 
associations of PA and CRF on infant birthweight, the main effects were first 
added to the model. Next, covariates were sequentially added. To examine the 
joint association of PA and CRF, we used an interaction term between PA and 
CRF. We first evaluated the joint association in an unadjusted model. Following 
this, covariates were sequentially added to the model. The following variables 
were expressed continuously: CRF (ml O2 ∙kg-1∙min-1), PA (steps per day), 
gestational weight gain (kg), age (y), and gestational age (weeks). Group 
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allocation was treated as a categorical variable. All analyses were conducted in 
SAS 9.4 (Cary, North Carolina) and the significance level was set at 0.05. 
Missing Data 
For the purposes of this study, only women with complete data on infant 
birthweight were included in the analyses. As a result, only 89 of the 124 women 
participating in the study were eligible for the final analyses. To determine the 
potential effects of selection bias, we tested the differences of select maternal 
characteristics (age, gestational age, BMI, and gestational weight gain) between 
women with complete and missing infant birthweight data. We found there to be 
no significant differences, thereby providing some evidence that excluding 
women without complete data on birthweight may not result in biased results. 
Thus, the final sample size for the analyses of this study was 89 pregnant 
women.  
Results 
The sample characteristics, inclusive of maternal, pregnancy and 
behavior-related factors are provided in Table 2.1. At 17 weeks of gestation, the 
average pregnant woman was 32 years old with a BMI classified as 
overweight/obese (BMI: 29.97 ± 7.14 kg/m2). In addition, these women, on 
average, delivered full-term, normal weight infants (gestational age: 38.64 ± 1.88 
weeks; birthweight: 3477.48 ± 577.48g) and gained approximately 6.5 kilograms 
in mid-pregnancy (17 to 28 weeks). The prevalence of macrosomia in this 
sample was 14%, nearly double the current prevalence estimate of macrosomia 
the United States (~8%). Only 4% of infants delivered were low-birthweight 
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(<2500 g). The cardiorespiratory fitness levels of the pregnant women were low 
(VO2peak: 19.85 ± 3.35 ml O2·kg-1·min-1), and considered ‘unfit’ (VO2peak: ≤ 21.0 ml O2·kg-1·min-1) 
compared to CRF levels of similar pregnant women established by Mottola et al. 
Similarly, on average, this sample accumulated 6600 steps per day, suggesting a 
‘low active’ level of daily physical activity (Tudor-Locke and Bassett, 2004). 
Nearly all characteristics between intervention conditions were similar with the 
exception of daily PA, where the exercise condition accrued more steps per day 
compared to the stretching condition (7718.19 ± 2223.78 vs 5185.53 ± 1750.39 
steps/day; p<0.0001). 
The adjusted linear regression coefficients for the independent 
associations between CRF, PA and infant birthweight are presented in Tables 
2.2 and 2.3, respectively. The independent association between CRF at 17 
weeks gestation and infant birthweight did not reach statistical significance (β= -
8.83 g, 95%CI: -42.2, 24.5 g), after adjusting for gestational age and weight gain, 
and group allocation. Similarly, the relationship between daily PA, expressed in 
steps per day, and infant birthweight (Table 2.3), was not statistically significant 
(β= 0.03 g, 95%CI: -0.03, 0.08g), after controlling gestational age and weight 
gain, and group allocation.  
The adjusted linear regression coefficients for the joint relationship 
between CRF and PA, and infant birthweight are depicted in Table 2.4. The joint 
association was assessed via an interaction between CRF and PA, and was 
found to not be significantly associated with infant birthweight (β= 0.006 g, 
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95%CI:  -0.005, 0.017 g), after adjusting for gestational age and weight gain, and 
group allocation. 
Discussion 
Considerable evidence indicates that maternal physical activity during 
pregnancy exerts a protective effect on infant birthweight. In a recent systematic 
review, Wiebe et al (2015) examined the effects of 28 PA interventions during the 
prenatal period on infant birth size. The conclusion of this review was that women 
participating in higher levels of maternal PA delivered lighter infants. These 
protective effects however, occurred only in normal weight pregnant women (22). 
Because nearly 50% of women of reproductive age are overweight or obese (7) 
and possess the greatest risk of delivering heavier infants (6), we thought it 
important to determine if a protective effect existed in overweight or obese 
pregnant women. Thus, in the present study, we examined the association 
between maternal PA in pregnancy and infant birthweight in a sample of 
overweight or obese pregnant women. The major finding of this study was that, in 
overweight and obese pregnant women, PA was not associated with infant 
birthweight. 
Our observation that maternal physical activity was not associated with 
infant birthweight in overweight or obese pregnant women is consistent with the 
limited number of previous studies assessing this relationship in this group (14, 
16, 18). For example, Nascimiento et al. (2012) examined the effects of a weekly 
supervised, light-to-moderate intensity exercise program on several maternal-
infant outcomes including infant birthweight. Similarly, Oostdam et al. (2012) 
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assessed the effects of a bi-weekly moderate intensity aerobic and strength-
training exercise program on maternal metabolic health (i.e. blood glucose and 
insulin sensitivity) and infant birthweight weight. Lastly, Ruiz et al. (2013) 
examined the effects of a light-to-moderate intensity exercise program consisting 
of aerobic and strength exercises, performed three times per week. Collectively, 
these studies found that maternal physical activity was not associated with infant 
birthweight. This conflicts with the established inverse relationship found in 
normal weight pregnant women.  A possible explanation for the conflicting 
evidence between these subpopulations is that the dose of PA was insufficient to 
influence infant birthweight. An obvious difference in these studies is the fact that 
overweight or obese women possess more fat mass. Consequently, increased 
adiposity and elevated blood lipids are posited to be one of the mechanisms 
leading to greater nutrient supply to the fetus, resulting in higher birthweights (8, 
12) . Strong evidence indicates that physical activity inversely associates with 
blood lipid levels (1, 10). As such, the amount of PA necessary to affect these 
levels in overweight or obese pregnant women, and thereby significantly impact 
infant birthweight, may be considerably higher than the levels of PA exhibited in 
this sample and those in previous studies.  
Currently, the U.S. Physical Activity Guidelines, with concurrence from the 
American College of Obstetricians and Gynecologists (4, 20) , recommend that 
pregnant women engage in 150 minutes per week of moderate-intensity aerobic 
and strength-training activities throughout pregnancy. Given the low amount of 
physical activity achieved by the pregnant women in this sample, it is likely they 
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did not meet the current recommendations. However, the physical activity 
prescribed in the aforementioned studies (14, 16, 18) appears to exceed this 
recommendation yet, infant birthweight remained unaffected across all studies. 
From these findings, two important observations can be made. First, the doses of 
physical activity levels in the current and other studies may have been insufficient 
to impact birthweight, suggesting that a higher dose of PA may be required. 
Second, given that the dose of PA prescribed in these studies exceeded the 
current PA guidelines, revised recommendations specific to overweight or obese 
pregnant women may be necessary. However, given the paucity of studies 
conducted in this population, more research assessing the effect of various 
doses of PA on infant size are essential to ascertain the existence of an effect. 
Another possible explanation for the null association found in this present 
study is low variability in PA levels. In this study, the average daily steps 
accumulated was 6579.91 steps with a SD of 2379.17 steps. While the variability 
in daily PA in this study is higher compared to previous studies (9), this amount 
may have been insufficient to detect an effect. Limited variability in the 
independent variable may result in a loss of power, thus reducing the likelihood 
of finding a statistically significant association (17). The reduced variability in PA 
found in this sample, may be result of strict eligibility criteria imposed during 
participant recruitment. Specifically, these women had a history of preeclampsia, 
which affects between 3 and 10% of all pregnancies (21). Common 
characteristics of women with preeclampsia are overweight or obesity and 
sedentarism (11, 15). Given the selective population from which these women 
47 
 
were drawn, it is not surprising that their daily PA patterns were similar, 
consequently reducing variability in this behavior. In addition, the small sample 
size in this study likely reduced our statistical power, potentially explaining our 
null findings. 
This study was novel in that it was the first to examine the association 
between maternal cardiorespiratory fitness and birthweight in a sample of 
overweight or obese pregnant women. The scientific knowledge on this 
relationship is non-existent in this group as previous studies limited their samples 
to normal weight pregnant women and reported conflicting effects on infant 
birthweight. Based on the strong metabolic effects of physical activity and posited 
influence on fetal nutrient supply (2), we hypothesized that maternal 
cardiorespiratory fitness, an indicator of habitual physical activity, would inversely 
associate with birthweight. However, the findings of this study demonstrated that 
maternal CRF appears not to influence infant birthweight. A potential explanation 
for the lack of an association demonstrated in this study may be limited variability 
in the levels of CRF in the study sample. Few studies have assessed CRF in 
overweight or obese pregnant women. Collectively, these studies have indicated 
reduced variability in the levels of CRF in this group. Mottola et al. (2006) 
measured CRF among an anthropometrically diverse sample of pregnant women 
(13) . The average CRF, expressed as peak oxygen consumption, was 23.7 ml 
O2·kg-1·min-1 with a standard error (SE) of 5.0 ml O2·kg-1·min-1. In a similar study, 
Davenport et al. (2008), assessed the CRF of overweight and obese pregnant 
women (5). Compared to CRF values found in the former study, lower levels of 
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CRF (21.6 ml O2·kg-1·min-1) and reduced variability (SE: 3.8 ml O2·kg-1·min-1) 
were found among overweight and obese pregnant women. The lower levels of 
CRF found in the latter study are similar to those found in our study with an 
average CRF of 19.85 ml O2·kg-1·min-1 and SE of 3.35 ml O2·kg-1·min-1. While 
low variability may be inherent in this specific subpopulation (i.e. history of 
preeclampsia, sedentarism), the additional requirement of a low fitness level (< 
50th percentile) likely further reduced the variability in cardiorespiratory fitness 
levels. Consequently, the limited variability potentially precluded our ability to 
ascertain an effect through a loss in statistical power.  
 This study has strengths and limitations. First, to our knowledge, this is the 
first study to address the independent and joint associations between maternal 
PA and CRF and infant birthweight, in a sample of overweight or obese pregnant 
women. Given the well-documented health benefits of CRF and PA, the 
investigation of its potential influence on maternal-fetal health was warranted. 
Second, objective measures of PA and CRF were used in this study, thus 
reducing biases associated with subjective assessments (e.g. self-report) (3). In 
addition to these significant strengths and the aforementioned limitations (i.e. 
limited variability, poor adherence/compliance), this study has other limitations. 
First, while our sample is one of the largest available that includes measures of 
PA, CRF and birthweight (i.e., n=89), it may have been too small to detect an 
association. The recruitment and retention of pregnant women, especially the 
overweight or obese subpopulation, is a considerable challenge in this field; poor 
study adherence is common. Second, we did not consider other potential health 
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behaviors that have been documented to influence infant size, including maternal 
diet (23). Third, the use of birthweight as a measure of fetal growth may have 
resulted in our inability to capture important changes in tissue composition and 
future health risks (2). Evidence indicated that PA and exercise may yield 
significant differences in tissue composition with no differences found in 
birthweight (19).  
In conclusion, the scientific evidence regarding the relationships between 
PA, CRF and birthweight is limited, especially among overweight and obese 
pregnant women. This study is the first provide important information regarding 
these relationships and contributes to this rapidly advancing area of research. 
Nonetheless, before any definitive conclusions are drawn from the findings of this 
study, further research is warranted. To address the aforementioned limitations 
of this study, future investigators should consider employing sampling strategies 
(e.g. purposive sampling) that may increase variability in the levels of maternal 
PA and CRF. Additionally, the development of novel strategies to enhance 
recruitment and retention should be encouraged given the established issues 
with the overweight and especially the obese subpopulations. Lastly, the 
underlying mechanisms that are posited to explain the relationships between 
physical activity and cardiorespiratory fitness and birthweight, such as maternal 
metabolic health and the associated biomarkers, are often neglected in these 
studies. Accordingly, we strongly recommend that future researchers collect data 
on the metabolic profiles of their study population. In closing, this study provide 
evidence that neither maternal PA nor CRF in the prenatal period are associated 
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with birthweight. However, given the established inverse relationship between PA 
and birthweight in normal weight pregnant women, we recommend further 
investigation into these potential relationships in overweight or obese pregnant 
women.  
Acknowledgements 
There are no funding sources to disclose. The authors would like to thank Dr. 
SeonAe Yeo and her investigative team for the data provided for the completion 
of this study.  
Conflict of Interest 
The authors have no conflicts to disclose.  
51 
 
References 
1. Aas V, Rokling‐Andersen M, Wensaas A, Thoresen G, Kase E, Rustan A. 
Lipid metabolism in human skeletal muscle cells: effects of palmitate and 
chronic hyperglycaemia. Acta Physiol Scand. 2005;183(1):31-41. 
2. Archer E. The childhood obesity epidemic as a result of nongenetic 
evolution: the maternal resources hypothesis. Mayo Clin Proc. 
2015;90(1):77-92. 
3. Archer E, Pavela G, Lavie CJ. The Inadmissibility of What We Eat in 
America and NHANES dietary data in nutrition and obesity research and 
the scientific formulation of national dietary guidelines. Mayo Clin Proc. 
2015;90(7):911-26. 
4. Artal R, O'Toole M. Guidelines of the American College of Obstetricians 
and Gynecologists for exercise during pregnancy and the postpartum 
period. Br J Sports Med. 2003;37(1):6-12.  
5. Davenport MH, Charlesworth S, Vanderspank D, Sopper MM, Mottola MF. 
Development and validation of exercise target heart rate zones for 
overweight and obese pregnant women. Applied Physiology, Nutrition, 
and Metabolism. 2008;33(5):984-9. 
6. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and 
diabetes on the prevalence of macrosomia. Am J Obstet Gynecol. 
2004;191(3):964-8.  
52 
 
7. Fisher SC, Kim SY, Sharma AJ, Rochat R, Morrow B. Is obesity still 
increasing among pregnant women? Prepregnancy obesity trends in 20 
states, 2003–2009. Prev Med. 2013;56(6):372-8.  
8. Herrera E. Lipid metabolism in pregnancy and its consequences in the 
fetus and newborn. Endocrine. 2002;19(1):43-55. 
9. Huberty JL, Buman MP, Leiferman JA, Bushar J, Adams MA. Trajectories 
of objectively-measured physical activity and sedentary time over the 
course of pregnancy in women self-identified as inactive. Prev Med Rep. 
2016;3:353-60.  
10. Kiens B. Skeletal muscle lipid metabolism in exercise and insulin 
resistance. Physiol Rev. 2006;86(1):205-43.  
11. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy expenditure 
resulting from altered body weight. N Engl J Med. 1995;332(10):621-8.  
12. Long NM, Rule DC, Zhu MJ, Nathanielsz PW, Ford SP. Maternal obesity 
upregulates fatty acid and glucose transporters and increases expression 
of enzymes mediating fatty acid biosynthesis in fetal adipose tissue 
depots. J Anim Sci. 2012;90(7):2201-10.  
13. Mottola MF, Davenport MH, Brun CR, Inglis SD, Charlesworth S, Sopper 
MM. VO2peak prediction and exercise prescription for pregnant women. 
Med Sci Sports Exerc. 2006;38(8):1389-95. 
14. Nascimento SL, Surita FG, Cecatti JG. Physical exercise during 
pregnancy: a systematic review. Curr Opin Obstet Gynecol. 
2012;24(6):387-94.  
53 
 
15. O’Brien TE, Ray JG, Chan W-S. Maternal body mass index and the risk of 
preeclampsia: A systematic overview. Epidemiology. 2003;14(3):368-74.  
16. Oostdam N, van Poppel M, Wouters M, Eekhoff E, Bekedam D, 
Kuchenbecker W, et al. No effect of the FitFor2 exercise programme on 
blood glucose, insulin sensitivity, and birthweight in pregnant women who 
were overweight and at risk for gestational diabetes: results of a 
randomised controlled trial. BJOG. 2012;119(9):1098-107. 
17. Rosenthal G, Rosenthal JA. Statistics and Data Interpretation for Social 
Work. 1st ed. New York (NY): Springer Publishing Company; 2012. 512p. 
18. Ruiz JR, Perales M, Pelaez M, Lopez C, Lucia A, Barakat R, editors. 
Supervised exercise–based intervention to prevent excessive gestational 
weight gain: A randomized controlled trial. Mayo Clin Proc; 
2013;88(12):1388-1397. 
19. Sewell MF, Huston-Presley L, Super DM, Catalano P. Increased neonatal 
fat mass, not lean body mass, is associated with maternal obesity. Am J 
Obstet Gynecol. 2006;195(4):1100-3. 
20. United States Department of Health Human Services. 2008 Physical 
Activity Guidelines for Americans. Washington D.C.: U.S. Department of 
Health and Human Services, Office of Disease Prevention and Health 
Promotion; 2008. 76p. Available from: 
http://health.gov/paguidelines/pdf/paguide.pdf. 
54 
 
21. Wallis AB, Saftlas AF, Hsia J, Atrash HK. Secular trends in the rates of 
preeclampsia, eclampsia, and gestational hypertension, United States, 
1987–2004. Am J Hypertens. 2008;21(5):521-6.  
22. Wiebe HW, Boule NG, Chari R, Davenport MH. The effect of supervised 
prenatal exercise on fetal growth: a meta-analysis. Obstet Gynecol. 
2015;125(5):1185-94. 
23. Grieger, JA, Clifton, VL. A review of the impact of dietary intakes in human 
pregnancy on infant birthweight. Nutrients, 2014;7(1):153-178.  
 
  
 
5
5
 
Table 2.1. Maternal and infant sample characteristics, by total and intervention group 
 
 
 
 
 
 
 
 
 
Note: a Demographic characteristics (age, weight, height, and body mass index) are reported at 17 weeks gestation.  
*Gestational weight gain represents weight gain during 17 weeks and 28 weeks of gestation (corresponding to 
participant laboratory visits).  **denotes significant between-group differences (p<0.0001). **For all behavioral 
characteristics (cardiorespiratory fitness [CRF], physical activity and number of days monitored) average values were 
calculated using all available time points throughout pregnancy: CRF (17 weeks), PA steps/day and days monitored 
(17 weeks until delivery). 
Sample Characteristics  Total (n=90)  Exercise (n=49)  Stretching (n=41) 
 N Mean SD N Mean SD N Mean SD 
Maternal a           
Age (y) 90 32.3 4.7 49 32.5 21.5 41 32.1 4.9 
Weight (kg) 90 80.4 18.7 49 79.9 19.1 41 81.0 18.4 
Height (m) 90 1.6 0.1 49 1.6 0.1 41 1.6 0.1 
Body Mass Index (kg/m2) 90 30.0 7.1 49 29.7 7.5 41 30.3 6.8 
Gestational Weight Gain * 90 6.45 3.6 49 6.0 2.9 41 7.0 4.2 
CRF (ml O2∙kg-1∙min-1) b 90 19.9 3.4 49 20.0 3.1 41 19.7 3.6 
Physical Activity (steps/day) 89 6579.9 2379.2 49 7718.2** 2223.8 40 5185.5 1750.4 
No. Days Monitored 89 114.2 32.6 49 114.6 32.6 40 113.6 33.0 
          
Infant          
Gestational Age (weeks) 90 38.64 1.9 49 38.5 2.0 41 38.8 1.7 
Birthweight (g) 90 3477.48 577.5 49 3475.5 613.4 41 3479.9 538.6 
Macrosomia (%) 90 14.44 ----- 49 7.8 ----- 41 6.7 ----- 
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Table 2.2. Adjusted linear regression coefficients assessing the independent 
association between CRF and birthweight (g). 
 
 
 
 
 
 
 
*Gestational weight gain represents weight gain during 17 weeks and 28 weeks 
of gestation (corresponding to participant laboratory visits).  **Stretching is the 
referent group.  
 Parameter Estimates 
Predictors β SE p-value 
    
Primary Exposures    
CRF (ml O2∙kg-1∙min-1)  -8.83 16.77 0.6000 
    
Covariates    
Maternal Age (y) 7.56 12.13 0.5347 
Gestational Age (weeks) 144.98 30.14 <0.0001 
Gestational weight gain* 10.64 7.30 0.1485 
Group Allocation**     
Exercise 60.54 112.38 0.5915 
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Table 2.3. Adjusted linear regression coefficients assessing the independent 
association between average PA (steps/day) in pregnancy and birthweight (g). 
 
 
 
 
 
 
 
*Gestational weight gain represents weight gain during 17 weeks and 28 weeks of 
gestation (corresponding to participant laboratory visits).  Note: No. of PA days 
represents the number of days the pedometer was worn during pregnancy. 
**Stretching is the referent group.  
 Parameter Estimates 
Predictors β SE p-value 
    
Primary Exposures    
Average PA (steps/day) 0.03 0.03 0.3037 
    
Covariates    
Maternal Age (y) 7.53 12.06 0.5342 
Gestational Age (weeks) 144.28 29.97 <0.0001 
Gestational weight gain*  10.76 7.24 0.1408 
Group Allocation**    
Exercise -16.06 131.98 0.9304 
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Table 2.4. Adjusted linear regression coefficients assessing the joint association 
between average PA (steps/day) and CRF in pregnancy and birthweight (g). 
  
 
 
 
 
 
 
 
*Gestational weight gain represents weight gain during 17 weeks and 28 weeks of 
gestation (corresponding to participant laboratory visits). **Stretching is the 
referent group.
 Parameter Estimates 
Predictors β SE p-value 
    
Primary Exposures    
Average PA (steps/day) -0.09 0.12 0.4441 
CRF (ml O2∙kg-1∙min-1)  -52.24 41.44 0.2111 
Average PA*CRF 0.006 0.006 0.2929 
    
Covariates    
Maternal Age 7.38 12.11 0.5439 
Gestational Age  143.64 30.17 <0.0001 
Gestational weight gain* 11.28 7.31 0.1268 
Group Allocation**     
Exercise -9.30 132.75 0.9443 
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CHAPTER 3 
ASSOCIATION BETWEEN CHANGE IN MATERNAL PHYSICAL ACTIVITY 
DURING PREGNANCY AND INFANT SIZE
 60 
 
Abstract  
Purpose: Significant evidence demonstrates that maternal physical activity (PA) 
decreases in the prenatal period. Declines in PA are known to produce adverse 
metabolic effects. The neonatal consequences of these decrements in maternal 
PA are largely unknown. Previous studies assessing the relationship between 
maternal PA and infant birthweight failed to account for the natural changes in 
PA that occur throughout pregnancy. Therefore, the purpose of this study was to 
describe the relationship between changes in prenatal PA and infant birthweight.  
Methods: This study employed a prospective design using data from a 
randomized controlled exercise intervention trial conducted in sedentary, 
overweight or obese pregnant women with a history of preeclampsia. Women 
with complete data for infant birthweight, peak oxygen consumption, and daily PA 
measured via a pedometer (17 weeks to delivery) were included in the analyses. 
Individual trajectories for prenatal PA were estimated via repeated measures 
analyses to represent the change in PA from mid-to-late pregnancy. Multiple 
linear regression models were then performed to determine the association 
between change in prenatal PA and birthweight. Gestational age, weight gain, 
maternal age and group allocation were covariates.  
Results: Eighty-nine pregnant women were included in this study and were, on 
average, 32 years old, overweight/obese (BMI 29.97 ± 7.14 kg/m2) and low-
active (6,579.91 ± 2379.17 steps/day). PA declined from the 4th to the 8th month 
of pregnancy (-399.73 ± 371.38 steps∙day-1∙month-1). After adjusting for 
covariates, multiple linear regression analyses showed that the decline in 
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prenatal PA (β= -0.28 g, 95%CI: -0.70, 0.25 g, p=0.35) was not associated with 
birthweight. In addition, CRF (β= 0.04 g, 95%CI: -0.06 g, 0.14 g, p=0.697) did not 
exhibit a moderating effect. 
Conclusions: The findings of this study demonstrated that maternal PA 
decreased from mid to late pregnancy. The observed decline was unrelated to 
infant birthweight. Future investigations employing more rigorous measurements 
of PA are recommended. 
Introduction 
Over the past two decades, increases in mean birthweight and the 
prevalence of large-for-gestational age neonates have been documented in the 
U.S. and other developed countries (4, 20). Several adverse health outcomes are 
associated with higher birthweight, including an increased risk of obesity and 
related co-morbidities in later life (8). Considerable evidence demonstrates that 
higher levels of physical activity (PA) during pregnancy are associated with lower 
infant birthweight (6, 30). This relationship is posited to be a function of the 
strong metabolic effects of PA (16, 27), whereby an active mother is better able 
to control the amount of energy supplied to her fetus (1).  
Despite the well-established metabolic benefits of PA, recent evidence 
indicates that over the past 50 years population trends in maternal physical 
activity have exhibited persistent declines (2). In addition to the population 
trends, research has demonstrated that maternal physical activity decreases 
throughout pregnancy (17, 24), with the most precipitous declines observed in 
the 3rd trimester. Declines in PA are known to result in adverse metabolic effects 
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including impaired control of serum glucose and lipids. Given these trends, 
decreased maternal PA is a plausible explanation for the rise in the prevalence of 
larger infants (1, 3).  
While reductions in PA during pregnancy are universal across all 
subgroups of pregnant women, overweight or obese women are the least active 
group (17, 24).  Heavier women have an increased risk of excessive gestational 
weight gain, thereby potentially exacerbating the decline in maternal PA leading 
to fetal overgrowth and larger neonates (19, 23, 28). This observation is 
supported by increased delivery of larger neonates among overweight or obese 
women (12) . Evaluating the association between the decline in maternal PA and 
neonatal birthweight in this subgroup is important given the increasing 
prevalence of obesity in women of reproductive age (13).  
Currently, no prospective studies have evaluated the relationship between 
the change in maternal physical activity during pregnancy and neonatal 
birthweight. Most studies have examined the relationship between average level 
of maternal physical activity across pregnancy or during specific trimesters and 
infant size (6). Consequently, these studies failed to account for the naturally 
occurring changes in physical activity. As such, the associations of the changes 
in maternal physical activity across the prenatal period and infant birthweight are 
largely unknown. In addition, no studies have evaluated the potential modifying 
effect of maternal cardiorespiratory fitness (CRF) on the relationship between 
change in maternal PA and infant birthweight. CRF is an indicator of habitual 
physical activity as such, women with higher levels of maternal CRF may protect 
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against the negative metabolic effects of decreasing levels of PA. Thus, the 
primary purpose of this study was to describe the relationship between changes 
in physical activity in mid-to-late pregnancy and infant birthweight, in a sample of 
overweight or obese pregnant women. A secondary purpose of this study was to 
evaluate the potential modifying effect of maternal cardiorespiratory fitness on 
this relationship. 
Methods 
Study Design 
The present study employed a prospective design using data from a five-
year randomized exercise comparative trial (RCT). This RCT was designed to 
assess the effects of a moderate exercise program in the prenatal period on the 
incidence of preeclampsia its pathological processes (e.g., oxidative stress). The 
secondary purpose of the study was to assess the effects of exercise on 
gestational weight gain and birth outcomes (31) .  
Participant Eligibility & Recruitment 
Pregnant women were recruited from nine prenatal clinics in Michigan. 
Women were enrolled in this intervention trial if they were 1) less than 14 weeks 
gestation, 2) history of preeclampsia, 3) had a peak oxygen consumption of ≤ 
50th percentile of women in their respective age-group, 4) had a sedentary 
lifestyle or had a self-reported physical activity energy expenditure of less than 
840 kcals per day. Women were excluded if they had: 1) chronic hypertension or 
pre-gestational diabetes, 2) medical or physical limitations that inhibit 
participation in exercise, 3) been advised against the participation in prenatal 
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exercise by a physician or 4) a low mental acuity and/or language barrier 
preventing effective communication with research staff. 
Randomization & Intervention Groups 
Two-hundred and ten pregnant women expressed interest in participating 
in the RCT, however 41% (n=86) did not meet the eligibility criteria. The 
remaining eligible pregnant women (n=124) were randomly assigned to an 
exercise program (n=64) or a stretching program (n=60). The exercise program 
recommended that the women walk for 40 minutes, five times per week at 
moderate intensity (55-69% of heart rate reserve). In the stretching program, 
participants were instructed to mimic the movements of a stretching video of 
equivalent frequency and duration as the exercise program. With regard to 
intensity, the participants were instructed to not increase their heart rate more 
than 10% above resting levels. To monitor compliance to the exercise intensity of 
each program, the participants wore Polar S810 heart rate monitors and 
wristwatch devices. More details on the exercise and stretching programs of the 
RCT can be found elsewhere (32). For the purposes of this study, data were 
collapsed across the two groups and group allocation was controlled for in the 
analyses. 
Outcome Variable: Infant Birthweight 
Infant birthweight, in grams, was the dependent variable in the present 
study. Birthweight was defined as the weight of the infant at the time of delivery. 
The data on birthweight was extracted from the mother’s medical records.  
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Exposure Variables:  
Change in Physical Activity  
Physical activity was assessed daily using a pedometer (Digiwalker 
SW200) from weeks 18 gestation until delivery. Each participant was instructed 
to wear the pedometer, attached via an elastic belt and worn directly above the 
right hip, during waking hours. Participants were to remove the pedometer prior 
to sleeping and participation in any water-based activities (e.g. showering, 
swimming). In addition, participants were asked to keep a daily record of their 
total daily step counts throughout their prenatal period. Daily steps were 
collapsed into four-week periods that corresponded to the months of pregnancy: 
month 4 (18 – 21 weeks), month 5 (22 – 25 weeks), month 6 (26 – 29 weeks), 
month 7 (30 – 33 weeks), and month 8 (34 – 37 weeks). Nearly 60% of data on 
daily step counts were missing in 9th month of pregnancy (38 – 41 weeks), likely 
due to delivery, so we excluded this month from the analysis. Prenatal PA was 
expressed as steps·day-1·month-1. We did not employ any exclusionary protocols 
for the PA data. The amount of steps accumulated in pregnancy ranged from 0 to 
16,503 steps per day. Change in prenatal physical activity was determined using 
individual trajectories in PA across the prenatal period (i.e. time) [see Statistical 
Analysis].  
Cardiorespiratory Fitness 
Cardiorespiratory fitness was defined as peak oxygen consumption 
(V̇O2peak) and expressed relatively as milliliters of oxygen per kilogram per minute 
(ml O2 ∙ kg-1 ∙ min-1). V̇O2peak was estimated via a submaximal treadmill test at 17 
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and 28 weeks gestation. The treadmill exercise test followed the Cornell Exercise 
protocol, a modified version of the Bruce Protocol Treadmill Test. The protocol 
consisted of each participant walking on a treadmill through eight, two-minute 
stages with progressive increments speed and grade. Prior to the test, resting 
levels of heart rate, blood pressure, fatigue, oxygen consumption, carbon dioxide 
production and minute ventilation were assessed. These same parameters were 
continuously monitored throughout the exercise test using a portable indirect 
calorimeter (VO2000, Medical Graphics Corporation, Minneapolis, MN). This 
device has been previously validated in a sample of sedentary pregnant women 
(33). Although in the scientific literature CRF is shown to not change significantly, 
the change in CRF levels between 17 and 28 weeks in this sample were quite 
variable. As such, for the purposes of this study, CRF at 17 weeks gestation was 
used to provide an estimate of the average CRF level in early pregnancy.  
Covariate Variables: Maternal and Infant Characteristics 
Several maternal and infant characteristics that may affect birthweight, PA 
and/or CRF were included as potential covariates. Maternal and infant 
characteristics included the following: age, gestational weight gain (GWG), 
gestational age and group allocation. Maternal age (in years) and gestational age 
(in weeks) were extracted from the participants’ medical records. Gestational 
weight gain in this study was calculated using a non-traditional approach. We 
used the difference in the weights that were objectively measured at 17 and 28 
weeks gestation to express gestational weight gain. GWG was not expressed 
using the traditional expression, difference in the weight at delivery and pre-
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pregnancy weight, because nearly 40% of the data for either of these metrics 
was missing. However, to compare our non-traditional expression of GWG to a 
more standard expression, we created an additional GWG variable that 
represented the difference in weight from 17 weeks gestation to delivery. 
Because it is assumed that minimal weight is gained in the first trimester (18) and 
self-reported pre-pregnancy is prone to significant error (26), we found it more 
appropriate to use the weight at 17 weeks gestation. To create this additional 
GWG variable, we performed multiple imputation for the ‘weight at delivery’ and 
then calculated the GWG variable. After this, we compared the results of the 
multiple regression analyses (see statistics section) for both expressions of GWG 
(data not shown). We found that each GWG variable impacted the regression 
coefficients and standard errors similarly. As a result, we elected to use the 
weight gained from 17 to 28 weeks gestation to represent GWG.  
Statistical Analyses 
Group differences in the maternal and infant characteristics between the 
exercise and stretching programs were determine using Student’s t-test and 
Pearson Chi-square tests. For the main analyses, we performed two multiple 
linear regression models. In this study, we sought to determine: 1) the effects of 
change in maternal physical activity in mid-to-late pregnancy on infant birthweight 
and 2) the modifying effect of CRF on the association between change in PA 
during pregnancy and infant birthweight. Change in PA in the prenatal period was 
determined using individual trajectories in PA across time. We performed a 
random intercept and slope mixed model with repeated measures to estimate 
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intercepts and slopes of each participant. These estimates were then created as 
individual variables with the intercept acting as a ‘baseline measure of PA’ and 
the slope representing the ‘change in PA’ across the prenatal period.  
For each analysis, infant birthweight was the dependent variable. In the 
first main analyses, change in maternal PA during pregnancy was the primary 
independent variable. In the second main analyses, change in maternal PA 
during pregnancy and CRF were the primary independent variable and modifying 
variable, respectively. In the latter analyses, we assessed the modifying effect 
with an interaction term between CRF and change in maternal PA in pregnancy. 
We first assessed the assumptions of linear regression and no major violations 
were found. Next, bivariate associations between all the independent variables 
(primary and secondary) and the outcome variable were performed. Following 
this, unadjusted multiple linear regression models were performed first, followed 
by a sequential inclusion of covariates. All analyses were conducted using SAS 
analytical software version 9.4 (Cary, North Carolina) and the significance level 
was set at α = 0.05. The following variables were express continuously: change 
in prenatal PA (steps ∙ day-1 ∙ month-1), CRF (ml O2 ∙ kg-1 ∙ min-1), GWG (kg), age 
(years), gestational age (weeks). Group allocation was treated as a categorical 
variable with the stretching program treated as the referent group.  
Missing Data 
For the purposes of this study, only women with complete data on infant 
birthweight, maternal PA in pregnancy and cardiorespiratory fitness were 
included in the analyses. As such, only 89 of the 124 eligible pregnant women 
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were used in the analyses. To assess the possibility of selection bias, we 
compared the differences in demographics, pregnancy-related and behavioral 
characteristics of women with and without complete data. We found no significant 
differences between these groups, thus providing some evidence that excluding 
these women may not provide biased estimates. 
Results 
Table 3.1 presents maternal, prenatal and behavior-related characteristics 
of this study sample. At 17 weeks of gestation, the average pregnant woman was 
32 years old with a BMI classified as overweight/obese (BMI: 29.97 ± 7.14 
kg/m2). On average, women delivered full-term, normal weight infants 
(gestational age: 38.64 ± 1.88 weeks; birthweight: 3477.48 ± 577.48g). The 
average weight gained in mid-pregnancy (17 to 28 weeks) was approximately 6.5 
kilograms. Roughly 14% of infants were born macrosomic, nearly double the 
prevalence in the United States (~8%) (20). Only 4% of infants delivered were 
low-birthweight (<2500 g). Women in this sample were considered ‘unfit’ with an 
average VO2peak of 19.85 ml O2·kg-1·min-1 (SD 3.35). In addition, these women 
accumulated, on average, 6600 steps per day, suggesting participation in a ‘low 
active’ lifestyle (Tudor-Locke and Bassett, 2004). In addition, during every month 
of pregnancy, PA decreased, on average, by nearly 400 steps per day. 
Specifically, Table 3.2 shows the patterns in maternal PA from mid-to-late 
pregnancy. As expected, maternal PA declined from month 4 (18 – 22 weeks) to 
month 9 (38 – 41 weeks), with women accumulating on average 7227.7 (± 
2618.5) steps·day-1 and 5848.5 (± 2778.9) steps·day-1), respectively. 
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Additionally, this table shows that the number of pregnant women recording their 
daily PA declined as well, most precipitously in the last month of pregnancy.  
The adjusted linear regression coefficients for the association between 
change in prenatal PA and infant birthweight are presented in Table 3.3. Change 
in prenatal PA was not significantly associated with infant birthweight (β= -0.28 g, 
95%CI: -0.70, 0.25 g, p=0.35), after adjusting for maternal age, gestational age, 
weight gain, and group allocation.  
Table 3.4 depicts the adjusted linear regression coefficients for the 
modifying effect of CRF on the relationship between the change in PA and infant 
birthweight. The interaction between CRF and change in PA and was not 
significantly associated with infant birthweight (β= 0.04 g, 95%CI: -0.06 g, 0.14 g, 
p=0.697), after adjusting for maternal age, gestational age, weight gain, and 
group allocation. 
Discussion 
The primary finding of this study was that, in overweight or obese women, 
the decrease in maternal physical activity from mid- to late-pregnancy was 
unrelated to infant birthweight. This study was unique in that it was the first to 
prospectively follow women from mid- to late-pregnancy and evaluate the 
association between change in physical activity and infant birthweight. Previous 
prospective studies assessing this relationship limited their evaluation to the 
average level of physical activity across pregnancy or during specific trimesters 
in pregnancy (6, 17). Thus, this study provides a unique examination of the 
relationship between the decline in PA during pregnancy and infant birthweight. 
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Moreover, this study was conducted in a sample of overweight or obese pregnant 
women, an understudied population. Further research is necessary in this group 
as these women are predisposed to excessive weight gain, low levels of PA and 
poor metabolic health, all of which are posited to be risk factors for the delivery of 
larger neonates.  
 A potential explanation for the null association between the change in 
maternal PA and infant birthweight is the small magnitude in the change in PA 
from mid-to late-pregnancy. In this study, a very modest reduction in maternal PA 
was observed likely consequent to the low active lifestyle led by these women, 
potentially demonstrating a floor effect. At 17 weeks gestation (i.e. baseline) this 
sample of women accumulated nearly 6600 steps·day-1·month-1, which is 
reflective of low activity. A majority (~3000 – 4000 steps) of these daily step 
counts were likely the results of everyday activities of daily living [ADLs] (29). The 
remainder potentially represented leisure time physical activity. Considering the 
necessity of the engagement in ADLs, PA attributed to ADLs likely did not 
change significantly during pregnancy. As such, the decrements in PA 
documented in this study were likely consequent to reductions in leisure-time 
physical activity (14). On average, the women in this sample decreased their 
daily steps per month by approximately 400 steps (-399.73 ± 371.38 steps) from 
the 4th month to the 8th month of pregnancy. Over a 5-month period, this 
corresponds roughly to a 2,000-daily step decrement over a 5-month period. This 
minimal change is consistent with previous studies. For example, Renault et al. 
(2010) assessed physical activity via pedometers and found an 1,850-step 
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decrement in steps per day from 13 weeks to 36 – 38 weeks gestation in obese 
women (24). The small magnitude of the decrement in maternal PA found in this 
study was likely insufficient to influence fetal energy supply and birthweight, 
thereby precluding our ability to detect an association.  
In support of this interpretation, Clapp et al. (2002) evaluated the effects of 
various doses of prenatal physical activity in normal weight women on infant size 
(10). They found that women who decreased their PA delivered heavier, fattier 
neonates reflected by higher birthweight and greater amounts of adipose tissue 
compared to women who maintained or increased their PA throughout the 
prenatal period. The considerable decrement in PA likely altered fetal energy 
supply, especially in the 3rd trimester. This is consequent to the reduction in the 
maternal skeletal muscle demand for energy, thus increasing energy availability 
to the fetus (22). The decrement in PA experienced by these women was 200 
minutes per week, a markedly greater reduction in the levels of PA relative to the 
400-daily step per month decline exhibited in the present study. As such, a larger 
decrement in prenatal PA may have been necessary to affect infant size.  
 Another unique aspect of this study was the examination of the 
moderating effect of maternal cardiorespiratory fitness on the relationship 
between the change in maternal PA during pregnancy and birthweight. 
Cardiorespiratory fitness is an indicator of habitual physical activity (7). In 
addition, given the strong metabolic effects of physical activity (27), we posited 
that maternal CRF may attenuate the potential adverse effects (i.e. reduced 
metabolic health) related to reductions in prenatal PA (5) on neonate size. The 
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findings of the aforementioned study of Clapp et al. (2002) support this 
hypothesis. The women in that study were previously active and subsequently 
possessed optimal levels of cardiorespiratory fitness. Despite the increased 
birthweight and adipose tissue among neonates born to the women who 
decreased their prenatal PA during the prenatal period, the birthweight and tissue 
composition of these neonates were still within the normal range (9). This may 
indicate that higher levels of PA and thus, CRF in the preconception period may 
have protected the neonate from overgrowth in spite of a decline in maternal PA 
during pregnancy.  In this study, however, we observed that maternal 
cardiorespiratory fitness does not moderate the relationship between the decline 
in maternal PA in the prenatal period and infant birthweight. 
 A possible explanation for the null observation regarding the moderating 
effects of maternal cardiorespiratory fitness is low variability. Previous studies 
assessing CRF levels in pregnancy observed low variability among the 
overweight or obese subpopulation. Davenport et al. (2008), assessed the CRF 
of overweight and obese pregnant women and found the average CRF, 
expressed as peak oxygen consumption, of 21.6 ml O2·kg-1·min-1 (± 3.8 ml O2·kg-
1·min-1) (11). The average value and variability (i.e. standard deviation) is lower in 
comparison to those found in an anthropometrically diverse sample of pregnant 
women by Mottola et al. (2006).  These authors found an average CRF of 23.7 
ml O2·kg-1·min-1 and SE of 5.0 ml O2·kg-1·min-1 (21). The lower levels of CRF 
found in the former study are similar to those found in the present study (VO2peak: 
19.85 ± 3.35 ml O2·kg-1·min-1). The low variability in CRF found in this study may 
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be due to the low-active lifestyles led by these women. Habitual PA is a strong 
predictor of CRF and as such, the low levels of PA found among this sample of 
women likely resulted in low levels and variability of CRF. In addition, the 
combination of limited variability in maternal CRF and the small magnitude of the 
change in PA during pregnancy may have precluded our ability to detect a 
moderating effect (25).  
 This study has strengths and limitations. Importantly, this is the first study 
to examine the association between the changes in maternal physical activity in 
mid-to-late pregnancy and infant birthweight in a sample of overweight or obese 
pregnant women. In addition, this study is the first to assess the potential 
moderating effect of maternal cardiorespiratory fitness on this relationship. An 
additional strength of this study is the longitudinal measurement of physical 
activity in the prenatal period. This evaluation allowed us to account for the 
natural changes in PA from mid-to-late pregnancy and led to a more accurate 
estimation of its relationship with infant birthweight. Lastly, the use of objective 
assessments increased the precision of the measurement of physical activity and 
cardiorespiratory fitness. In addition to these significant strengths, this study has 
limitations. First, only PA in mid-to-late pregnancy was observed. Thus, any 
changes occurring prior to 17 weeks of gestation were missed, potentially 
resulting in a less accurate representation of the changes in PA during 
pregnancy. Second, the sample size for this study was small (n=90) possibly 
limiting our ability to detect an association, especially a moderating effect. Third, 
we did not consider other potential health behaviors that have been documented 
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to influence infant size, including maternal diet (34). Fourth, while birthweight is 
the most widely used measure of infant size, it fails to provide information on the 
tissue composition of the neonate, which is important to future health risks (15).   
 In conclusion, this study demonstrated that the decline in maternal 
physical activity during the prenatal period was unrelated to birthweight. In 
addition, we observed that maternal cardiorespiratory fitness did not moderate 
the association between the decline in maternal PA during pregnancy and infant 
birthweight. In spite of these null observations, this study contributes to this 
rapidly growing area of research in an understudied and important subpopulation.  
Several recommendations are suggested to address the limitations of this study 
that will ensure higher quality assessments of these relationships in future 
investigations. First, the employment of sampling strategies aimed to increase 
the variability in PA and CRF (i.e. purposive sampling) are encouraged. Second, 
while pedometers provide an objective assessment of physical activity, they are 
limited to providing information on PA volume. Consequently, pedometers are 
unable to capture other important components of PA such as intensity. Intensity 
of PA may be an important factor to fetal growth given its strong relation to 
metabolic health. Third, future research should include the assessment of 
metabolic biomarkers, such as glycemic and lipidemic control, as these 
parameters are considered the underlying mechanisms to excessive fetal growth 
and are often ignored in studies. Lastly, more precise measurements of infant 
anthropometry are needed (i.e. lean and fat mass) as these are important to 
future health risks of the offspring. In closing, the findings of this study provide no 
 76 
 
evidence that the declines in maternal PA during mid-to-late pregnancy are 
related to infant birthweight and that maternal CRF exerts a moderating effect on 
this relationship. 
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 Table 3.1. Sample characteristics of pregnant women, by total and intervention group 
 
 
 
 
 
 
 
 
 
 
 
Note: *Gestational weight gain represents weight gain during 17 weeks and 28 weeks of gestation 
(corresponding to participant laboratory visits).  **denotes significant between-group differences 
(p<0.0001). ¥ PA data on one participant was removed as no data on PA wwere available, however all 
  Total  
(n=90) 
 Exercise  
(n=49) 
 Stretching 
(n=41) 
 N Mean SD N Mean SD N Mean SD 
Maternal and Infant 
Characteristics 
         
Demographics          
Age (y) 90 32.3 4.7 49 32.5 4.4 41 32.1 4.9 
Weight (kg) 90 80.4 18.7 49 79.9 19.1 41 81.0 18.4 
Height (m) 90 1.6 0.1 49 1.6 0.1 41 1.6 0.1 
Body Mass Index (kg/m2) 90 30.0 7.1 49 29.7 7.5 41 30.3 6.8 
Pregnancy-Related          
Gestational Age (weeks) 90 38.6 1.9 49 38.5 2.0 41 38.8 1.7 
Gestational Weight gain* 90 6.5 3.6 49 6.0 2.9 41 7.0 4.2 
Birthweight (g) 90 3477.5 577.5 49 3475.5 613.4 41 3479.9 538.6 
Macrosomia (%) 90 14.4 ----- 49 7.8 ----- 41 6.8 ----- 
Behavioral¥          
CRF  90 19.8 3.4 49 20.0 3.1 41 19.7 3.6 
Physical Activity  89 6588.7 2416.6 49 7801.4** 2236.4 40 5103.1 1706.
0 
Change in PA  89 -399.7 371.4 49 -470.6** 374.1 40 -312.9 353.4 
No. Days Monitored 89 114.2 32.6 49 114.6 32.6 40 113.6 32.96 
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other pertinent data were available. CRF was expressed as ml O2∙kg-1∙min-1. Physical activity was 
expressed as steps∙day-1∙month-1
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Table 3.2. Maternal patterns of average physical activity (steps·day-1) from mid-to-late pregnancy, 
by group 
 
 
 
 
 
 
 
Note: *The weeks of gestation that correspond to each month of pregnancy are as follows: Month 4 
(18 – 21 weeks), Month 5 (22 – 25 weeks), Month 6 (26 – 29 weeks), Month 7 (30 – 33 weeks), 
Month 8 (34 – 37 weeks) and Month 9 (38 – 41 weeks) 
  Total  Exercise  Stretch  
  Mean SD 
(range) 
Mean SD 
(range) 
Mean SD 
(range) 
Gestation* N       
Month 4  87 7227.7 2618.5 
(2426.6-16503.2) 
8726.3 2246.8 
(4369.2-16503.2) 
5465.5 1809.3 
(2426.6-9922.4) 
Month 5  86 7093.6 2679.5 
(1987.8-17526.3) 
8333.6 2574.2 
(376306-17526.3) 
5599.2 1960.9 
(1987.8-9867.11) 
Month 6  85 6614.4 2551.1 
(1705.9-15788.6) 
7852.6 2412.9 
(4020.7-15788.6) 
5082.9 1783.3 
(1705.9-8140.1) 
Month 7  84 6135.2 2618.1 
(186.7-15627.4) 
7407.9 2466.9 
(3400.7-15627.4) 
4666.7 1947.7 
(186.7-8260.2)  
Month 8  75 5797.2 2521.4 
(598.6-14033.9) 
6814.8 2408.4 
(1915.0-14033.9) 
4569.9 2094.5 
(598.6-8517.6) 
Month 9  37 5848.5 2778.9 
(1302.0-14133.5) 
6666.4 3121.9 
(1858.0-14133.5) 
4886.3 1995.3 
(1302.00-8315.0) 
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Table 3.3. Adjusted linear regression coefficients assessing the association 
between change in prenatal PA and infant birthweight, in grams 
Note: †Change in PA is represented by individual trajectories (slopes) of PA 
across the prenatal period (See Methods section). *Baseline PA is represented by 
the intercepts of individual trajectories of PA (See Methods section). **Gestational 
weight gain represents weight gain during 17 weeks and 28 weeks of gestation 
(corresponding to participant laboratory visits).  *** Stretching group is referent. 
Physical activity was expressed as steps∙day-1∙month-1.  
 Parameter Estimates 
Predictors β SE p-value 
    
Primary Exposures    
PA Change†  -0.227 0.234 0.3462 
    
Covariates    
Baseline PA*  0.017 0.029 0.5512 
Maternal Age (y) 5.24 12.00 0.6637 
Gestational Age (weeks) 156.17 30.32 <0.0001 
Gestational weight gain**  18.31 16.02 0.2565 
Group Allocation***     
Exercise -44.46 135.23 0.7431 
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Table 3.4. Adjusted linear regression coefficients assessing the modifying 
effect of CRF on the association between change in prenatal PA and infant 
birthweight, in grams 
Note: Change in PA is represented by individual trajectories (slopes) of PA 
across the prenatal period (See Methods section).  *Baseline PA is represented 
by the intercepts of individual trajectories of PA (See Methods section). 
**Gestational weight gain represents weight gain during 17 weeks and 28 weeks 
of gestation (corresponding to participant laboratory visits).  *** Stretching group 
is referent. CRF was expressed as ml O2∙kg-1∙min-1. Physical activity was 
expressed as steps∙day-1∙month-1.
 Parameter Estimates 
Predictors β SE p-value 
    
Primary Exposures    
PA Change  -0.98 1.01 0.3355 
CRF  10.08 25.94 0.6987 
CRF*PA change 0.040 0.051 0.4333 
    
Covariates    
PA Intercept*  0.023 0.030 0.4473 
Maternal Age (y) 5.46 12.12 0.6538 
Gestational Age (weeks) 152.29 31.01 <0.0001 
Gestational weight gain**  18.22 16.39 0.2695 
Group Allocation***     
Exercise -61.75 137.94 0.6556 
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CHAPTER 4 
OVERALL DISCUSSION
 88 
 
In the United States, nearly 20% of children and adolescents are classified 
as obese(29). Several adverse cardio-metabolic health outcomes are associated 
with obesity including type II diabetes and non-alcoholic fatty liver disease(20, 
36). Rigorous scientific evidence indicates that participation in sufficient levels of 
physical activity may reduce the risk of the development of child obesity(23). 
However, child levels of physical activity cannot explain obesity at birth or 
infancy. Recent epidemiological evidence indicates that over the past 20 years, 
the average birthweight of U.S.-born infants has increased(27). In addition, 
increasing trends in infant macrosomia and large-for-gestational age infants are 
documented(3, 7, 9). Consequently, heavier neonates have altered grow 
trajectories(19), predisposing them to obesity. Because child levels of physical 
activity cannot explain obesity at birth or infancy, this suggests that the 
development of obesity occurs in utero(17, 31). The prenatal period is the most 
critical period for fetal growth and development and is vulnerable to disturbances. 
It is well-documented that maternal phenotype (e.g. body mass) and her 
behaviors can significantly impact fetal growth(4). Thus, it is important to identify 
maternal factors that may affect fetal growth and subsequently infant size. 
 Considerable evidence indicates that higher levels of maternal physical 
activity in the prenatal period protect neonates from overgrowth(35). This 
relationship is hypothesized to result from improved maternal metabolic health 
thereby controlling the amount of energy suppled to the fetus, resulting in the 
development of a healthy-sized neonate(4). This protective effect, however, has 
only been demonstrated in normal weight women. Little is known about how 
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maternal physical activity might influence infant size in the overweight or obese 
population(28, 30, 33). In addition, very few studies have evaluated the 
association between maternal cardiorespiratory fitness, an indicator of habitual 
physical activity, and neonatal size. The findings of previous studies are 
inconsistent with reports of positive, negative and null associations(8, 12, 24). 
Moreover, to our knowledge, no studies have assessed this relationship in the 
overweight or obese population. The lack of studies among this subgroup is 
problematic given the increasing prevalence of obesity in women of reproductive 
age(18). Moreover, overweight or obese women are the least active in 
pregnancy(22, 32) and are at an increased risk for excessive gestational weight 
gain(26), predisposing them to higher rates of delivering macrosomic 
neonates(16). Therefore, three studies in this dissertation investigated the 
relationships between maternal body mass, physical activity and 
cardiorespiratory fitness, prior to and during pregnancy, and infant size. 
The purpose of study one was to evaluate the moderating effect of 
maternal physical activity in the preconception and prenatal periods on the 
relationship between maternal body mass and infant macrosomia. The purpose 
of study two was to examine the independent and joint associations between 
maternal physical activity, cardiorespiratory fitness and infant birthweight, in a 
sample of overweight or obese pregnant women. The purpose of study three was 
to describe the relationship between change in maternal PA in the prenatal 
period and infant birthweight, in a sample of overweight or obese pregnant 
women. In addition, we examined the potential moderating effect of maternal 
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cardiorespiratory fitness on the relationship between change in maternal PA and 
infant birthweight. 
In study one, it was observed that maternal body mass was a significant, 
positive predictor of infant macrosomia. Overweight or obese mothers had 
increased odds of delivering a macrosomic infant. However, contrary to 
hypotheses, neither preconceptual nor prenatal PA moderated the association 
between maternal body mass and infant macrosomia. In study two, it was 
observed that overweight or obese women led very-low active lifestyles. Maternal 
PA from mid-to-late pregnancy was unrelated to infant birthweight. Maternal 
cardiorespiratory fitness was also unrelated to infant birthweight in this group. In 
addition, maternal cardiorespiratory fitness did not moderate the association 
between maternal PA and infant birthweight. In study three, it was observed that, 
in overweight or obese women, maternal PA declined from mid-to-late 
pregnancy. This decrease in PA was found to be unrelated to infant birthweight.  
Overall, this dissertation did not support the hypothesis that maternal PA 
prior to or during pregnancy affects the relationship between maternal body mass 
and infant macrosomia. In addition, these studies did not find that maternal PA 
and cardiorespiratory fitness are related to infant birthweight. Previous evidence 
regarding the modifying effect of maternal PA is extremely limited. Only one 
study, to our knowledge, has examined this relationship(25) and found that 
overweight or obese women reporting little to no PA prior to pregnancy were 
more likely to deliver a macrosomic infant. In study two, our null observations 
regarding the independent associations of maternal PA and infant birthweight are 
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consistent with previous studies among overweight or obese women. However, 
these studies conflict with studies conducted among normal weight women which 
collectively suggest that maternal PA in pregnancy protects against the delivery 
of larger infants(35). Study two also provided unique information about the 
relationship between maternal cardiorespiratory fitness and infant birthweight. No 
previous studies have assessed this relationship in overweight or obese pregnant 
women. The null observation of the association between change in maternal PA 
and infant birthweight, found in study three, conflicts with current literature. Clapp 
et al. (2002), found that considerable reductions in maternal PA in mid-to-late 
pregnancy resulted in the delivery of larger, fatter infants compared to mothers 
maintaining or increasing their PA(12). Despite the null findings observed in this 
dissertation, these studies contribute to the this rapidly growing area of research, 
specifically in the overweight or obese subpopulation. 
There are several limitations of this dissertation. For study one, maternal 
body mass and physical activity were evaluated using self-reported methods. It is 
well-documented that these measures may lead to biased, and less precise 
estimated associations(5, 34). These methods are prone to misreporting due to 
social desirability(1), the individual’s inability to remember certain behaviors and 
the length of the recall period(2). The implementation of objective measures of 
maternal body mass and physical activity behaviors, which are demonstrated to 
produce more accurate estimates, in future studies are encouraged. 
In studies two and three, a small sample size was a significant limitation. 
The small sample size in this study may have limited our ability to detect and 
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association via a reduction in statistical power. This limitation however, is 
common in studies conducted in the pregnant population. Because women 
become pregnant sporadically, at any given point in time, the number of women 
in the early stages of pregnancy that are available for study recruitment is small. 
Thus, recruiting large samples of pregnant women is challenging. Another 
limitation to these two studies was the assessment of maternal PA. While 
pedometers are an objective measurement tool, they only capture volume of PA. 
It is well-documented that other components of PA, including frequency, duration 
and intensity, are important to several health parameters(21). Thus, objective 
measurements of PA that are able to measure all components of PA, such as 
accelerometers, should be used. In addition, we did not consider other potential 
health behaviors that have been documented to influence infant size, including 
maternal diet(37). Lastly, a limitation across all studies, is the measurement of 
infant size. Birthweight is a ubiquitous measure of infant size. However, this 
metric fails to provide information on the tissue composition of the infant including 
fat and fat-free mass(11). Determining these parameters is important to future 
health risks and should be included in future research. 
The maternal-child health field is a rapidly growing area of research. While 
several studies examining the association between maternal PA and infant size 
have been conducted, much remains to be learned about this relationship, 
especially in overweight or obese women. Although there is an established 
inverse relationship between maternal PA and infant size in normal weight 
women(35), the few studies conducted in overweight or obese women have 
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reported null associations(28, 30, 33). A lack of a relationship in this subgroup is 
problematic given that 50% of women of reproductive age are overweight or 
obese(18). Moreover, these women are predisposed to excessive gestational 
weight gain(26) and the delivery of larger infants(16). As such, it is imperative 
that more research is conducted in this understudied subpopulation. Specifically, 
it would be of public health interest to determine a dose of PA that protects 
against infant macrosomia. Discovery of such information would be valuable for 
exercise prescription guidelines for pregnant women. 
Much of the evidence evaluating the relationship between maternal PA 
and infant size is epidemiological. This type of research is important to scientific 
progress; however, it is only the initial step in describing this relationship. Thus, 
our knowledge on the mechanisms that underlie this relationship are largely 
unknown. Further, little research has examined the effects of maternal PA on 
placental growth and function and its relation to infant size(10, 13). The placenta 
is a critical organ as it is the conduit through which the mother and fetus 
communicate and regulates fetal energy supply(6, 14, 15). Thus, evaluating the 
effects of maternal PA on placental development and function and its relation to 
fetal growth is important. Further research into these mechanisms will provide a 
more in-depth understanding of the relationship between maternal PA and infant 
size. 
In summary, the moderating, independent and joint relationships between 
maternal PA and CRF and infant size were investigated. Across all three studies, 
maternal PA and CRF were unrelated to infant birthweight or macrosomia. 
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Similarly, for all three studies, low levels of maternal PA and CRF with restricted 
variability were a common explanation for the null findings. Despite the null 
observations, these studies contribute important information on these 
relationships and serve as an important starting point for this rapidly growing 
area of research. Given the paucity of studies investigating these relationships, 
specifically in overweight or obese women, more research is warranted. In 
closing, these studies did not support the hypotheses that maternal PA or CRF 
impact infant size.  
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CHAPTER 5 
PROPOSAL
 102 
 
Introduction 
In the United States, the prevalence of infants born macrosomic or large-
for-gestational age is increasing(114). Evidence suggests that neonates with 
excess adiposity at birth may experience altered growth trajectories possibly 
attributed to augmented tissue growth during periods of accelerated 
development(71, 179, 187) (e.g. adiposity rebound, puberty). Consequently, this 
may predispose neonates to obesity(180) and the associated morbidities in 
childhood and adolescence.(60, 130) 
Maternal size has been identified as a significant predictor of infant size 
such that larger mothers produce larger offspring(94, 178). Substantial evidence 
has demonstrated that this relationship is potentially a function of nutrient supply. 
Nutrient supply has been suggested to be the strongest predictor of fetal growth 
as any alterations to the availability of nutrients may have dramatic fetal effects 
such as growth restriction or macrosomia(15, 136). In order to optimize fetal 
growth, several maternal physiological changes occur, including the onset of 
peripheral insulin resistance.(76, 81) However, in pregnancies complicated by 
maternal obesity, these changes have been demonstrated to be 
exacerbated.(32, 104) In addition, preexisting obesity-related metabolic 
consequences including central insulin resistance(51) and poor glycemic and 
lipidemic control(90, 145) may result in the availability of excess nutrients in the 
intrauterine environment.  Given this and the fact that nearly 50% of women of 
reproductive age in the U.S. are overweight or obese(63), identifying factors that 
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enable pregnant women to control their metabolic intrauterine environment 
should be a major public health priority. 
Among non-pregnant populations cardiorespiratory fitness and physical 
activity have been consistently demonstrated to exhibit protective effects on 
several morbidities and mortality.(24, 25, 168) These effects are likely due to the 
cardiovascular(49), metabolic(75) and musculoskeletal adaptations(156) that 
occur with chronic exercise training that may result in improvements such as 
increased insulin sensitivity and improved glycemic and lipidemic control. 
Additionally, these effects persist even in the presence of excess adiposity, 
suggesting that a “healthy” level of cardiorespiratory fitness and participation in 
an adequate amount of physical activity may mitigate the negative effects of 
obesity on cardio-metabolic health outcomes.(106, 181) It is reasonable to 
suggest that this phenomenon may exist during pregnancy, such that a higher 
level of cardiorespiratory fitness and engagement in a sufficient dose of physical 
activity at the onset and during the perinatal period may alleviate the adverse 
consequences of maternal adiposity on infant birthweight via a controlled 
metabolic intrauterine environment. However, to our knowledge, the impact of 
cardiorespiratory fitness and/or physical activity on the relationship between 
maternal adiposity and infant birthweight is largely unknown. 
Statement of the Problem 
The major purpose of the proposed study is to determine if participation in 
physical activity and/or higher levels of cardiorespiratory fitness in the perinatal 
 104 
 
period alleviate the adverse effects of maternal overweight and obesity on infant 
weight status. Specifically, this proposed study will: 
1. Determine if maternal physical activity in the preconception and prenatal 
period moderates the relationship between maternal weight status and 
infant weight status, in a nationally representative and diverse sample of 
mothers delivering live-birth infants. 
 
2. Determine if maternal prenatal cardiorespiratory fitness and objectively-
measured physical activity independently associate with infant weight 
status, among a sample of overweight and obese pregnant women. 
 
3. Determine if maternal cardiorespiratory fitness and objectively-measured 
physical activity jointly associate with infant weight status, among a 
sample of overweight and obese pregnant women. 
 
4. Determine if change in objectively-measured physical activity is 
associated with infant weight status, among a sample of overweight and 
obese pregnant women. 
 
5. Determine if cardiorespiratory fitness influences the relationship between 
change in maternal objectively-measured physical activity and infant 
weight status, among a sample of overweight and obese pregnant women. 
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Aims 
The overarching purpose of this dissertation is to evaluate a developing 
hypothesis that higher levels of maternal physical activity and cardiorespiratory 
fitness in the preconception and prenatal periods will reduce the negative effects 
of maternal weight status on infant weight status. 
Aim 1: To observe the potential effect of maternal physical activity during the 
preconception and prenatal periods on the association between maternal weight 
status and infant weight status, in a representative and diverse sample of women 
delivering live-birth infants. 
Objective 1A: To determine if self-reported prenatal physical activity 
modifies the relationship between maternal pre-pregnancy weight status 
and infant weight status. 
Objective 1B: To determine if self-reported pre-pregnancy physical activity 
alters the moderating effect of prenatal physical activity on the relationship 
between maternal pre-pregnant weight status and infant weight status. 
 
Aim 2: To observe the potential effect of maternal cardiorespiratory fitness and 
objectively-measured physical activity during pregnancy on infant birthweight, in 
a sample of overweight and obese women. 
Objective 2A: To determine the effect of cardiorespiratory fitness in mid-
pregnancy on infant birthweight. 
Objective 2B: To examine the effect of objectively-measured physical 
activity in mid-pregnancy on infant birthweight. 
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Objective 2C: To examine the joint effect of cardiorespiratory fitness and 
objectively-measured physical activity in mid-pregnancy on infant 
birthweight. 
Aim 3: To observe the potential effect of changes in maternal physical activity 
and cardiorespiratory fitness during pregnancy on infant birthweight, in a sample 
of overweight and obese women. 
Objective 3A: To evaluate the effect of change in objectively-measured 
physical activity from mid- through late pregnancy on infant birthweight. 
Objective 3B: To determine if cardiorespiratory fitness in mid-pregnancy 
modifies the association between changes in objectively-measured 
physical activity from mid- through late pregnancy and infant birthweight. 
Scope 
Secondary data analyses from one population-based study and one, 
randomized controlled exercise intervention trial will be performed to address the 
aims and objectives of this proposed study. (1) The National Maternal and Infant 
Health Survey sampled resident mothers who had a live birth, fetal death or 
infant death in the United States in 1988. Mothers aged 15 years and older, 
delivering live-birth infants, who provided data on anthropometrics (i.e. height 
and weight) and self-reported physical activity behaviors in the preconception 
and perinatal periods will be included in the proposed study. In addition, infants 
of these mothers where data on weight status are provided will also be included 
in this study. (2) The randomized controlled exercise intervention trial sampled 
women in early pregnancy (<14 weeks gestation) whom were at risk for 
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preeclampsia (i.e., sedentary, previous preeclamptic pregnancy) from nine 
prenatal clinics in one county in the state of Michigan. Pregnant women who had 
anthropometry and cardiorespiratory fitness measurements and an objective 
measure of physical activity in the perinatal period will be included in this study. 
In addition, the infants of these mothers where data on weight status are 
available will also be included in this proposed study. The study findings from the 
first study will be generalizable to all U.S. mothers aged 15 years and older, who 
had live-births in 1988. Generalizations from the second trial will be to all women 
at high-risk for preeclampsia that are able to participate in physical activity in the 
perinatal period. 
Assumptions 
The proposed study will make the following assumptions: 
1. Pre-pregnancy body mass index is a valid and reliable measure of 
maternal adiposity in the preconception period. 
2. The mother is able to accurately recall her pre-pregnancy weight and 
height after an average period of 17 months postpartum. 
3. Self-reported physical activity is a valid and reliable measure of physical 
activity behavior in the preconception and perinatal periods. 
4. The mother is able to accurately recall her physical activity prior to and 
during pregnancy after an average period of 17 months postpartum. 
5. Pedometers are a valid and reliable measure of physical activity, and daily 
step counts are an accurate measure of daily physical activity behavior. 
 108 
 
6. Last menstrual period and ultrasounds are valid and reliable measures to 
estimate gestational age. 
7. Data extracted from the birth certificates and medical records are reported 
consistently and accurately across all levels (i.e. hospitals, clinics, and 
states). 
Limitations 
Pre-pregnancy body mass index will be calculated based on self-reported 
maternal height and weight which rely on the ability of the individual to recall this 
information after an extended period of time (~17 months). It has been 
demonstrated that women over-report their height and underreport their weight, 
and there may be a systematic bias based on their “actual” level of adiposity, 
such that larger women may report less accurately.(150) As a result, larger 
women may be misclassified into lower body mass index categories. Further, 
self-reported physical activity measures are prone to misreporting (over-reporting 
or underreporting) due to several reasons (e.g., inability to remember, social 
desirability)(4, 161), as such women may be inaccurately categorized as active 
which may nullify the potential moderating effect of physical activity on maternal 
weight status and infant weight status. One study sampled pregnant women that 
were at high-risk for preeclampsia and whom completed a run-in period which 
limits the generalizability of these findings to more compliant pregnant women 
and may introduce a sampling bias. 
  
 109 
 
Relevance of the Proposed Study 
The proposed study will determine if cardiorespiratory fitness and physical 
activity in the preconception and prenatal periods impact the association between 
maternal weight status and infant weight status. Consistent evidence has 
indicated that maternal weight status is positively associated with infant weight 
status.(98, 193) This relationship is suggested to be a function of nutrient supply, 
a strong predictor of fetal growth(178). In addition, considerable evidence in non-
pregnant populations has demonstrated protective effects of higher levels 
cardiorespiratory fitness and physical activity on metabolic health outcomes, 
independent of adiposity.(106) Given the potent metabolic effects of physical 
activity and exercise,(148) it is of great interest and relevance to determine if 
higher levels of cardiorespiratory fitness and physical activity in pregnancy 
mitigate the negative impacts of maternal adiposity on infant weight status. The 
findings from this study will provide information on whether cardiorespiratory 
fitness and/or physical activity are potential strategies that enable a mother to 
protect her fetus from overgrowth. 
Review of the Literature 
Infant Birthweight 
Birthweight, defined as the weight in grams at the time an infant is 
delivered, has been identified as an indicator of fetal wellbeing and is considered 
a strong predictor of infant morbidity and mortality(119, 149). The severity of the 
health outcomes associated with birthweight is the most marked at the extremes 
of the birthweight distribution (i.e. growth restriction, macrosomia). Infants 
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suffering from fetal growth restriction (FGR) or macrosomia are burdened with 
increased risk of many immediate and long-term health consequences including 
fetal and neonatal death, obesity, type 2 diabetes mellitus and metabolic 
syndrome(14, 15, 33, 136). While the suffering of infants born at both birthweight 
extremes are of significant public health importance, it appears that the birth of 
larger neonates has become a growing concern, particularly among developing 
countries. 
Trends in Infant Birthweight 
Since the 1970s, evidence has suggested upward shifts in the distribution 
of infant birthweight among several developing countries. Specifically, Skjaerven 
et al. (2000) reported a 100g-increase in mean birthweight over a 30-year period 
(1967-1998) in Norway(160). In China, Lu et al. (2011) reported a significant 
increase in infant birthweight (+73g) from 1994 to 2005(112), with similar 
increases reported in Queensland, Australia from 1988 to 2005 
(+1.9g/year)(103), Sweden from 1992 to 2001 (+35g)(169), Canada from 1981 to 
1997 (+35g)(182) and in the United States (1985 to 1998)(9). Conversely, in the 
United States, some evidence has indicated that mean birthweight declined by 
approximately 52g from 1990 to 2005(56). This coincides with a recent report by 
Oken (2013) which suggested that mean birthweight continued to decline (as of 
2008) since 1990(128). However, birth data from the most recent National Vital 
Statistics Report (2013) indicates that from 2006 to 2013 there has been an 
upward shift in the birthweight distribution for U.S. infants, suggesting that on 
average infants are being born heavier.(114) Specifically, this report indicates 
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that the proportion of infants born greater than 3,000g increased from 2006 to 
2013 (73.30% to 73.75%, respectively), while the proportion of low birthweight 
(i.e. 2,500-2,999g) infants has declined over the same 7-year period (18.44% to 
18.22%). Despite some inconsistencies in the scientific literature regarding 
trends in infant birthweight over the past several decades, particularly in the 
United States, this evidence is suggestive that mean infant birthweight has 
increased, and that on average, infants are born heavier. 
Although some evidence suggests that, on average, infants are born 
heavier, the mean birthweights reported fall within a “normal” range (i.e. 2500 to 
4000g) for a “healthy” infant(81). Given this, it is unclear whether the upward 
shifts in the birthweight distribution affect the proportion of infants born at the 
upper extremes (90th percentile), representing the largest infants. As such, the 
use of mean birthweight as a metric to track changes in infant anthropometry, 
specifically larger infants, may be inadequate. Birthweight is a crude measure of 
infant anthropometry. Consequently, this metric cannot quantify the tissue 
composition of an infant. It is generally accepted that a higher birthweight is 
indicative of greater adiposity and comparable lean body mass compared to 
infants with a normal birthweight(36). However, it is possible that an infant with 
an “average or normal” birthweight (2.5 to 3.9 kg), may have significant variations 
in tissue composition that cannot be detected with the birthweight metric. Sewell 
et al. (2006) demonstrated this concept when comparing birthweights of infants 
born to overweight/obese and lean women.(154) These authors reported that 
mean birthweight did not significantly differ (3436g vs 3284g, respectively) 
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between these groups of women, however, significant differences in percent 
body fat (11.6% vs 9.7%, respectively) and fat mass (420g vs 380g, respectively) 
of infants were found. Infants born to overweight/obese women had higher levels 
of adiposity compared to their lean counterparts, with no differences in lean body 
mass. This suggests that birthweight may not be an appropriate measure to 
evaluate trends in the prevalence of larger infants, specifically those that may be 
more likely to possess an unfavorable tissue composition. As such, to improve 
the surveillance of the delivery of larger infants, other metrics may be necessary. 
Trends in Macrosomia and Large-for Gestational Age Infants 
In the scientific literature, there are two metrics frequently used to describe 
a “large” infant. The first metric is macrosomia, which is defined as an infant 
weighing 4,000 g (> 4.0 kg) or more at delivery, regardless of gestational age. 
The second metric is large-for-gestational age (LGA), which is defined as an 
infant born with a birthweight that is at the 90th percentile or higher for a specific 
gestational age, compared to a reference population(127). Because these 
metrics are specifically used to identify larger infants, it is possible that they may 
more accurately capture changes in the proportion of infants born at the upper 
extreme of the birthweight distribution. 
Similar to the trends in mean infant birthweight, many developing 
countries have reported increases in the proportion of infants born macrosomic 
and large-for-gestational age. Specifically, in China, Shan et al. (2014) 
documented increases in the prevalence of macrosomic infants from 1996 (6.6%) 
to 2010 (17.0%)(155). Vranes et al. (2015) reported increases in the proportion of 
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infants born macrosomic from 1985 (10.2%) to 2009 (13.6%) in Croatia(177). 
Similarly, in Queensland, Australia, there was an increase in the rate of (+0.8% 
per year) of macrosomic infants from 1988 to 2005(103). In addition, other 
countries including North England (1962 to 2000)(19) and Belgium (1991 to 
2010)(73) also reported increases in the prevalence of macrosomia, 25% and 
18%, respectively. Trends in the proportion of the delivery of large-for gestational 
age infants are similar in that many developing countries have documented 
increases in LGA infants. Wen et al. (2003) reported that from 1981 to 1997 there 
were significant increases in the proportion of term infants (37-40 weeks) born 
LGA in Canada(182). In addition, Ananth et al. (2002) reported increases in term 
LGA infants in both Canada from 1985 to 1998.(9) In China, Lu et al. (2011) 
reported an increase in LGA infants from 1994 to 2000 (13.72% to 18.98%)(112), 
and remained stable through 2005. Moreover, in Sweden, Surkan et al. (2004) 
documented a 23% increase in the proportion of LGA infants from 1992 to 
2001(169). 
Consistent with the conflicting trends in mean birthweight found in the 
United States, trends in the prevalence of macrosomia and LGA infants in the US 
follow similar patterns. The trends for both these metrics have been reported to 
increase, decrease or remain stable over time. For example, Donahue et al. 
(2010) reported that the prevalence of infants born LGA declined from 1990 to 
2005(56). Extending the previous work of Donahue and colleagues, Oken et al. 
(2013)(128) reported that the proportion of infants born LGA decreased in male 
and female infants from 1990 (11.1% and 10.5%, respectively) to 2005 (9.4% 
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and 9.1%, respectively). Ananth et al. (2002) and Zhang et al. (2010) reported 
stable prevalence estimates for LGA infants from 1985 to 1998 and 1992 to 
2003, respectively(9, 195). Interestingly, the former study also reported a 25% 
reduction in the proportion of infants born macrosomic (2.2% to 1.6%). In 
addition, Oken et al. (2013) suggested that the prevalence of macrosomia 
declined nearly 50% from 1990 to 2008(128). Conversely, the most recent data 
available (2013) from the National Vital Statistics System has documented that 
the prevalence of macrosomia in the United States is approximately 8.0%(114). 
While this is lower than the prevalence recorded in 1990 (10.88%) by Oken et al. 
2013, it is higher than the prevalence rates reported in 2006 (7.82%) and 2008 
(7.62%), which may indicate the emergence of an increasing trend in infant 
macrosomia. Recent data however, on the trends in the proportion of infants born 
LGA, do not appear to be present in the current scientific literature. 
Overall, the evidence suggests there are increases in the trends of 
macrosomic and LGA infants; however, as with the mean infant birthweight 
measure, there are significant limitations to these metrics that may result in the 
misestimation of the magnitude of these trends and warrant consideration. First, 
there is a lack of consensus in the scientific literature regarding the birthweight 
threshold used to define macrosomia. Currently, several thresholds are used 
(4000 g, 4500 g, or 5000 g) which may affect not only the direction but the 
magnitude of the trends reported. This was demonstrated in the study conducted 
by Oken et al. (2013) where macrosomia was defined as a birthweight greater 
than 5,000 g and the authors reported a 50% reduction in macrosomia from 1990 
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to 2005. The use of a different threshold, such as 4000 g, would have decreased 
the magnitude of this reported reduction by 50%, suggesting that macrosomia 
only declined roughly 25% during this time period. The incongruity regarding the 
birthweight threshold for macrosomia may be in part due to the outcome 
associated with a particular threshold. For example, Boulet et al. (2003) 
investigated adverse outcomes associated with various birthweight thresholds 
that are often used to define macrosomia (i.e. 4000g, 4500g and 5000g)(27). The 
authors found that risks of labor complications, birth injuries, and neonatal 
morbidity increased with each grade of macrosomia, however only infant 
mortality was associated with infants weighing 5000g or more. The authors 
suggested that the 4000g-threshold may be best used to predict labor and 
neonatal complications, however higher thresholds may be more predictive for 
neonatal morbidity (>4500g) and mortality (>5000g). 
In addition to lack of consensus on the definition of macrosomia, the 
application of a universal threshold for macrosomia across all infants may be 
inappropriate. It is well-documented that infant birthweight differs by country, 
race, and infant sex. While determining the prevalence of macrosomia across 23 
countries, Koyanagi and colleagues (2013) demonstrated the existence of 
considerable variability in birthweight among various countries. For example, the 
average birthweight was lower in Asian (2697-3181g) and Latin (3119-3311g) 
countries compared to the United States (3455g) and China (3369g)(96). 
Moreover, it is well-established that male and White infants are born significantly 
heavier (~200g) than their female and Black infant counterparts.(7) The latter is 
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supported by a recent study by Ye et al. (2014) that reported a significant 
increase in risk of adverse perinatal outcomes at different birthweight thresholds 
for White (>4500g) and Black (>4300g) infants.(189) Given this, it seems that the 
universal application of the 4000 g or greater threshold may be inappropriate. 
In addition to the limitations of macrosomia, there are also drawbacks to the use 
of the large-for-gestational age metric. First, the LGA measure relies on the 
accuracy of the measurement used to estimate gestational age.(17) The most 
common method to estimate gestational age is by maternal recall of the first day 
of her last menstrual period (LMP). The LMP method is subject to considerable 
error. Kramer et al. (1988) demonstrated that despite a positive predictive value 
(PPV) of 95% for predicting a term infant, the ability of this method to accurately 
estimate gestational age significantly decreased for preterm (PPV=0.775) and 
post-term infants (PPV=.119)(97). This is problematic as the inaccuracy of this 
method may lead to significant misclassification and misestimation of the 
prevalence of LGA infants. Second, the classification of an LGA infant is typically 
determined using an established country-specific reference population; however, 
many other maternal and fetal factors that have been demonstrated to affect fetal 
growth are excluded, including maternal weight, parity, race/ethnicity and infant 
sex.(5, 6, 80) In light of this, the use of customized birthweight percentiles to 
identify LGA infants have been proposed and studied. For example, Pasupathy 
et al. (2012) compared the prevalence rates of LGA and macrosomia using 
customized birthweight percentiles, corrected for gestational age, maternal 
weight and height, parity, ethnicity and infant sex, to birthweight percentiles of a 
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standard reference population.(132) This study found that 53% of macrosomic 
and 25% LGA infants, defined using the standard references population, were 
misclassified after the adjustment for maternal and fetal characteristics. This 
suggests that maternal and fetal factors that have been demonstrated to affect 
fetal growth should be accounted for in the identification of larger infants. 
Based on the evidence presented, there appears to be increasing trends 
in the average birthweight of infants and the proportions of macrosomic and 
large-for-gestational age infants in many developing countries including the 
United States. Considering the importance of fetal growth to the health and 
wellbeing of the infant, the increasing trends in delivery of larger infants, likely 
characterized by an unfavorable tissue composition (i.e. increased adiposity), 
should be considered a major public health concern. 
Maternal-Fetal and Neonatal Consequences to Macrosomia 
 The increasing trends in excessive fetal growth are problematic as 
macrosomia poses numerous and significant health risks to the mother, fetus and 
neonate(194). Mothers carrying a macrosomic fetus are at increased risks of 
complications during labor (e.g. delayed(158)), delivery (e.g. cesarean 
sections(167)) and the postpartum period (e.g. perineal laceration(8), 
hemorrhage(163)). Fetuses that are macrosomic may have an elevated risk of 
mortality, several morbidities (e.g. asphyxia, congenital anomalies)(93), and 
physical injuries incurred during delivery (e.g. shoulder dystocia(82)). Neonates 
born macrosomic may be burdened with both immediate (e.g. hypoglycemia, 
respiratory distress)(93) and long-term (e.g. overweight/obesity(180), altered 
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growth trajectories(101)) health risks. Given this, the development and delivery of 
a macrosomic infant is a significant obstetric and public health challenge. 
Maternal Environment and Nutrient Supply 
While numerous factors have been demonstrated to be related to fetal 
growth(115) (e.g., maternal age, parity, race/ethnicity), the strongest predictor 
and likely the underlying mechanism between these factors and fetal growth is 
nutrient supply to the fetus(74, 178). To ensure that an optimal level of nutrients 
is available to the fetus, several physiological adaptations occur throughout the 
gestational period(76, 81). Glucose and amino acids are the primary sources of 
fuel that are necessary for fetal growth(18). As such, the maternal environment 
during pregnancy adjusts to prioritize the availability of these substrates. 
Marked physiological alterations to maternal metabolism begin and are 
maximized in the 2nd and 3rd trimesters of pregnancy, respectively, concurrent 
with the acceleration of fetal growth. The most critical adaptation to the maternal 
environment is the development of insulin resistance (IR)(165). This adaptation is 
transient as it subsides in the postpartum period and is often referred to as the 
“diabetogenic” state of pregnancy. The onset of IR occurs in the 2nd trimester and 
progressively worsens through the middle of the 3rd trimester. The IR 
predominantly affects the periphery (e.g. skeletal muscle) with reported 
reductions in insulin sensitivity between 55 to 70%(37). The primary purpose of 
the development of IR is to reduce maternal uptake and utilization of glucose and 
amino acids in an effort to spare these substrates for the fetus(131, 164). To 
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satisfy the metabolic needs of the mother, catabolism of the maternal fat stores 
deposited in early pregnancy increases dramatically(95). 
The presence and severity of IR in pregnancy is most evident in the basal 
and postprandial periods. In the basal state, consistent evidence indicates that 
levels of glucose and amino acids are lower compared to non-pregnant women 
suggesting enhanced fetal uptake of these substrates(66). This phenomenon is 
often referred to as “accelerated starvation.” Also during this state, maternal 
levels of free fatty acids are significantly elevated compared to non-pregnant 
counterparts(95). In addition, insulin levels are also elevated and are higher 
compared to non-pregnant women. Despite higher levels of insulin, hepatic 
glucose production is increased (16 to 30%(38)) in the fasting state, likely as an 
attempt to increase the amount of glucose available to the fetus. Because insulin 
inhibits the mobilization of glucose, the increased levels of hepatic glucose 
production may be suggestive of slight central insulin resistance(52). 
In the postprandial period, several exaggerated metabolic responses 
occur. First, the glucose levels increase significantly to a higher peak and are 
sustained for a prolonged period in pregnant women compared to non-pregnant 
women, due to the presence of insulin resistance. Second, in order to 
compensate for the sustained hyperglycemia, the insulin response is augmented 
by 200 to 250%(31, 34). In an effort to overcome the hyperglycemia found in the 
postprandial period the significant increase in insulin levels is suggested to help 
“push” the nutrients (i.e. glucose and amino acids) to the uteroplacental unit for 
fetal uptake and is referred to as “facilitated anabolism(67).” Failure of the 
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pancreatic β cells to adequately compensate to the elevated glucose levels often 
results the diagnosis of gestational diabetes mellitus(28). 
Given the importance of nutrient supply to optimal fetal growth and 
development, the maternal metabolic environment adjusts to ensure adequate 
availability of nutrients. Disturbances in the maternal environment that may affect 
nutrient supply may have adverse effects on fetal growth. These disruptions often 
result in fetal growth restriction or fetal overgrowth, each possessing immediate 
and long-term effects on the health of the progeny. 
Nutrient Supply and Fetal Overgrowth 
In the scientific literature, disruptions in nutrient supply often result in 
reduced or excessive fetal growth(14, 136). Given the current rise in the delivery 
of macrosomic and LGA infants occurring in the U.S., disturbances that lead to 
excess nutrient availability are of particular interest. The most demonstrable 
example of the effects of excess nutrient supply is found among women with 
pregnancies complicated by diabetes. 
Over a half century ago, while working with women diabetic pregnancies, 
Jorgen Pedersen formulated the hyperglycemic-hyperinsulinemic model, 
commonly known as the Pedersen Hypothesis(134, 135). This hypothesis 
suggests that fetal overgrowth was due to repeated exposure of higher levels of 
maternal glucose (i.e. hyperglycemia) during pregnancy. In addition, Pedersen 
speculated that the excessive glucose transferred to the fetus induced fetal 
hyperinsulinemia. Because maternal insulin cannot cross the placenta(122), it 
was hypothesized that in response to hyperglycemia, the fetal pancreas secreted 
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heightened levels of insulin. This is supported by evidence demonstrating 
enhanced fetal pancreatic growth via increased β cell mass and function (i.e. 
insulin content and secretion) found among fetuses of diabetic mothers.(142, 
192) Augmented levels of insulin are suggested to further stimulate the release of 
growth-promoting factors (e.g. insulin-like growth factors) subsequently 
increasing adipocyte deposition in the fetus(65). In support of this, studies have 
found higher levels of c-peptide, a marker of insulin secretion, and growth factors 
in macrosomic infants compared to normal weight infants(13). 
While diabetic pregnancies (e.g. type I, II and gestational) are associated 
with the highest risk of delivering a macrosomic infant, only 14% of pregnancies 
are complicated by diabetes(83). This suggests that diabetic pregnancies are 
likely not a significant contributor to the increasing trend in the delivery of 
macrosomic and LGA(58). This may suggest that other maternal factors 
exhibiting similar perturbations on the intrauterine environment (i.e. 
hyperglycemia) may be a more plausible explanation. Interestingly, a common 
co-morbidity of women with diabetic pregnancies is the presence of overweight 
or obesity. Evidence has indicated that nearly 70% of women with gestational 
diabetes are overweight of obese(89). Accumulating evidence suggests that 
maternal pre-pregnancy obesity is a significant, independent risk factor for the 
delivery of a macrosomic infant(23, 69). In addition, a recent epidemiological 
surveillance study indicated that nearly half (46%) of women of reproductive age 
(20 to 39 years) are overweight or obese, with evidence of an increasing 
trend(63). Given this and evidence supporting maternal body mass as an 
 122 
 
independent risk factor for augmented fetal growth, it is plausible that maternal 
overweight and obesity may be the dominating factor explaining the rise in infant 
macrosomia. 
Maternal Obesity and Fetal Growth 
Consistent evidence has demonstrated that maternal size is a significant 
predictor of fetal size, such that larger mothers produce, on average, larger 
offspring(74, 178). This relationship is suggested to exist as a function of nutrient 
supply, whereby larger mothers deliver more nutrients to their fetus compared to 
their smaller counterparts; potentially due to the augmented amount of maternal 
energy resources and disruption of the metabolic environment(110, 145). 
Evidence suggests that the mechanisms that underlie the relationship between 
maternal obesity and infant macrosomia are similar to the hyperglycemic-
hyperinsulinemic model in the Pedersen hypothesis.(133, 136) Specifically, some 
studies have indicated that obese mothers may enter the perinatal period with 
existing metabolic dysfunction (e.g. insulin resistance) which may exacerbate the 
normal physiological adaptations that occur throughout pregnancy.(90) 
Consequently, it is the augmentations of these changes that are suspected to 
result in increased nutrient availability to the fetus and subsequently enhance 
fetal growth. 
The exacerbations of the pregnancy-induced changes to maternal 
metabolism are most evident when fetal growth is accelerating. As previously 
described, the onset of peripheral insulin resistance begins in the second 
trimester, primarily affecting maternal peripheral glucose uptake. Compared to 
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non-obese pregnant women, obese pregnant women are suggested to present 
with pronounced insulin resistance, higher levels of glucose, amino acids, and 
free fatty acids in the fasting and postprandial periods.(90) Maternal insulin levels 
are substantially increased (~130%)(34). Despite this, the actual insulin response 
to a glucose stimulus is reduced compared to non-obese pregnant women (~200-
250%)(31), suggesting a potential pancreatic β cell impairment. Further, the 
suppression of hepatic glucose production via increased insulin levels has been 
demonstrated to be delayed up to four hours in obese pregnant women which 
suggests a greater level of central insulin resistance compared to non-obese 
pregnant women(159). Collectively, these findings indicate that the exaggerated 
metabolic adaptations in pregnancy found among obese pregnant women may 
result in a “hypernutrient” intrauterine environment in which the fetus is exposed 
to prolonged periods of excess nutrient availability. Similar to the Pedersen 
Hypothesis, the fetal consequences of exposure to excess nutrients in the 
intrauterine environment include increased adipocyte deposition, altered 
pancreatic growth and function, and organomegaly(65, 166, 170). In addition, 
recent evidence has also demonstrated that infants born to obese mothers may 
have early signs of metabolic syndrome(35). 
Considering that nearly half of women of reproductive age are overweight 
and obese(63), it is plausible that pre-pregnancy overweight and obesity is the 
dominating force behind the increasing trends in infant birthweight and 
prevalence of macrosomic infants. Consistent evidence has demonstrated that 
maternal overweight and obesity exacerbates the normal physiological 
 124 
 
adaptations to maternal metabolism occurring throughout gestation potentially 
resulting in excess nutrient availability to the fetus. The repeated exposure to the 
maternal metabolic dysfunction in the intrauterine environment may have 
significant adverse consequences to fetal growth and development, specifically 
increased adiposity at birth and risk of poor metabolic health outcomes in the 
future(105). 
Maternal Resources Hypothesis 
The substantial body of evidence underlying the Pedersen hypothesis has 
provided significant insight to the etiology of infant macrosomia, especially in 
pregnancies complicated by diabetes. More recent evidence however, has 
indicated that diabetes need not be present in the gestational period for 
metabolic perturbations to exist in the intrauterine environment.(32) While it 
suggested that maternal overweight and obesity may play a more significant role 
in explaining the increasing trends in larger infants(58), a majority of overweight 
and obese women do not give birth to macrosomic or large-for-gestational age 
neonates. In fact, a recent meta-analysis evaluating the relationship of maternal 
obesity on the occurrence of fetal macrosomia found that while the odds of 
delivering a large-for-gestational age or macrosomic infant (>4000g or >4500g) 
are increased among obese mothers, only 22.4%, 15.3%, and 3.9% of obese 
mothers delivered overgrown fetuses, respectively(70). Additionally, 50% of the 
macrosomic infants in the sample were born to normal weight mothers, and the 
remaining 50% to overweight and obese mothers. This potentially suggests that 
other factors may be more influential on fetal growth. 
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While the evidence to support the adverse influence of maternal weight 
status on fetal growth is significant, it fails to consider and explain one critical 
factor that has been demonstrated to have potent effects on human metabolism, 
that is, physical activity. Until recently, the potential important impact of maternal 
physical activity on the intrauterine environment and fetal growth has been 
mostly ignored. The maternal resources hypothesis is a recently developed 
theory that extends upon the current hypotheses on the influence of the 
intrauterine environment, with regard to nutrient supply, and fetal growth. The 
maternal resources hypothesis attempts to explain how maternal phenotype, 
specifically maternal body composition (i.e. obesity) and behavior (i.e. physical 
activity) impact the intrauterine environment and subsequently, the development 
of the fetus(10). 
Physical Activity and Nutrient Supply 
During pregnancy, maternal and fetal tissues compete for nutrients. 
Competition in early pregnancy is low as fetal energy demand is minimal. As 
pregnancy progresses coincident with accelerated fetal growth, the competition 
for nutrients increases dramatically. Alterations to the maternal environment in 
pregnancy (e.g. IR) are orchestrated in a manner to tightly control the 
competition for nutrients such that adequate levels of nutrients are available to 
both the mother and fetus. Additionally, maternal behaviors may also change in 
order to maintain a balanced competition for nutrients such as increases caloric 
intake (~200-300 kcal per day) and/or reductions in physical activity(91, 92).  
However, severe changes in these compensatory maternal behaviors, 
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specifically physical activity, may create an imbalance in the nutrients available to 
the maternal and fetal tissues thereby adversely affecting fetal growth. For 
example, higher levels of energy expenditure akin to hard physical labor may 
result in maternal tissues out-competing the fetus for nutrients and consequently 
restricting fetal growth. Such an extreme level of physical activity is often found 
among pregnant women in developing countries(172). Conversely, significant 
decrements in maternal physical activity may decrease the competition for 
nutrients between maternal and fetal tissues such that excess nutrients are 
supplied to the fetus. This extreme is likely what is characteristic of maternal 
physical activity behavior in the United States. This is evidenced by significant 
decrements in physical activity with advancing gestation, reports of pregnant 
women spending nearly 50% of their day in sedentary behaviors and less than 
25% of pregnant women achieving the daily 30-minute physical activity 
recommendation set forth by the American Congress of Obstetricians and 
Gynecologists (ACOG) and Physical Activity Guidelines for Americans(12, 61, 
62). 
Impact of Physical Inactivity on Metabolic Control and Fetal Growth 
The maternal resources hypothesis posits that maternal physical inactivity 
is the primary determinant to the excess nutrient availability in the intrauterine 
environment as a result of metabolic dysfunction. In support of this hypothesis, it 
is well established that skeletal muscle tissue accounts for 40% of body mass 
and nearly 80% of insulin-mediated glucose uptake(16) and as such, is a major 
determinant of whole-body glucose and lipid homeostasis(2). Consequently, any 
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disturbances to this function may have adverse metabolic effects to the maternal 
and fetal environment. 
In non-pregnant populations, considerable evidence has demonstrated 
that physical inactivity is associated with significant reductions glycemic 
control(21). Specifically, decreased energy expenditure is suggested to induce 
decrements in peripheral insulin sensitivity, glucose uptake and oxidation via 
disruption of the insulin signaling pathways(68). Additionally, excess glucose in 
the muscle is converted to lipids via de novo lipogenesis thereby increasing lipid 
accumulation in muscle(20). Elevated levels of intramuscular lipids are also 
proposed to inhibit insulin signaling, therefore may play a role in peripheral 
IR(138). Collectively, these alterations in the energy flux of the skeletal muscle 
may induce hyperglycemia. 
Decreased levels of physical activity are also suggested to adversely 
affect lipidemic control(88). Evidence indicates that physical inactivity 
downregulates lipoprotein lipase (LPL) activity, a key enzyme in the regulation of 
free fatty acid uptake in skeletal muscle, resulting in elevated blood lipid levels. In 
addition, free fatty acid oxidation in skeletal muscle is also reduced and available 
fatty acids are suggested to be diverted to storage, further perpetuating the loss 
in lipidemic control. Moreover, hyperlipidemia, in addition to hyperglycemia is 
also hypothesized to increase de novo lipogenesis in the liver and adipose 
tissue, further elevating blood lipid levels. Consequently, it appears that the 
presence of hyperglycemia and hyperlipidemia are initiated by physical inactivity 
and are augmented by each other’s presence(26, 87). 
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While a substantial proportion of the evidence supporting the adverse 
metabolic effects of physical inactivity has been demonstrated among non-
pregnant populations and pregnant animal models, these mechanisms are 
suggested to occur similarly in pregnant humans. The maternal resources 
hypothesis hypothesizes that the metabolic consequences of the low levels of 
physical activity and high levels of sedentary behavior(61, 62) found among 
pregnant women may augment the existing pregnancy-induced metabolic 
adaptations (e.g. IR). Specifically, low levels of physical activity may worsen 
peripheral insulin resistance thereby exacerbating hyperglycemia and 
hyperlipidemia, especially in the postprandial periods(121) and thus, increasing 
the maternal-fetal glucose and lipid concentration gradient favoring the diffusion 
of these nutrients across the placenta and creating a ‘hypernutrient’ environment 
for the fetus(48, 77). 
The fetal consequences to the repeated exposure to a ‘hypernutrient’ 
environment proposed in the maternal resources hypothesis reflect those found 
in the Pederson Hypothesis. Excess nutrient availability in the intrauterine 
environment is suggested to induce fetal hyperinsulinemia via a heightened 
insulin response of the fetal pancreas(166). As demonstrated, the pancreases of 
fetuses grown in hyperglycemic environment are shown to have increased mass 
and function126. The fetal hyperinsulinemic environment has been demonstrated 
to augment the presence of growth factors which may contribute to adipocyte 
hyperplasia(65, 86) (i.e. more adipocytes). In addition, the maternal resources 
hypothesis posits that excess nutrient availability has been suggested to 
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exacerbate fetal adipogenesis via increased number of free fatty acids and 
glucose transporters, uptake of free fatty acids into fetal adipocytes and 
triglyceride storage in addition to elevated enzymes that have been suggested to 
stimulate de novo lipogenesis in fetal adipose tissue(57, 110). 
Another unique contribution of the maternal resources hypothesis is the 
suggestion the excess nutrient availability induced by maternal physical inactivity 
may also alter fetal skeletal muscle development and function. Skeletal muscle 
development is nearly complete by the second trimester of pregnancy suggesting 
that any disruptions in early pregnancy may have a significant and permanent 
impact on the function of fetal skeletal muscle tissue129. Some evidence indicates 
that maternal metabolic dysfunction has been demonstrated to be associated the 
reduction in the size of muscle fibers and increased collagen accumulation within 
fetal skeletal muscle tissue(113). Smaller muscle fibers and accretion of fibrous 
tissue may impair the ability of muscle to generate force and overall function of 
skeletal muscle. 
The negative effects of physical inactivity on maternal metabolic health 
posited in the maternal resources hypothesis may be of particular concern for 
overweight and obese pregnant women. In non-pregnant and pregnant 
populations, overweight and obese women have been demonstrated to be the 
least active subgroup(50). Low levels of physical activity in the preconception 
period may increase the risk of a woman entering pregnancy with existing 
metabolic dysfunction (e.g., insulin resistance, poor glycemic/lipidemic 
control)(21, 68). This is problematic given that the development of the fetal 
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pancreas occurs early in pregnancy(139). As previously described, poor 
metabolic health may increase nutrient availability and alter the development and 
function of the growing fetal pancreas, specifically the β-cells. Moreover, 
evidence has indicated overweight and obese pregnant are at an increased risk 
of gaining excessive weight during pregnancy(53, 55, 79). In fact, nearly 60% of 
this subpopulation exceed the weight gain guidelines put forth by the Institute of 
Medicine(188). Substantial evidence in the scientific literature has demonstrated 
that excessive gestational weight gain is fairly strongly associated with the 
delivery of a larger infant. Given the established positive relationship between 
body weight and energy expenditure(108), it is reasonable to suggest that the 
augmented levels of weight gained found among overweight and obese pregnant 
women may be a result of decreased levels of physical activity. That is, the 
heightened level of energy expenditure of a larger pregnant woman that is 
required for a given activity may reduce physical activity. Consequently, there are 
adverse maternal and fetal effects to the decrements in this behavior and weight 
gain. First, as previously discussed, physical inactivity has negative effects on 
metabolic health. The associated poor glycemic and lipidemic control affects both 
the mother and her fetus due to increments in the availability of nutrients. For the 
mother, the excess nutrients may be partitioned to her fat stores thereby 
increasing fat deposition and weight gain(29). Unfortunately, this unnecessary 
gain in weight may perpetuate further reductions in physical activity potentially 
augmenting metabolic dysfunction and promoting excessive weight gain. For the 
fetus, the metabolic dysfunction as a direct and indirect consequence of physical 
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inactivity and weight gain, respectively, may lead to increased placental transfer 
of nutrients(48, 77) and subsequently enhance fetal growth via altered growth 
and function of the fetal pancreatic β-cells(166) and consequent adipocyte 
deposition(86). 
Collectively, the maternal resources hypothesis hypothesizes that the 
disturbances to nutrient supply, the strongest predictor of fetal growth, are a 
result of reduced levels of physical activity that likely occur in the preconception 
and perinatal periods. Physical inactivity during gestation is suggested to perturb 
the metabolic intrauterine environment via considerable decrements in skeletal 
muscle tissue energy demand and augmentation of the pregnancy-induced 
insulin resistance resulting in poor glycemic and lipidemic control. Subsequently, 
excess nutrients are provided to the fetus thereby altering fetal pancreatic β cell 
mass and function, inducing fetal hyperinsulinemia and promoting hypertrophy 
and hyperplasia of adipocytes and altered fetal skeletal muscle development. 
Consequently, the effects of the exposure to metabolic insults in pregnancy 
potentially result in a metabolically compromised, heavier, fattier neonate with 
less functional skeletal muscle tissue and a predisposition to adverse cardio-
metabolic health outcomes as a child, adolescent and adult (e.g. obesity, type II 
diabetes). 
Physical Activity or Exercise and Fetal Growth 
According to the maternal resources hypothesis, the low levels of physical 
activity in the perinatal period are suggested to be the primary mechanism for the 
increasing trends in infant macrosomia and LGA infants. As such, it seems 
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reasonable to speculate that the participation in adequate levels of physical 
activity or exercise in pregnancy may improve glycemic and lipidemic control, 
thereby controlling nutrient supply and protecting against fetal overgrowth. 
Among pregnant populations, several studies have examined the impact of 
physical activity or exercise on fetal growth(183).  Although physical activity and 
exercise are related, differences in their influence on health outcomes exist(72, 
184). Physical activity is defined as any movement produced by the skeletal 
muscles that elicit levels of energy expenditure above that equivalent to resting. 
While exercise falls under the overarching definition of physical activity, exercise 
is defined as a type of physical activity that is structured, repetitive and goal-
oriented with the purpose of improving or maintaining physical fitness(30). Given 
the differences in these terms, it may be anticipated that the evidence regarding 
their respective effects on fetal growth may differ and as such, they will be 
reported separately. 
Physical Activity in Pregnancy and Fetal Growth 
Evidence from studies evaluating the impact of physical activity in 
pregnancy on fetal growth is equivocal. A recent study from Mudd and 
colleagues (2014) reviewed studies examining the relationship between leisure 
time physical activity (LTPA) on several maternal and fetal outcomes including 
fetal growth. The study found that, in general, LTPA was inversely associated 
with the delivery of a macrosomic or LGA infant and importantly, no increase in 
risk for the delivery of a small-for-gestational age (SGA) infant(124). These 
findings are in conflict with another review by Takito et al. (2009), which reviewed 
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studies assessing the impact of maternal physical activity on neonatal outcomes, 
inclusive of infant weight status. This study found that women engaging in lower 
intensity physical activity were associated with increases in infant birthweight 
whereas participation in vigorous activities was associated with decrements in 
infant birthweight(173). These associations were only significant in the third 
trimester of pregnancy, likely due to the increased fetal energy demand. 
Interestingly, the association found between vigorous physical activity and infant 
birthweight varied by activity status of the mother. These authors found that 
active women reporting participation in vigorous activity in pregnancy was 
protective against the delivery of a low birthweight infant, however for sedentary 
women, engaging in vigorous activity in pregnancy increased the risk of a low 
birthweight infant. The latter finding may be due to the combination of the 
unaccustomed stress of high intensity activity and the stress from pregnancy-
related changes, which may result in a compensatory augmented uptake(175) of 
nutrients (e.g. glucose) and an abnormal reduction in the nutrients available to 
the fetus. The former finding is supported by a controlled trial conducted among 
elite athletes in pregnancy(84). In this study, pregnant athletes were assigned to 
a moderate or vigorous exercise training regimen. The authors reported 
increased birthweights among the high intensity group compared to the moderate 
intensity group. 
Studies evaluating the impact of objectively-measured physical activity on 
fetal growth did not provide any clearer insight on this relationship. Rufriok et al. 
2014 performed a secondary data analysis using data from two randomized 
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controlled trials(151). Physical activity was assessed at 15 weeks and between 
32 to 35 weeks of gestation using an Actigraph accelerometer. These authors 
found that participation in moderate-to-vigorous physical activity or sedentary 
behavior had no effect on infant birthweight. Similarly, in a prospective cohort 
study, Morgan and colleagues (2014) found that physical activity was not 
associated with the delivery of a macrosomic infant(123). Conversely, in a 
prospective cohort study, Reid et al. (2014) compared the free-living physical 
activity and sedentary behaviors, via SenseWear Armband, of women predicted 
to deliver macrosomic infants relative to controls(146). This study reported that 
women predicted to deliver a macrosomic infant engaged in less physical activity 
and more sedentary behavior compared to women predicted to deliver non-
macrosomic infants. 
Based on the findings from these studies, it appears that the impact of 
physical activity on infant weight status is inconclusive. Several factors may 
account for the equivocal nature of the evidence of this relationship. First, a 
majority of studies examining the association between physical activity and fetal 
growth utilize self-report measures (e.g., questionnaires, interviews) which vary 
considerably in the questions used to quantify physical activity and the time 
period for recall of this behavior (e.g. 1 year, 3 months). Moreover, self-reporting 
methods are notorious for providing inaccurate estimates of physical activity 
behavior given issues with recall, social desirability etc(4, 161). Further, the 
timing of the measurements may have also influenced the findings (e.g. early, 
mid or late pregnancy). While objective measures of physical activity have been 
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demonstrated to provide more accurate estimates of physical activity, many of 
the cut-point thresholds used in these studies were derived from studies 
conducted among non-pregnant populations(111). Considering substantial 
physiological changes occur in pregnancy including increases in resting energy 
expenditure(3, 143), it is reasonable to suggest that the intensity threshold 
between pregnant and non-pregnant populations are dissimilar. Lastly, the 
ambiguity of this relationship could be due to the variability in the metric used to 
define infant weight status. Among these studies, various weight status metrics 
used included infant birthweight, large-for-gestational age (>90th percentile), 
macrosomia (e.g., >4000g, 4500, or >5,000g). Based on the mixed results and 
limitations of these studies, it appears that the evidence regarding the effect of 
maternal physical activity in pregnancy on infant weight status is inconclusive. 
Exercise in Pregnancy and Fetal Growth 
Given that exercise is structured, repetitive, and progressive in nature(30) 
it is plausible that exposure to this type of physical activity may exhibit stronger 
effects on fetal growth. Additionally, compared to the studies assessing free-
living physical activity, exercise training studies likely employ more rigorous study 
designs and methodologies (i.e. randomized controlled trials, supervised) which 
may provide better insight nature of the relationship between exercise and fetal 
growth. 
Recently, Wiebe et al. (2015) conducted a systematic review of 
randomized controlled and controlled trials that examined the effects of 
supervised prenatal exercise on fetal growth(183). The authors of this review 
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reported that, in general, women participating in supervised exercise programs 
during the perinatal period had lower odds (31%) of delivering a macrosomic or 
large-for-gestational age infant. Additionally, reductions in mean infant 
birthweight were found among infants born to mothers who exercised during 
pregnancy compared to infants born to non-exercising mothers. Interestingly, this 
significant finding was restricted to studies conducted among normal weight 
women (n=26). The three studies implemented among overweight and obese 
pregnant women found that participation in an exercise program did not elicit any 
effect on infant birthweight or the delivery of a macrosomic or large-for-
gestational age infant. The lack of a significant effect of exercise on infant weight 
status among overweight and obese pregnant women is similar to the findings of 
another review assessing the effects of exercise on gestational weight gain. 
McDonald et al. (2016) examined the effects of exercise interventions on 
gestational weight gain and found that 75% of interventions that found a 
statistically significant reduction in weight gain were conducted among normal 
weight women(117). Considerable evidence has demonstrated a positive 
relationship between body weight and energy expenditure(11, 108). This 
suggests that there is increased difficulty with movement among heavier 
individuals, which may explain why overweight and obese women are the least 
active in the pregnant population and tend to have the worst compliance to 
exercise interventions. Lower compliance found among these women likely 
results in a reduced exercise dose and as such, may be insufficient to impact 
infant size. 
 137 
 
Conversely, Leet & Flick (2003) conducted a meta-analysis on 30 
randomized controlled, controlled trials, and prospective cohort studies 
evaluating the effects of prenatal exercise on fetal growth(107). Overall, this 
review found that maternal exercise does not have an appreciable effect on 
mean infant birthweight. However, among mothers who continued vigorous 
exercise into the 3rd trimester, significant reduction in birthweight (200 to 400g) 
were found compared to active controls. Interestingly, this reduction in 
birthweight only applied to women engaging in endurance activity during 
pregnancy. Participation in non-endurance exercise in the perinatal period did not 
exhibit any effect on infant birthweight. A recent review evaluated the impact of 
various types of exercise training (i.e. aerobic, resistance and combined) on 
maternal and infant health, inclusive of infant weight status. Perales and 
colleagues (2016) found that for aerobic exercise training studies, reductions in 
birthweight were found(137). Among resistance exercise training studies, too few 
studies assessed the effects on infant weight status for the authors to draw any 
conclusions. Studies exposing pregnant women to both aerobic and resistance 
training found decreased risk in the delivery of macrosomic infants and 
reductions in infant birthweight. However, these findings represent only 3 of 21 
studies evaluating this relationship, with the remainder reporting no effect on 
infant weight status. 
The conflicting findings regarding the effects of physical activity and 
exercise on fetal growth may be due to the influence of factors related to the 
exercise regimen prescribed including, volume and type, timing in pregnancy 
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(e.g. trimesters), and pre-pregnancy activity of the mother. Clapp and colleagues 
demonstrated the impact of some of these exercise-related factors in a series of 
prospective controlled trials implemented in the perinatal period(41, 42, 46). 
Clapp et al. (2002) examined the effect of exercise volume in pregnancy on fetal 
growth among a group of active women(42). This study found that pregnant 
women that maintain or increase their exercise volume ≥ 50% of preconception 
levels in mid- to late pregnancy, on average, deliver lighter (3390g vs 3810g) and 
leaner (8.3% vs 12.1%) infants compared to women who decrease their exercise 
below this level in similar trimesters. Interestingly, in another study, Clapp & 
Capeless (1990) compared the effects of two types of endurance exercise 
(running vs dance aerobics) on birthweight in a sample of active pregnant 
women(40). Compared to active (pre-pregnancy) controls, women engaging in 
either types of endurance exercise throughout pregnancy delivered lighter 
(3381g vs 3691g) and leaner (11.2% vs 16.1%) infants. The birthweights and/or 
anthropometrics of infants did not differ between the two endurance groups. 
Conversely, Clapp (2003) speculated that the effect of exercise type on fetal 
growth may be found when comparing weight-bearing to non-weight bearing 
exercise(44). Similar controlled studies conducted among active women in 
pregnancy who were exposed to non-weight bearing exercise (e.g. cycling) found 
that this type of exercise did not have an effect on birthweight(47). The difference 
in the effect of these types of exercises on fetal growth may be due to the level of 
energy expenditure that is associated with each type(102). Consistent evidence 
has demonstrated that weight-bearing exercise elicits greater levels of energy 
 139 
 
expenditure compared to non-weight-bearing exercise. This suggests that the 
former may reflect a higher intensity of exercise and may explain the reduction in 
birthweight associated with this type of exercise. 
Findings from another study by Clapp et al. (2000) suggest that the effect 
of exercise on fetal growth may differ based on the activity status of the mother in 
the preconception period(41). In this study, non-active women were randomized 
to an exercise condition or control at eight weeks of gestation. Contrary to the 
findings reported by Clapp et al. (1990, 2002) among active women, the findings 
from this study demonstrated a positive effect of exercise on birthweight. 
Previously inactive women that initiated an exercise regimen in pregnancy were 
found to have heavier infants (3660g vs 3430g) compared to sedentary controls. 
Body composition (e.g. lean and fat mass) however, was similar between the 
groups. These findings are in contrast with the meta-analysis of controlled trials 
conducted by Wiebe et al 2015 and with a large prospective cohort study in 
Norwegian pregnant women, which found that women reporting an inactive 
lifestyle in the preconception period delivered lighter infants and were less likely 
to deliver a macrosomic infant(99). In another study however, Löf et al. (2008) 
found that pre-pregnancy physical activity was not associated with infant 
birthweight(109). 
Taken together, it appears that the evidence regarding the effects of 
physical activity and exercise on fetal growth is suggestive of an inverse 
relationship, such that mothers continuing or initiating exercise in pregnancy may 
be associated with reduced infant birthweight or decreased risk of delivering a 
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macrosomic or LGA infant. In addition, it appears that the effect of exercise on 
fetal growth may vary depending on the exercise-related (e.g. volume) and 
maternal (e.g. body mass index, activity level) factors. Further, the evidence for 
this relationship is very limited for overweight and obese women. This is likely 
due to several factors, which may include small number of exercise trials, low 
activity levels among this subgroup(50), which likely increases the difficulty of 
participant recruitment, and this subgroup are often the least compliant(117), 
which may result in poor adherence to the exercise protocol and potentially 
diminished effects. The lack of evidence is unfortunate as nearly 50% of women 
in the preconception period are overweight or obese. Given the considerable 
evidence demonstrating a positive relationship between maternal adiposity on 
fetal growth(69, 90), determining whether exercise may be a useful strategy for 
alleviating the negative effects of maternal weight status on infant weight status 
should be a public health priority. 
Cardiorespiratory Fitness in Pregnancy and Fetal Growth 
Cardiorespiratory fitness is defined(171) as the “ability to engage in 
physical activities that rely on oxygen consumption as the primary source of 
energy…and the body’s ability to transport and utilize oxygen.”  Among diverse 
non-pregnant populations, cardiorespiratory fitness has been demonstrated to be 
inversely associated with several cardio-metabolic morbidities(118, 168) and 
mortality(25, 106). Because cardiorespiratory fitness is an attribute of an 
individual, the mechanisms that underlie its relationship with many cardio-
metabolic health outcomes are likely due to the cardiovascular(49), 
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musculoskeletal(75), and metabolic(156) adaptations that occur as a result of 
chronic exercise training. As such, higher levels of cardiorespiratory fitness have 
been demonstrated to be positively associated with metabolic health, 
characterized by improved glycemic(162) and lipidemic(147) control, insulin 
sensitivity(120) etc. As indicated in the maternal resources hypothesis, poorer 
metabolic health in pregnancy as a result of low physical activity, has been 
suggested to be the primary mechanism that leads to fetal overgrowth. Based on 
the evidence among non-pregnant populations regarding the relationship 
between cardiorespiratory fitness and metabolic health, it seems reasonable to 
speculate that pregnant women possessing a higher level of fitness may 1) 
demonstrate better metabolic health and 2) deliver infants with reduced 
birthweights compared to their lower fit counterparts. 
Cardiorespiratory Fitness in Pregnancy 
Several studies have assessed cardiorespiratory fitness in the perinatal 
period; however much of this literature has focused on three areas 1) changes in 
cardiorespiratory fitness with advancing gestation, 2) improvements in 
cardiorespiratory fitness in response to exposure to exercise training, and 3) 
responses to exercise, submaximal and maximal fitness testing among active 
and inactive women. 
Although there appears to be inconsistency in the scientific literature 
regarding the changes in cardiorespiratory fitness with advancing gestation, there 
is a suggestion that cardiorespiratory fitness is maintained(39, 54, 59, 100, 116, 
174). In support of this idea, well-documented maternal physiological adaptations 
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that occur in pregnancy mimic those achieved by chronic exercise training 
including increased cardiac output, blood and plasma volume, hematocrit and 
hemoglobin  and decreases in systemic vascular resistance(45, 81). There are 
two primary purposes to these adaptations. First, these maternal changes ensure 
that there is adequate blood flow to deliver oxygen and nutrients to the 
uteroplacental unit and fetus. Second, these alterations also make certain that 
the mother’s normal physiological function is not comprised thereby enabling her 
to continue usual activities in pregnancy. From an evolutionary perspective, if 
cardiorespiratory fitness were to decline, this may limit the mother from carrying 
out necessary tasks (e.g. activities of daily living) potentially reducing metabolic 
health and imposing adverse effects on the fetus. Additionally, reduced 
cardiorespiratory fitness may also be disadvantageous during labor and delivery 
as well as in the early postpartum period, all of which consist of energy 
demanding tasks (e.g., birth, childcare). 
Nonetheless, the ambiguity present in the literature regarding this 
relationship may be due to several factors. First, the cardiorespiratory fitness 
testing procedures differ considerably between studies including the mode of 
exercise (cycle versus treadmill), type of fitness testing (submaximal versus 
maximal), and equations used to estimate maximal oxygen consumption, which 
are often validated in non-pregnant populations. Second, significant individual 
variability exists among these studies which may in part be inherent in nature, but 
also may be due to the use of small sample sizes. Third, many studies use non-
pregnant or postpartum controls to assess changes in cardiorespiratory fitness. 
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This is problematic as 1) the control subjects used are not the same individual 
being tested, despite matching on demographic variables, and 2) with respect to 
postpartum controls, the timeframe in which pregnancy related changes (e.g., 
cardiac output, blood volume) are normalized is uncertain and varies 
considerably (e.g. 2 weeks to 52 weeks).  Lastly, a considerable majority of the 
studies assessing cardiorespiratory fitness across pregnancy are conducted 
among healthy, normal weight pregnant women, which severely limits the 
generalizability of these findings. In addition, given nearly 50% of women of 
reproductive age are overweight or obese, there is a large gap in knowledge on 
how pregnancy influences cardiorespiratory fitness in this population. This is 
particularly concerning considering the established cardio-metabolic health 
outcomes that are associated with cardiorespiratory fitness found among non-
pregnant populations(106, 168). 
Given the cardio-metabolic health outcomes associated with 
cardiorespiratory fitness, a few studies in the current literature assessed the 
effects of exercise training in pregnancy on cardiorespiratory fitness. Perales et 
al. (2016) reviewed the effects of prenatal exercise training on maternal and fetal 
health and reported that of the four high-quality randomized controlled trials that 
assessed cardiorespiratory fitness as an outcome, three found significant 
improvements in aerobic capacity(137). While these results are encouraging, not 
all exercise training studies that measured fitness were included in this review, 
and controlled studies have found that exercise did not elicit improvements in 
cardiorespiratory fitness(78). Although evidence suggests that cardiorespiratory 
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fitness is maintained in pregnancy, decrements in cardiorespiratory fitness have 
been documented among control groups in exercise training studies(47, 78, 153, 
157). Interestingly, most pregnant women participating in exercise training 
studies are healthy, potentially active and possess higher levels of fitness. This 
might suggest that when these women participate as non-exercising controls, 
they may experience some degree of detraining, which has been demonstrated 
to reduce aerobic capacity(20), as a result of detraining. Additionally, the 
maintenance of cardiorespiratory fitness in pregnancy may only apply to those 
who continue their “usual” activities in the perinatal period. 
Perales et al. (2016) concluded that the evidence regarding the positive 
effect of prenatal exercise training on cardiorespiratory fitness is strong; however, 
there are enough conflicting findings to suggest more research is needed. For 
studies reporting null effects, factors that may have attributed to these findings 
include the prescription of an insufficient exercise dose, poor compliance(117), 
small sample sizes etc. Another limitation to the evidence regarding this 
association is the limited number of studies that include overweight and obese 
pregnant women. It is encouraging however, that the few randomized controlled 
trials conducted among this population have found significant positive 
effects(144, 153, 176). In addition, it would be of great interest to evaluate how 
changes in cardiorespiratory fitness as a result of exercise training influence the 
infant health. 
Another major focus of the scientific literature with regard to 
cardiorespiratory fitness in pregnancy is its effect on responses to exercise. To 
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address this question, much of the literature has compared the responses to 
exercise testing between “fit” and sedentary pregnant women. Pivarnik et al. 
(1993) demonstrated that, in the third trimester of pregnancy, fit women had a 
higher cardiovascular respiratory efficiency in response to submaximal exercise, 
indicated by increased cardiac output, alveolar ventilation, and decreases in the 
physiological dead space-to-tidal volume ratio relative to sedentary controls(140). 
In addition, O’Neill et al. (1993), found that a given submaximal workload, trained 
pregnant women had significantly lower heart rates, and marginally significant 
increases in oxygen consumption, stroke volume and cardiac output relative to 
untrained controls(125). Moreover, Wolfe et al. (1994), reported that at peak 
exercise, aerobically conditioned pregnant women had higher power output, 
oxygen uptake and heart rate compared to a non-exercising control group(185). 
Two important concepts can be suggested based on the evidence regarding the 
relationship between prenatal cardiorespiratory fitness and responses to 
exercise. First, enhanced responses to exercise as a result of higher levels of 
cardiorespiratory fitness appear to be maintained throughout pregnancy 
compared to lower fit pregnant women. With regard to Pivarnik et al. (1993), 
because the fit women continued to engage in physical activity throughout 
pregnancy, it is difficult to discern whether the enhanced responses to exercise 
would have been maintained in pregnancy had these women not participated in 
exercise. As such, it cannot be concluded that the maintenance of these 
responses are entirely due to higher levels of cardiorespiratory fitness in 
pregnancy. However, Clapp et al. (1989) demonstrated that fit women who 
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continued a moderate-to-high intensity exercise program throughout pregnancy 
maintained their augmented response to exercise reflected by a similar oxygen 
consumption at a given submaximal workload across all three trimesters(43). 
Conversely, the enhanced responses to exercise among fit women whom 
discontinued their exercise program at the beginning of pregnancy were 
negatively attenuated, illustrated by increased oxygen consumption at a given 
submaximal workload throughout pregnancy. These findings potentially suggest 
that in order to maintain pre-pregnant cardiorespiratory fitness levels in 
pregnancy, a woman may need to continue to participate in her “usual” activities. 
Collectively, from this evidence it seems that cardiorespiratory fitness may 
be maintained throughout pregnancy, however this may be dependent on the 
change in activity level of the preconception to prenatal period. In addition, it 
appears that cardiorespiratory fitness can be improved as a result of prenatal 
exercise training. Because the exercise programs varied considerably among the 
exercise training studies, it is difficult to determine a dose that elicits an increase 
in fitness suggesting more research in this area is needed. Further, it seems that 
the enhanced responses to exercise as a result of increased fitness (e.g. cardiac 
output) are maintained in pregnancy; however, this may also be dependent on 
maternal activity in pregnancy. Lastly, a considerable limitation of this research is 
the paucity of these studies conducted among overweight and obese pregnant 
women, a population that may benefit the most from increase aerobic capacity. 
Prenatal Cardiorespiratory Fitness and Fetal Growth 
 147 
 
Given the established cardio-metabolic health outcomes associated with 
higher levels of cardiorespiratory fitness (e.g. improved glycemic/lipidemic 
control) it seems reasonable to speculate that increased aerobic capacity in the 
perinatal period may have favorable effects on infant weight status. The 
underlying mechanisms to support this hypothesis are consistent with those 
suggested in the maternal resources hypothesis whereby improved glycemic and 
lipidemic control may control nutrient supply to the infant and restricting growth to 
within normal ranges. 
While several studies have assessed cardiorespiratory fitness in 
pregnancy, a small number of studies have examined its influence on infant 
weight status. As such, the evidence for this relationship is limited. Wong et al. 
(1987) found that infants born to fit pregnant women were, on average, heavier 
(3733g vs 3680g) compared to lower-fit counterparts(186). Similarly, Errkola 
(1975) reported that trained pregnant women delivered more infants weighing 
greater than 3500g compared to lower-fit women suggesting a higher level of 
fitness was associated with increased birthweight(59). Kardel (1998) evaluated 
the effect of exercise intensity on maternal and infant outcomes among pregnant 
elite athletes(84). Pregnant women participating in the higher intensity exercise 
program resulted in higher levels of cardiorespiratory fitness and the delivery of 
larger infants (3650g vs 3590g) compared to women in the moderate intensity 
exercise program. Conversely, Clapp et al (2002) demonstrated that fit pregnant 
women continuing their exercise program into late pregnancy had lighter (3390g 
vs 3810g) and leaner (8.3% vs 12.1%) infants compared to less fit women whom 
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decreased their exercise in mid-pregnancy(42). Both Pomerance et al. (1973), 
Price et al. (2005) and Bisson (2013) found that cardiorespiratory fitness had no 
association with infant birthweight(22, 141, 144). 
Based on the current scientific literature it appears that the evidence 
regarding the effect of maternal cardiorespiratory fitness on infant weight status 
is equivocal and very limited. Several limitations may explain the present 
ambiguity. First, there was considerable variability in the fitness testing protocols 
such as the mode (cycle vs treadmill), equations used to estimate maximal 
oxygen consumption and thresholds used to determine “fit” versus “unfit.” 
Second, although evidence indicates that cardiorespiratory fitness is maintained 
during pregnancy, the timing of the fitness assessments (i.e. 1st – 3rd trimester) 
between studies was highly variable, potentially attenuating the magnitude of its 
association with infant weight status. Third, various metrics of infant weight status 
were used across the studies including birthweight, macrosomia and percent 
body fat each of which provide different information on infant anthropometry. 
Fourthly, most of these studies utilized small samples potentially increasing the 
difficulty of detecting a difference in infant weight status. Lastly, nearly all of the 
studies were conducted among normal weight samples suggesting that the 
evidence of this relationship among overweight and obese pregnant women is 
severely limited. 
The Moderating Role of Prenatal Physical Activity and Cardiorespiratory Fitness 
Given the well-documented potent effects of both physical activity and 
cardiorespiratory on cardio-metabolic health, it seems reasonable to suggest that 
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active and/or fit pregnant women may demonstrate improved metabolic control 
enabling better control of nutrient supply to the fetus thereby protecting the fetus 
from potential overgrowth. Considerable evidence has indicated that high levels 
of maternal adiposity are positively associated with the delivery of larger 
infants(69). In addition, increased adiposity has also been demonstrated to be 
associated with decreased metabolic health.  Assuming this, it may be 
hypothesized that physical activity and/or cardiorespiratory fitness may moderate 
the association between maternal adiposity and infant weight status. That is, 
physical activity and/or a higher level of cardiorespiratory fitness in the 
preconception-prenatal period may alleviate the negative effects of maternal 
adiposity on birthweight such that the fetus may be protected from overgrowth. 
Currently, to our knowledge, only two studies exist in the scientific 
literature that have assessed physical activity as a potential moderator on the 
relationship between maternal adiposity and infant weight status. Fleten et al. 
(2010) evaluated the direct and indirect associations between exercise in 
pregnancy on infant birthweight and maternal adiposity in a large Norwegian birth 
cohort(64). These authors found that exercise (at 17 and 30 weeks gestation) 
when accounting for maternal body mass index, resulted in a minor impact on 
infant birthweight. Interestingly, these authors did not explore the impact of the 
change in exercise from early to late pregnancy and the potential influence on 
birthweight. In addition, the authors did not describe in any amount of detail the 
potential moderating effect of exercise in pregnancy on the relationship between 
maternal adiposity and infant birthweight. In another study, Krogsgaard et al. 
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(2013) assessed the moderating effect of pre-pregnancy physical activity on the 
relationship between maternal adiposity and infant weight status in a Norwegian 
cohort(99). These authors found that for overweight and obese women, those 
women who reported no or low level of physical activity in the preconception 
period were more likely to give birth to a heavier neonate and had increased 
odds of delivering a macrosomic infant compared to women who reported 
participating in physical activity in the pre-pregnancy period. According to these 
authors, concluded participation in pre-pregnancy physical activity may attenuate 
the association between maternal adiposity and infant weight status. 
In the present scientific literature, no studies exist which assess the 
potential moderating effect of cardiorespiratory fitness on the association 
between maternal adiposity and infant weight status. However, assumptions 
based on evidence in non-pregnant populations may be drawn to support this 
relationship. Considerable evidence among non-pregnant populations has 
demonstrated that higher levels of cardiorespiratory fitness are inversely 
associated with several cardio-metabolic health outcomes independent of 
adiposity(106). This may suggest that higher fitness may alleviate the adverse 
effects of adiposity on metabolic health. Thus, among pregnant women it is 
hypothesized that a higher level of cardiorespiratory in pregnancy may attenuate 
the association between maternal adiposity and infant weight status. However, to 
our knowledge this has not yet been assessed in the literature. 
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Summary 
Given the high prevalence of overweight and obesity in the pregnant 
population and the robust association between maternal weight status and infant 
weight status, a strategy that enables a woman to control her metabolic 
intrauterine environment should be a public health priority. Considering the 
potent effects of physical activity and cardiorespiratory fitness on metabolic 
health, it seems reasonable to suggest that these factors influence fetal growth in 
the perinatal period. However, the evidence regarding the potential moderating 
effect of physical activity and/or fitness on the relationship between maternal 
adiposity and infant weight status is largely unknown. 
Study One 
Purpose 
The aim of this study is to determine if maternal physical activity in the 
preconception and perinatal periods modify the association between maternal 
weight status and infant weight status among a nationally representative and 
diverse sample of women delivering live-birth infants. We will address the 
purpose of this study with two objectives. In the first objective (Objective 1A), we 
will determine if prenatal physical activity modifies the association between 
maternal weight status and infant weight status. In the second objective 
(Objective 1B), we will determine if pre-pregnancy physical activity alters the 
moderating effect of prenatal physical activity on the relationship between 
maternal weight status and infant weight status. 
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Methods 
Study Design & Sampling 
The National Maternal Infant Health Survey (NMIHS), conducted by the 
National Center for Health Statistics in 1988, employed a follow-back survey 
study design. Existing data from this study will be used to address the aim of this 
study. The NMIHS sampled women who had a live birth, fetal death or infant 
death in 1988. In order to make inferences on the nationally representative 
sample, the NMIHS used a complex survey design that drew stratified samples 
from live births, fetal and infant deaths in the U.S. (except Montana and South 
Dakota), identified via registered birth and death certificates. For the purposes of 
this study, only women delivering live-birth infants will be included. Within live-
birth sampling frame, two sampling strata were formed based on the child’s race 
(Black or other than Black) and infant birthweight (<1500g, 1500-2499g, ≥2500g). 
Within each of the sampling stratum, birth certificates were sorted by maternal 
marital status and age prior to sampling. In this study, Black infants and very low-
birthweight (<1500g) and moderately low-birthweight infants were oversampled. 
Further details on the sampling procedures are provided elsewhere(152). 
Study Population & Data Collection 
A total of 13,417 live-birth infants were sampled. Mothers of these infants 
were mailed a 35-page questionnaire which inquired about prenatal care, 
maternal health habits, delivery of the infant, hospitalizations pre- and post-
delivery, previous and subsequent pregnancies, maternal and paternal 
sociodemographic characteristics and the infant’s health. The recall period, 
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defined as the time between the delivery of the infant and the receipt of the 
maternal questionnaire, was on average 17 months (6 to 32 months). Of the 
13,417 mothers who delivered a live-birth infant, 9,953 mothers responded to the 
questionnaire (74.2%). The characteristics of mothers differed among those 
whom responded and did not respond to the questionnaire. The questionnaire 
was more likely to be completed by mothers who were between 20 to 39 years, 
White, married, had fewer than four children, received early prenatal care, more 
education, and resided in the Midwest region of the U.S. Additionally, mothers of 
low birthweight infants (<2500g) were also less likely to respond. Because there 
are maternal and fetal physiologic differences between single and multiple (e.g., 
twins) pregnancies, our analyses will be further restricted to women with 
singleton pregnancies who delivered a live-birth infant (n=9089). 
Outcome Variable: Infant Birthweight 
Infant weight status will act as the primary outcome variable of interest 
and be expressed as a continuous and categorical variable. As a continuous 
outcome, infant weight status will be expressed as infant birthweight, defined as 
the weight in grams at the time of delivery. As a categorical outcome, we will use 
established cut-points in the scientific literature to identify large-for-gestational-
age infants (≥90th percentile), average-for-gestational age (11th to 89th percentile) 
and small-for-gestational age (≤10th percentile)(6). Data on infant birthweight and 
gestational age were extracted from the infant birth certificate. 
Exposure Variable: Maternal Pre-Pregnancy Body Mass Index 
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Maternal pre-pregnancy body mass index (BMI) will act as the primary 
independent variable. BMI will be calculated using the standard equation: BMI=
Weight (kg)
Height (m)2
. Maternal height was self-reported on the mother’s questionnaire in feet 
and inches as follows: “How tall are you as of now?” Because height does not 
change during pregnancy, her height at the time the questionnaire was 
administered will serve as “maternal pre-pregnancy height.” Pre-pregnancy 
weight was self-reported on the mother’s questionnaire in pounds as follows 
“What was your weight just before becoming pregnant…” For ease of 
interpretation, maternal pre-pregnancy BMI will be categorized into three groups 
using widely accepted cut-points(1) as follows: underweight (≤18.49 kg/m2), 
normal (18.50 – 24.99 kg/m2), overweight (25.00 – 29.99 kg/m2) and obese 
(≥30.00 kg/m2). 
Moderating Variables: Maternal Physical Activity 
Maternal physical activity in the preconception and perinatal periods will 
act as moderating variables. Pre-pregnancy physical activity was self-reported on 
the mother’s questionnaire by the following question: “Did you exercise or play 
sports at least three times a week before you got pregnant?…include brisk 
walking for ½ hour or more, jogging, aerobics swimming etc.” The response was 
recorded as “yes” or “no.” Prenatal physical activity will be was self-reported on 
the mother’s questionnaire by the following question: ““Did you exercise or play 
sports at least three times a week after you got pregnant?…include brisk walking 
for ½ hour or more, jogging, aerobics swimming etc.” The response was 
recorded as “yes” or “no.” Additionally, in order to quantify a dose of prenatal 
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physical activity, we will use the following question: “How many months of this 
pregnancy did you exercise or play sports at least 3 times per week?” The 
response format was 0 to 10 months.  While we acknowledge that these 
questions specifically refer to ‘exercise’ in the preconception and prenatal 
periods, we surmise that the information provided with regard to this behavior is 
more reflective of ‘physical activity.’ As such, we will use the term ‘physical 
activity’ when referring to this behavior. 
Maternal Covariates 
Demographics 
Maternal demographic characteristics that may be considered potential 
covariates include age and race/ethnicity. These data were self-reported and 
extracted from the birth certificate and mother’s questionnaire, respectively. 
Maternal age was reported in number of years. Race was reported in the 
following groups: White, Black, Asian or Pacific Islander or Other. For ethnicity, 
mothers indicated whether they were from Spanish or Hispanic origin or 
ancestry. Responses were recorded as “yes” or “no.” Racial and ethnic groups 
will be collapsed into the following categories: Non-Hispanic White, Non-Hispanic 
Black, Hispanic and Other. 
Pregnancy-Related Covariates 
Maternal pregnancy-related characteristics that may be considered 
potential covariates include net gestational weight gain and parity. Net 
gestational weight gain will be calculated using three variables: pre-pregnancy 
weight, weight just prior to delivery and infant birthweight. Weight gain variables 
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were self-reported in pounds and were retrieved from the mother’s questionnaire. 
Infant birthweight was extracted from the birth certificate. Gestational weight gain 
will be calculated by first subtracting pre-pregnancy weight from weight just prior 
to delivery to determine gestational weight gain. 
Maternal Behaviors 
Maternal behaviors that may be considered potential covariates include 
smoking status and alcohol use. These data were self-reported and extracted 
from the mother’s questionnaire. Smoking status and alcohol use were 
determined by whether or not the mother smoked and/or drank in the last 12 
months before delivery. Responses were recorded separately, in a “yes” or “no” 
format. 
Infant Covariates 
Infant characteristics that may be considered potential covariates include 
sex and gestational age. Data on infant sex and gestational age were extracted 
from the birth certificate. Sex of the infant was recorded as male or female. 
Gestational age was reported in weeks. The method used to calculate 
gestational age likely varied but may have included last menstrual period or 
physician’s estimate (e.g. ultrasound or Dubowitz/Ballard). 
Statistical Analyses 
To determine if pre-pregnancy and prenatal physical activity influence the 
relationship between maternal weight status and infant weight status, multiple 
linear and multinomial logistic regression analyses will be performed. The only 
difference between these two analyses is the expression of the outcome variable 
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(infant weight status). In the multiple linear regression analyses, infant weight 
status will be expressed continuously as birthweight in grams. In the multinomial 
logistic regression analyses, infant weight status will be expressed as a 
categorical variable with three levels: large-for-gestational age (LGA), average-
for-gestational age (AGA) and small-for-gestational age (SGA). AGA will act as 
the referent group. For both analyses, the expressions of the primary 
independent, moderating and covariate variables and the model building steps 
will be identical. 
Study Variables 
For all the analyses the following variables will be expressed categorically: 
maternal body mass index (four levels: underweight, normal weight [referent], 
overweight, and obese), pre-pregnancy and prenatal physical activity (two levels: 
yes and no [referent]), maternal race/ethnicity (four levels: Non-Hispanic White 
[referent], Non-Hispanic Black, Hispanic, and Other), smoking and alcohol status 
(two levels: yes and no [referent]), and infant sex (two levels: male [referent] and 
female). The following variables will be expressed continuously: physical activity 
dose (number of months), maternal age (years), net gestational weight gain 
(pounds), and gestational age (weeks). 
Model Building 
All statistical models will be built in the following stages. (1) Bivariate 
associations will be assessed between all the predictor variables (i.e. 
independent, moderating and covariates) and both expressions of the outcome 
variable. (2) The crude association between maternal body mass index and 
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infant weight status will be examined with a bivariate association and 
assumptions of the statistical methods will be assessed (e.g. linearity, normality). 
(3) To assess the main effect of prenatal physical activity, this variable will be 
entered into the model with the maternal body mass index. (4) To determine the 
unadjusted moderating effect of prenatal physical activity, an interaction term 
between maternal body mass index and prenatal physical activity will be entered. 
(5) Maternal and infant covariates will then be individually added to the model. 
To determine if pre-pregnancy physical activity alters the impact of prenatal 
physical activity on the association between maternal body mass index and infant 
weight status, steps 3 through 5 will be repeated to build a new model inclusive 
of this variable. That is, pre-pregnancy physical activity will first be added the 
unadjusted model (from step 3) as a main effect. Then, the interaction between 
prenatal physical activity and maternal BMI will be added (see step 4). To 
address the moderating effect of pre-pregnancy physical activity a three-way 
interaction term will be generated. However, before this, two additional two-way 
interactions must also be entered into to the unadjusted model, 1) maternal BMI 
and pre-pregnancy physical activity, and 2) pre-pregnancy and prenatal physical 
activity. The two-way interactions will be entered individually, followed by a three-
way interaction between pre-pregnancy physical activity, maternal BMI and 
prenatal physical activity. Lastly, maternal and infant covariates will be added 
separately. 
In addition, the NMIHS employed a complex survey design in order to collect a 
nationally, representative sample of registered births (and deaths) of infants born 
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to mothers in the U.S. in 1988. Weights were generated to account for this study 
design and allow for inferences to be made on the population level. As such, 
weights will be used in all statistical analyses. All statistical analyses will be 
performed in SAS, using PROC SURVEYREG and SURVEYLOGISTIC (version 
9.4). An alpha level of 0.05 will be used to denote statistical significance for all 
analyses. For multiple linear regression analyses, mean regression coefficients 
(β) and their respective 95% confidence intervals will be estimated. For 
multinomial logistic regression analyses, odds ratios and the corresponding 95% 
confidence intervals will be calculated. 
Study 2 
Purpose 
The aim of this study is to determine the effect of maternal 
cardiorespiratory fitness and objectively-measured physical activity on infant 
weight status in a sample of overweight and obese pregnant women. We will 
address this study with three objectives. In the first objective (Objective 2A), we 
will evaluate the independent association between cardiorespiratory fitness in 
mid-pregnancy on infant weight status. In the second objective (Objective 2B), 
we will examine the independent association between objectively-measured 
physical activity in the perinatal period and infant weight status. In the third 
objective (Objective 2C), we will assess the joint association of maternal 
cardiorespiratory fitness and objectively-measured physical activity in the 
perinatal period and infant weight status. 
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Methods 
Study Design 
To address the aim of this study, data from a randomized comparative trial 
(RCT) conducted between November 2001 and July 2006 will be used(190). 
Briefly, the primary purpose of the RCT was to examine the effects of moderate 
intensity exercise during pregnancy on the incidence of preeclampsia and the 
pathophysiological progress of preeclampsia (e.g. oxidative stress). Secondary 
outcomes of the exercise trial included maternal weight gain and birth outcomes. 
Participant Eligibility & Recruitment 
Pregnant women were recruited from nine prenatal clinics under two 
medical care systems in Michigan. From 14 to 17 weeks of gestation, a run-in 
period was conducted with weekly lab visits that consisted of a medical record 
review, cardiorespiratory fitness test, survey administration and a thorough 
explanation of the exercise trial. 
In order to be eligible for the exercise trial pregnant women were: 1) less 
than 14 weeks gestation, 2) diagnosed with preeclampsia in a previous 
pregnancy, 3) had a peak oxygen consumption ≤ 50th percentile of women in 
their respective age-group, 4) participated in a sedentary lifestyle or had a self-
reported energy expenditure of < 840 kcals per day. Pregnant were excluded 
from the exercise trial if they: 1) were diagnosed with chronic hypertension or 
pre-gestational diabetes, 2) had medical or physical limitations that prevented 
them from participating in exercise, 3) were instructed not to exercise during 
pregnancy by a physician or 4) were unable to communicate with research staff 
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due to low mental acuity or unable to speak English. A total of 210 women 
agreed to participate in the study and 41% (n=86) of these women were excluded 
during the run-in period. 
Randomization and Intervention Groups 
After the four-week run-in period (18 weeks of gestation), 124 participants 
were randomly allocated to the intervention group (n= 64) or comparative group 
(n=60) using a random numbers table. The intervention group consisted of a 
walking exercise program. Participants in this group were instructed to walk for 
40 minutes, five times per week at a moderate intensity (55-69% maximum heart 
rate). In the comparative group, participants engaged in a stretching program of 
equivalent frequency and duration of the exercising group, however were 
instructed to not exceed a 10% increase in resting heart rate. Stretching sessions 
consisted of the women following stretching movements delivered via a 
videotape. All participants wore Polar S810 heart rate monitors to validate their 
adherence to the exercise or stretching programs. In addition, women wore 
wristwatch devices to enable them to track their heart rates during exercise or 
stretching sessions to monitor their target heart rates. Target heart rates were 
calculated using the Karvonen formula(85) for the desired exercise intensities. 
Outcome Variable: Infant Weight Status 
Infant weight status will act as the primary outcome variable of interest 
and be expressed as a continuous and categorical variable. As a continuous 
outcome, infant weight status will be expressed as infant birthweight, defined as 
the weight in grams at the time of delivery. As a categorical outcome, we will use 
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established cut-points in the scientific literature to identify large-for-gestational-
age infants (≥90th percentile), average-for-gestational age (11th to 89th percentile) 
and small-for-gestational age (≤10th percentile)(7). Data on infant birthweight and 
gestational age were extracted from medical records. 
Exposure Variables: Cardiorespiratory Fitness and Physical Activity 
Cardiorespiratory Fitness 
Cardiorespiratory fitness (CRF) will act as a primary exposure variable 
and be expressed as a continuous variable. CRF was defined as peak oxygen 
consumption (V̇O2peak) which was estimated via a submaximal treadmill test. CRF 
was assessed twice, at 17 and 28 weeks of gestation. The exercise testing 
followed the Cornell Exercise Protocol(129). This protocol consisted of walking 
on a treadmill through eight, two-minute stages with progressive increments in 
speed and grade. Prior to the initiation and throughout the exercise test, heart 
rate, blood pressure, fatigue, oxygen consumption, carbon dioxide production 
and minute ventilation were continuously monitored. The metabolic and 
respiratory markers were assessed using a portable indirect calorimeter 
(VO2000, Medical Graphics Corporation, Minneapolis, MN), which has been 
previously validated in a sample of sedentary pregnant women(191). Heart rate 
was measured using a Polar S810 heart rate monitor (Warminster, PA) and 
blood pressure was assessed using a standard sphygmomanometer. Fatigue 
was measured using the Borg’s Scale of Rating of Perceived Exertion(126). 
The exercise test was terminated if one of the following criteria is achieved: 1) an 
RPE of 13 to 14, 2) the participant’s heart rate fell between values that 
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correspond to their 85% target heart rate and 85% age-predicted max heart rate, 
3) participant request to terminate, or 4) diastolic blood pressure increases more 
than 10 mmHg. V̇O2peak was determined by the highest amount of oxygen 
consumed during the exercise test. V̇O2peak was expressed relative to 
participants’ body weight as milliliters of oxygen per kilogram per minute (mL 
O2∙kg-1∙min-1). 
Physical Activity 
Physical activity will be the primary exposure variable and be expressed 
as a continuous variable. Daily physical activity was measured using a 
pedometer (Digiwalker SW200) worn on the participants’ waist. The participants 
were instructed to wear the pedometer during waking hours and to remove them 
during sleep and any water-based activities (e.g., showering, swimming). 
Additionally, the participants were asked to keep a log of their total daily step 
counts. The pedometers were distributed to the participants at 18 weeks of 
gestation and were retrieved at the end of pregnancy (prior to delivery). For the 
purposes of this study, total daily steps counts will be averaged across all the 
available days for each participant to provide an estimate of average daily 
physical activity. 
Covariate Variables: Maternal and Infant Characteristics 
Maternal and infant characteristics that may be considered potential 
covariates include: maternal body mass index (BMI), maternal age, gestational 
weight gain (GWG), gestational age and group allocation. Maternal BMI will be 
calculated using the standard equation: BMI=
Weight (kg)
Height (m)2
. Due to the considerable 
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missing data for the self-reporting of pre-pregnancy weight (39%), both maternal 
height and weight at 17 weeks of gestation will be used to calculate BMI. Height 
and weight were objectively measured during a research lab visit using a 
standard stadiometer and balance beam scale, respectively. Maternal age and 
gestational age were extracted from the participants’ medical records. Because 
the exposure of this intervention trial was exercise, which may influence some of 
the primary independent variables and the outcome variable, we will control for 
group allocation. 
In the scientific literature, GWG is often calculated using self-reported pre-
pregnancy weight and weight recorded just prior to delivery. Although both of 
these variables are available, a significant proportion of these data are missing, 
39% and 38%, respectively. As such, GWG will be calculated using three 
alternative weight variables: weight measured at 17 and 28 weeks gestation and 
infant birthweight as follows [((weight28weeks – weight17weeks) + birthweight)]. In the 
3rd trimester of pregnancy, fetal growth continues to accelerate and a large 
proportion of the weight gained is attributable to the weight of the fetus. Because 
the weight gained during weeks 17 and 28 only capture the beginning of third 
trimester (weeks 26 to 40), we will add infant birthweight (in pounds) to the 
weight gained between weeks 17 and 28 as a surrogate measure for maternal 
gestational weight gain. We recognize that weight may be gained in the first 
trimester, however only minimal amounts have been documented and 
consequently we may underestimate GWG. 
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To determine whether our calculation would be an appropriate representation of 
maternal weight gain, we compared it to another GWG method which utilized the 
limited data available on weight just prior to delivery [(weight delivery – weight17 
weeks)]. We calculated the difference between these two measures as follows: 
((weight28weeks – weight17weeks + birthweight) – (weight delivery – weight17 weeks)). We 
then computed the average of these differences, in pounds. The average 
difference between these measures was -2.62 lbs. That is, our measure of GWG, 
underestimated weight gain, on average, by 2.62 lbs. Based on what appears to 
be a minimal difference between these two measures, we will use the alternative 
measure of GWG in order to maximize all available data. 
Statistical Analysis 
To determine the effect of maternal cardiorespiratory fitness and prenatal 
physical activity on infant weight status, multiple linear and multinomial logistic 
regression analyses will be performed. The only difference between these two 
analyses is the expression of the outcome variable (infant weight status). In the 
multiple linear regression analyses, infant weight status will be expressed 
continuously as birthweight in grams. In the multinomial logistic regression 
analyses, infant weight status will be expressed as a categorical variable with 
three levels: large-for-gestational age (LGA), average-for-gestational age (AGA) 
and small-for-gestational age (SGA). AGA will act as the referent group. For both 
analyses, the expressions of the primary independent and covariate variables 
and the model building steps will be identical. 
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Study Variables 
For all the analyses the following variables will be expressed continuously: 
cardiorespiratory fitness (ml O2/kg/min), prenatal physical activity (steps per 
week), maternal body mass index (kg/m2), maternal age (years), gestational 
weight gain (pounds), and gestational age (weeks). Group allocation (two levels: 
intervention and control) will be expressed as a categorical variable. 
Model Building 
All statistical models will be built in the following stages. (1) Bivariate 
associations will be assessed between all the predictor variables (i.e. 
independent and covariates) and the both expressions of the outcome variable. 
(2) To assess the independent effects of the primary independent variables (i.e. 
cardiorespiratory fitness and physical activity) on infant weight status, will be 
assessed with a bivariate analysis in separate models. (3) Maternal and infant 
covariates will then be individually added to each model. 
To determine the joint effect of cardiorespiratory fitness and physical 
activity, we will create an interaction term between cardiorespiratory fitness and 
physical activity. Prior to examining the interaction between cardiorespiratory 
fitness and physical activity, we will include cardiorespiratory fitness as a main 
effect in the unadjusted model (from step 2). After this, we enter the interaction. 
Maternal and infant covariates will then be added individually to each model. This 
analysis will be carried out separately with both expressions of infant weight 
status. Given that participants in this sample have a cardiorespiratory fitness 
level ≤50th percentile of their respective age-group, we will retain 
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cardiorespiratory fitness as a continuous variable to avoid further reducing the 
variability in this variable. If the interaction term is significant, we will then assess 
the effect of physical activity on infant weight status on varying levels of 
cardiorespiratory fitness by generating estimate statements. Because there are 
no established standards for cardiorespiratory fitness in pregnant women, we will 
select fitness levels for the estimate statements that correspond to values at the 
25th, 50th and 75th percentiles. We will use these values and compare the 
differences in the slopes for the effect of physical activity on infant weight status 
between the selected cardiorespiratory fitness levels.  For all analyses statistical 
significance will be determined at an alpha level of 0.05. For multiple linear 
regression analyses, mean regression coefficients (β) and their respective 95% 
confidence intervals will be estimated. For multinomial logistic regression 
analyses, odds ratios and the corresponding 95% confidence intervals will be 
calculated. 
Study 3 
Purpose 
The aim of this study is to determine the effect of change in prenatal 
physical activity and cardiorespiratory fitness on infant weight status in a sample 
of overweight and obese pregnant women. We will address this study with two 
objectives. In the first objective (Objective 3A), we will evaluate the association 
between the change in prenatal physical activity and infant weight status. In the 
second objective (Objective 3B), we will examine the potential moderating effect 
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of cardiorespiratory fitness on the association between prenatal physical activity 
and infant weight status. 
Methods 
Study Design 
To address the aim of this study, the same data from the randomized 
comparative trial (RCT) in Study Two will be used. Briefly, the primary purpose of 
the RCT was to examine the effects of moderate intensity exercise during 
pregnancy on the incidence of preeclampsia (PE) and the pathophysiological 
progress of preeclampsia (e.g. oxidative stress). Secondary outcomes of the 
exercise trial included maternal weight gain and birth outcomes(190). 
Participant Eligibility & Recruitment 
Pregnant women were recruited from nine prenatal clinics under two 
medical care systems in Michigan. From 14 to 17 weeks of gestation, a run-in 
period was conducted with weekly lab visits that consisted of a medical record 
review, cardiorespiratory fitness test, survey administration and a thorough 
explanation of the exercise trial. 
In order to be eligible for the exercise trial pregnant women were: 1) less 
than 14 weeks gestation, 2) diagnosed with PE in a previous pregnancy, 3) had a 
peak oxygen consumption ≤ 50th percentile of women in their respective age-
group, 4) participated in a sedentary lifestyle or had a self-reported energy 
expenditure of < 840 kcals per day. Participant exclusion criteria are detailed in 
Study Two.  A total of 210 women agreed to participate in the study and 41% of 
these women were excluded during the run-in period. 
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Randomization and Intervention Groups 
After the four-week run-in period (18 weeks of gestation), 124 participants were 
randomly allocated to the exercise intervention group (n= 64) or comparative 
[stretching] group (n=60) using a random numbers table. Further details on the 
exercise and comparative groups are provided in Study Two. 
Outcome Variable: Infant Weight Status 
Infant weight status will act as the primary outcome variable of interest 
and be expressed as a continuous and categorical variable. As a continuous 
outcome, infant weight status will be expressed as infant birthweight, defined as 
the weight in grams at the time of delivery. As a categorical outcome, we will use 
established cut-points in the scientific literature to identify large-for-gestational-
age infants (≥90th percentile), average-for-gestational age (11th to 89th percentile) 
and small-for-gestational age (≤10th percentile)(7). Data on infant birthweight and 
gestational age were extracted from medical records. 
Exposure Variable: Physical Activity 
Physical activity will also act as a primary exposure variable and be 
expressed as continuously. Daily physical activity was measured objectively 
using a pedometer (Digiwalker SW200) worn on the participants’ waist. The 
participants were instructed to wear the pedometer during waking hours and 
were to be removed during sleep and any water-based activities (e.g., showering, 
swimming). Additionally, the participants were asked to keep a log of their total 
daily step counts. The pedometers were distributed to the participants at 18 
weeks of gestation and were retrieved at the end of pregnancy (prior to delivery). 
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For the purposes of this study, an average change score in physical activity will 
be calculated (for details see Statistical Analysis section). 
Moderating Variable: Cardiorespiratory Fitness 
Cardiorespiratory Fitness 
Cardiorespiratory fitness (CRF) will act as a moderating variable and be 
expressed as a continuous variable. CRF was defined as peak oxygen 
consumption (V̇O2peak) which was estimated via a submaximal treadmill test. CRF 
was assessed twice, at 17 and 28 weeks of gestation. V̇O2peak was expressed 
relative to participants’ body weight as milliliters of oxygen per kilogram per 
minute (mL O2∙kg-1∙min-1).  Given that CRF has been demonstrated to remain 
constant throughout pregnancy, we will average the CRF values at 17 and 28 
weeks gestation to represent the ‘average prenatal CRF level.’ For further 
methodological details on the CRF testing, please refer to the Methods section in 
Study Two. 
Covariate Variables: Maternal and Infant Characteristics 
Maternal and infant characteristics that may be considered potential 
covariates include: maternal body mass index (BMI), maternal age, gestational 
weight gain (GWG), gestational age, group allocation and baseline physical 
activity. Maternal BMI will be calculated using the standard equation: BMI=
Weight (kg)
Height (m)2
 . Due to the considerable missing data for the self-reporting of pre-
pregnancy weight (39%), both maternal height and weight at 17 weeks of 
gestation will be used to calculate BMI. Height and weight were objectively 
measured during a research lab visit using a standard stadiometer and balance 
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beam scale, respectively. Maternal age and gestational age were extracted from 
the participants’ medical records. Because the exposure of this intervention trial 
was exercise, which may influence some of the primary independent variables 
and the outcome variable, we will control for group allocation. 
In the scientific literature, GWG is often calculated using self-reported pre-
pregnancy weight and weight recorded just prior to delivery. Although both of 
these variables are available, a significant proportion of these data are missing, 
39% and 38%, respectively. As such, GWG will be calculated using three 
alternative weight variables: weight measured at 17 and 28 weeks gestation and 
infant birthweight as follows [((weight28weeks – weight17weeks) + birthweight)]. For 
further details on the calculation of this variable, please see the Methods section 
in Study Two. 
Statistical Analysis 
To determine the effect of maternal cardiorespiratory fitness and change 
in prenatal physical activity on infant weight status, multiple linear and 
multinomial logistic regression analyses will be performed. The only difference 
between these two analyses is the expression of the outcome variable (infant 
weight status). In the multiple linear regression analyses, infant weight status will 
be expressed continuously as birthweight in grams. In the multinomial logistic 
regression analyses, infant weight status will be expressed as a categorical 
variable with three levels: large-for-gestational age (LGA), average-for-
gestational age (AGA) and small-for-gestational age (SGA). AGA will act as the 
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referent group. For both analyses, the expressions of the primary independent 
and covariate variables and the model building steps will be identical. 
Change in Prenatal Physical Activity 
To best represent the change in the observed patterns of physical activity 
behavior, we will calculate a change score that maximizes the available data. 
Prenatal physical activity was measured daily via pedometry from week 18 of 
gestation until delivery, and is expressed as step counts. We will calculate the 
change in step counts through a series of stages. First, we will collapse daily step 
counts into average weekly steps counts for each individual. Second, we will then 
calculate a baseline level of physical activity by averaging weekly step counts for 
the first four weeks of measurement (i.e. 18 to 22 weeks). Using a four-week 
measurement period may provide some advantages including accounting for 
changes in behavior due to reaction to the device and providing a more accurate 
representation of physical activity behavior. Also, during this four-week period, 
gestational weight gain has not yet accelerated, which may influence levels of 
physical activity and thus, minimal changes in physical activity patterns will likely 
have occurred. Third, we will create five, four-week periods (22 to 26 weeks, 26 
to 30 weeks, 30 to 34 weeks, 34 to 38 weeks, and 38 to 42 weeks) and for each 
we will compute the average weekly step counts. Fourth, we will then determine 
the average change (or difference) in step counts between each of these five 
periods and baseline physical activity levels. Based on previous scientific 
literature, we will assume that the change in physical activity may differ between 
trimesters, with the largest declines occurring in the third trimester. As such, we 
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will initially create two “physical activity change variables,” one for the second 
trimester (weeks 22 to 26) and another for the third trimester (weeks 26 to 42).  
In addition, it is possible that within the third trimester, the changes in the 
average weekly steps across the remaining four periods may differ considerably. 
As a result, we will examine the four periods of the third trimester to determine if 
large differences in the changes in average weekly step counts are present. A 
10% difference between the monthly periods will be considered a “large” 
difference. If no large differences are present, then all four periods will be 
collapsed and an average weekly step count for the entire third trimester will be 
calculated. In the case where large differences exist, then an additional physical 
activity change variable in the third trimester may be created. 
Study Variables 
For all the analyses the following variables will be expressed continuously: 
changes in prenatal physical activity in the second trimester and third trimester 
(steps per week), baseline physical activity (steps per week), cardiorespiratory 
fitness (ml O2/kg/min), maternal body mass index (kg/m2), maternal age (years), 
gestational weight gain (pounds), and gestational age (weeks). Group allocation 
(two levels: intervention and control) will be expressed as a categorical variable. 
Model Building 
All statistical models will be built in the following stages and performed 
separately with each expression of infant weight status. (1) Bivariate associations 
will be assessed between all the predictor variables (i.e. independent, moderator 
and covariates). (2) Because there will be more than one variable that represents 
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change in physical activity (i.e. 2nd and 3rd trimesters), each variable will be 
entered individually into the model, beginning with the change in the 2nd 
trimester. This will assess the unadjusted effect s of changes in prenatal physical 
activity on infant weight status. (3) Maternal and infant covariates will then be 
individually added to each model. 
Next, to determine the moderating effect of cardiorespiratory fitness on the 
relationship between changes in prenatal physical activity on infant weight status, 
we will create an interaction term between cardiorespiratory fitness and each 
change in physical activity variable. Prior to examining the interaction, we will 
thoroughly assess the relationships between these variables in the subsequent 
stages. (1) We will first examine the unadjusted main effects of cardiorespiratory 
fitness and change in physical activity in the 2nd trimester on infant weight status. 
(2) We will assess the unadjusted main effects of cardiorespiratory fitness and 
change in physical activity in the 3rd trimester on infant weight status. (3) We will 
then examine the unadjusted main effects of cardiorespiratory fitness and the 
changes in physical activity in the 2nd and 3rd trimesters, added sequentially. (4) 
Using the model from step 3, we will enter an interaction term between 
cardiorespiratory fitness and change in physical activity in the 2nd trimester. (5) 
Using the model from step 4, we will add another interaction term between 
cardiorespiratory fitness and change in physical activity in the 3rd trimester. (6) 
Maternal and infant covariates will then be added individually to each model. 
Given that participants in this sample have a cardiorespiratory fitness level ≤50th 
percentile of their respective age-group, we will retain cardiorespiratory fitness as 
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a continuous variable to avoid further reducing the variability in this variable. If 
the interaction term is significant, we will then assess the effect of physical 
activity on infant weight status on varying levels of cardiorespiratory fitness by 
generating estimate statements. Because there are no established standards for 
cardiorespiratory fitness in pregnant women, we will select fitness levels for the 
estimate statements that correspond to values at the 25th, 50th and 75th 
percentiles. We will use these values and compare the differences in the slopes 
for the effect of changes in physical activity in the 2nd and 3rd trimesters on infant 
weight status between the selected cardiorespiratory fitness levels.  For all 
analyses, statistical significance will be determined at an alpha level of 0.05. For 
multiple linear regression analyses, mean regression coefficients (β) and their 
respective 95% confidence intervals will be estimated. For multinomial logistic 
regression analyses, odds ratios and the corresponding 95% confidence intervals 
will be calculated.  
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